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Abstract
Having a child diagnosed with a chronic illness such as epilepsy is a major source of
stress for caregivers. Up to half of mothers of children with epilepsy are at increased
risk for clinical depression and symptoms of maternal depression are associated
with poorer health outcomes in these children. The purpose of this study was to: 1)
estimate the prevalence and course of depressive symptoms over 24 months among
mothers of children with new-onset epilepsy; 2) identify subgroups of mothers that
share similar trajectories of depressive symptoms; and, 3) assess the family factors
involved in the causal pathway between maternal depressive symptoms and child
health-related quality of life.
The data for this study originated from the Health-related Quality of Life of Children
with Epilepsy Study (HERQULES), a national prospective cohort study designed to
examine the determinants of health-related quality of life in children with epilepsy
during the first 24 months after diagnosis. A total of 339 mothers participated in the
study. Depressive symptoms were measured using the Center for Epidemiological
Studies Depression Scale and health-related quality of life was measured with the
Quality of Life in Childhood Epilepsy. Maternal, child, and family factors were
measured using valid and reliable measures with a proven track record of use in this
population. Multiple regression was utilized to test whether depressive symptoms
affected mothers’ reports of child outcomes. Latent class growth modeling and
multinomial logistic regression were used to identify trajectories of depressive
symptoms and predictors of trajectory group membership, respectively. Individual
growth curve modeling was used to examine the impact of maternal depressive
symptoms on child health-related quality of life, including the moderating and
mediating effects of the family environment.
Depressive symptoms were not observed to affect mothers’ reports of child healthrelated quality life in this sample. Four distinct trajectories of depressive symptoms
were observed: low stable, borderline, moderate increasing, and high decreasing. A
iii

unique set of predictors was found for membership in each trajectory group.
Maternal depressive symptoms were found to have a negative impact on child
health-related quality of life during the 24 month follow-up. This relationship was
moderated by family resources and the magnitude of moderation varied over time.
The relationship between depressive symptoms and health-related quality of life
was mediated by family functioning and family demands.

Keywords: child, depression, depressive symptoms, epilepsy, family environment,
family-centered care, growth curve modeling, health-related quality of life,
longitudinal study, mother, trajectory modeling
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Chapter One
Introduction and Research Objectives
Background
Estimates of depression are typically derived from depression rating scales
designed to measure psychological distress or by clinician interview involving
assessment with standardized instruments based upon diagnostic criteria from the
Diagnostic and Statistical Manual of Mental Disorders.1 Instruments that screen for
psychological distress are most often self-report measures used to estimate the
levels of depressive symptoms in the general population.2 In contrast, clinical
depression is characterized by a departure from normal functioning and the
occurrence of at least five distinct depressive symptoms present during the same
two-week period; symptoms must include the presence of a depressed mood and/or
loss of interest or pleasure in activities, and may include disturbances in sleep,
appetite, energy, motor activity, and concentration, feelings of worthlessness and
guilt, and suicidal ideation. While measures of depressive symptoms do not provide
a clinical diagnosis of depression, individuals who score above a given threshold are
likely at increased risk for clinical depression.3
Maternal depression is a universal term encompassing a range of depressive
symptoms and syndromes that may affect women during the prenatal period,
immediately after childbirth, or later during their child’s growth through to
adolescence.4 For women in their reproductive years, the prevalence rate of
depression ranges from 8% to 47%, making it the leading cause of disease burden
within this population.5-13 As well, researchers have shown that mothers of disabled
or chronically ill children generally experience a higher rate of depression
compared to mothers of healthy children. In a recent meta-analysis conducted by
Singer, between 6% and 24% more mothers of children with developmental
disabilities scored above clinical cutoffs for depression compared to mothers of
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children without developmental disabilities.14 While considerable research has been
conducted to understand depression among mothers of developmentally disabled
children, very little research has been conducted in other childhood neurological
conditions, including epilepsy.
Epilepsy is one of the most common neurological illness affecting children, with an
estimated prevalence of 5/1000 children and incidence of 40-50/100,000 children
per year in developed countries.15 Epilepsy is not a single, distinct condition;
instead, it is a heterogeneous family of disorders having in common an abnormally
increased predisposition to seizures.16,

17

Recent evidence suggests that many

children with epilepsy experience increased rates of psychosocial18-20 and
cognitive21-23 problems that can reduce their health-related quality of life. As well,
children with epilepsy have increased mortality and sudden death compared to
healthy children.24-26 Despite a marked improvement in the treatment of childhood
epilepsy with novel therapeutics and surgical techniques, many children never
achieve clinical remission24,

27, 28

and many adverse consequences of childhood

epilepsy continue into adulthood.29-31
Similar to other childhood chronic illnesses, the impact of epilepsy is not limited to
the child experiencing seizures, but affects all members of the family to a certain
degree.32-34 Hoare and Kerley observed that compared to control families, families
with a child with epilepsy experienced significantly more stress, anxiety, and
restrictions in family life.33 Thompson and Upton demonstrated that families with a
child with epilepsy had increased levels of stress and dissatisfaction with their
social situation, decreased levels of marital satisfaction, and low perceived
support.34 In a recent review by Rodenburg et al., families with a child with epilepsy
experienced parent-child relationships of lower quality, less competence in
parenting, and more problems with family functioning and adaptation compared to
control families.35
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Since mothers are most often the primary caregivers of children,36 it is reasonable to
assume that mothers may experience most of the psychological disturbances in
response to their children’s epilepsy. Despite results showing some evidence
supporting this hypothesis,37, 38 no one study adequately focuses on parent mental
health status, specifically, maternal depressive symptoms in this population. In
particular, little is known about the prevalence and predictors of maternal
depressive symptoms and how maternal depressive symptoms may impact the
health-related quality of life of a child newly-diagnosed with epilepsy and which
family factors potentially moderate or mediate this proposed causal relationship.
The causal mechanisms underlying intra-family interactions are important in
identifying potential targets for intervention in order for paediatric neurology
healthcare professionals to provide optimal family-centered care.
Research Objectives
The wide recognition of the impact of a chronically ill child on the family, especially
the mother, challenges paediatric healthcare professionals to develop better familycentered care. Within this context, the aims of this research were to prospectively
estimate the prevalence and course of depressive symptoms among mothers of
children with newly-diagnosed epilepsy seen by a paediatric neurologist across
Canada, identify predictors of maternal depressive symptoms, and assess the causal
mechanisms that describe the impact of maternal depressive symptoms on the
health-related quality of life of children with epilepsy. Specific objectives for the
proposed study were to:
1. Estimate the prevalence and course of depressive symptoms over 24 months
among mothers of children with new-onset epilepsy.
a. What is the prevalence of elevated depressive symptoms among mothers
at baseline, and 6, 12, and 24 months after the child’s diagnosis of
epilepsy?
b. How do depressive symptom trajectories change over time?
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2. Identify subgroups of mothers that share similar trajectories of depressive
symptoms and assess maternal, child, and family factors associated with group
membership.
a. What subgroups of mothers share trajectories of depressive symptoms?
b. What maternal, child, and family factors predict depressive symptom
trajectory group membership?
3. Assess the family factors involved in the causal pathway between maternal
depressive symptoms and child health-related quality of life over 24 months and
the extent to which family factors moderate or mediate this relationship.
a. Do changes in maternal depressive symptoms predict changes in child
health-related quality of life?
b. Do family resources moderate the relationship between maternal
depressive symptoms and child health-related quality of life?
c. Does perception of patient-centered care moderate the relationship
between maternal depressive symptoms and child health-related quality
of life?
d. Does family functioning mediate the relationship between maternal
depressive symptoms and child health-related quality of life?
e. Do family demands mediate the relationship between maternal
depressive symptoms and child health-related quality of life?
Prior to examining the specific research objectives for this study, a methodological
issue central to the analyses was identified. Given that much of the data collected in
the study was obtained via maternal reports, an investigation to determine whether
mothers of children with new-onset epilepsy exhibiting depressive symptoms
provide accurate reports of child outcomes was conducted. The specific question
asked was, “Do depressive symptoms moderate the relationship between mothers’
and neurologists’ reports of children’s health-related quality of life?”

5
Conceptual Framework
The theoretical framework used to guide this research was adapted from Pearlin’s
stress process model and is illustrated in Figure 1.1.39, 40 This framework is rooted in
both social stress theory and empirical findings from the medical sociology
literature.40, 41 It has a strong track record of use in epidemiologic research and has
been used in an variety of studies examining psychological disturbances in several
populations.42-46 As stated by Turner and Lloyd, the stress process identifies and
specifies the inter-relationships among experiences and social and personal
resources hypothesized as relevant to a health outcome.46 It is through these
relationships that researchers are able to elucidate the causal mechanisms between
a specific stressor and outcome and identify potential targets for intervention so as
to negate the negative effect a stressor may have on an individual’s health.
According to this particular model, the stress process consists of primary stressors
(i.e., diagnosis of childhood epilepsy, living with childhood epilepsy), secondary
stressor (i.e., maternal depressive symptoms), stress mediators (i.e., family demands
and functioning), stress moderators (i.e., family resources, perception of patientcentered care), a stress outcome (i.e., child health-related quality of life), and
various potential confounders (e.g., child and maternal age, marital status,
socioeconomic status, etc.) influencing the process.
Stressors can appear in two common forms: life events and chronic strains. Life
events are classified as having a discrete, identifiable point in time at which it
occurred (e.g., diagnosis of childhood epilepsy), whereas chronic stressors are more
likely to emerge insidiously and be persistent (e.g., living with epilepsy). Pearlin et
al. note that life events and chronic strains may produce stress in two ways.39 First,
the experience of stressful life events may alter meanings of existing strains; second,
life events may generate new or magnify existing strains. The initial stressor is
considered the primary stressor and those that follow as secondary. The terms
“primary” and “secondary” do not imply that one is more influential on outcomes;
instead, the terms are used to distinguish the temporal order in which the stressors
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are observed.40 Therefore, the model presumes that stressors do not arise
simultaneously in individuals’ lives, but appear sequentially as the process unfolds,
therefore clarifying the causal mechanisms between exposure and outcome.47
Evidence for the meditational role of family factors between maternal depressive
symptoms and child outcomes have been demonstrated in a number of longitudinal
studies.48-52 Recently, Cummings et al. studied a community sample of 235 parents
of kindergarten children and observed that family stressors and functioning,
specifically, marital conflict, significantly mediated the relationship between
parental depressive symptoms and child psychosocial outcomes.53

Child Age
Child Sex
Co-morbidities
Maternal Age
Employment Status
Marital Status

Epilepsy Severity/Type
Age of Onset
Anti-epileptic Drugs
Education
Number of Children
Family Income

Family Functioning
Family Demands

Diagnosis of
Childhood
Epilepsy
Maternal Depressive
Symptoms
Living with
Childhood
Epilepsy

Child Heath-related
Quality of Life

Family Resources
Perception of Family-centred Care

Figure 1.1. Conceptual Framework based on a Stress Process Model.
In addition to hypothesizing the existence of mediating effects between maternal
depressive symptoms and child health-related quality of life, the model also permits
the inclusion of hypothesized moderating effects that can exert their effects on
various pathways within the process. The examination of these relationships
increases the complexity of the model, but provides richer, more accurate data for
understanding this particular stress process.41 Moderators of this relationship have
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been identified and include, family factors, such as resources, as well as child
characteristics including, gender and age. In their review, Elgar et al. discussed the
evidence supporting family resources as a moderator in the relationship between
maternal depression and child adjustment problems, whereby greater resources
buffer the negative effects of maternal depression.54 Other researchers have
highlighted gender-51, 52, 55 and age-specific pathways.48, 56 In a study of 69 motherchild dyads, Carter et al. showed that maternal depressive symptoms predicted
behaviour problems in male, but not female children.57 Ghodsian et al. observed that
the negative impact of maternal depression on child behaviour problems were
significant for older children only.58 Stress mediators and moderators represent
components along the causal pathway that may be amenable to interventions that
mute the potential negative influence maternal depressive symptoms may have on
the health-related quality of life of children.
The stress outcome, in this case, child health-related quality of life represents the
converging consequences of all other components in the model. The impact of
maternal depressive symptoms on child health-related quality of life is a reasonable
hypothesis considering the fact that stressors experienced by one family member
most often induce stress in other members of the family.39-41 Evidence supporting
this hypothesis has been demonstrated in several longitudinal examinations of
maternal depressive symptoms and child behaviour problems.55,

58-66

In each of

these studies, symptoms of depression in mothers preceded subsequent child
behaviour problems including, defiance, aggression, and hyperactivity. Potential
confounders are included in the stress process in order to obtain unbiased measures
of effect among components of the model.
Structure of the Thesis Document
In accordance with The University of Western Ontario’s School of Graduate and
Postdoctoral Studies’ guidelines, the work of this thesis will be presented in a series
of four manuscripts. A brief description of these manuscripts is provided below. A
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complete description of the methodological details of this thesis is provided in
several appendices at the end of this document (Appendices A, C, and E). Additional
appendices are provided for statements of ethics approval (Appendix B), survey
instruments (Appendix D), and additional information and analyses for the thesis
(Appendices F through J).
The literature review is presented in Chapter Two. A version of this chapter was
published entitled, “Depressive symptoms among mothers of children with epilepsy:
a review of prevalence, associated factors, and impact on children” in Epilepsia in
2009. This paper contains a review of the literature with an evaluation of the
studies’ results within the context of their methodological strengths and
weaknesses.
Chapter Three includes a manuscript entitled “Do depressive symptoms affect
mothers’ reports of child outcomes in children with new-onset epilepsy?” was
published in 2010 in Quality of Life Research. Given that mothers were the primary
informant for this research, this manuscript was developed to examine the
methodological issue of whether depressive symptoms distort mothers’ reports of
child outcomes.
Chapter Four includes a manuscript entitled “Prevalence and trajectories of
depressive symptoms in mothers of children newly-diagnosed with epilepsy” was
published in 2011 in the journal Epilepsia. The purpose of this manuscript was to
address the first and second objectives of this thesis.
Chapter Five includes a manuscript entitled “The impact of maternal depressive
symptoms on health-related quality of life in children with epilepsy: a prospective
study of family environment as mediators and moderators” was published in 2011
in Epilepsia. The purpose of this manuscript was to address the third objective of
this thesis.
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The final chapter, Discussion: Summary and Conclusions (Chapter Six), summarizes
the main findings of this dissertation and relates each of the chapters to one
another, as well discusses the implications for future research. A broader discussion
of the strengths and limitations of the study is included in this chapter.
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Chapter Two
Literature Reviewa
Background
Research thus far has demonstrated that childhood epilepsy affects families in terms
of its psychosocial consequences. Since mothers are most often the primary
caregivers of children,1 it is reasonable to assume that mothers may be particularly
at risk for distress in response to their children’s epilepsy, most notably
depression.2,

3

Thus, it is important to critically evaluate the available evidence

regarding the prevalence of elevated levels of depressive symptoms among mothers
of children with epilepsy, correlates of maternal depressive symptoms, and the
impact of maternal depressive symptoms on child outcomes.
Methodology
A literature search of published studies was conducted in February 2009. The
electronic databases MEDLINE and EMBASE were searched simultaneously via the
OVID system using the following keywords: 1) adolescent OR child; 2) mother; 3)
epilepsy OR childhood epilepsy; 4) depression OR depressive symptoms OR
psychological distress; 5) maternal depression OR maternal depressive symptoms
OR maternal psychological distress; 6) #1 AND #3; 7) #2 OR #4; 8) #5 OR #7; 9) #6
AND #8. All Medical Subject Heading (MeSH) terms were exploded in order to
broaden the search for relevant studies. In addition, the ancestry method of
reviewing the references of empirical studies and reviews for other relevant articles
not identified with the initial search strategy was used to identify further studies
reporting on maternal depressive symptoms in childhood epilepsy. As well, the Web
aA

version of this section was published elsewhere as, Ferro MA, Speechley KN. Depressive symptoms
among mothers of children with epilepsy: a review of prevalence, associated factors, and impact on
children. Epilepsia 2009;50(11):2344-354.
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of Science electronic database was used to identify newer publications that cited
studies already retrieved. The result of each stage of the search methodology
employed in this review is illustrated in Figure 2.1.

Articles identified with
search strategy (N=193)
Articles not written in
English (n=39)
Article titles/abstracts
reviewed (n=154)
Articles not related to
childhood epilepsy (n=76)
(refer to Box A)

Articles reviewed in-depth
for relevance (n=78)

Details of articles deemed irrelevant for
current analysis
Box A.
• Not related to childhood epilepsy (n=63)
• Physiology of neurologic conditions (n=11)
• Legal issues (n=1)
• Measurement instruments (n=1)
Box B.
• Treatment for childhood epilepsy (n=42)
• Child depression in childhood epilepsy (n=18)
• Co-morbidities (not depression) in childhood
epilepsy (n=12)

Articles not related to MDS
(n=72) (refer to Box B)
Articles searched with
ancestry method (n=6)
Articles included in
analysis (n=17)

Figure 2.1. Search Process Utilized and Outcomes Obtained in Identifying
Articles for the Review. MDS, maternal depressive symptoms.
To meet the criteria for inclusion in this review, a study needed to: 1) report on
prevalence of maternal depressive symptoms and/or the relationship between
maternal depressive symptoms and child outcomes in families of a child with
epilepsy; 2) include families of a child with epilepsy up to 18 years of age; and, 3) be
written in English. Studies included mothers of children with various epileptic
seizure and syndrome types and children with or without other conditions, such as
cognitive disability.
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Retrieved articles underwent quality assessment utilizing a modified version of the
Quality Index.4 While initially developed to systematically rate the research quality
of both randomized and non-randomized studies of healthcare interventions to aid
with evidence-based medical decision-making, it has been shown to be valid and
reliable for measuring the methodological quality of epidemiologic and health
research.4-9 For the purposes of this review, the original 27-item Quality Index was
modified to exclude assessment of items related specifically to intervention studies,
including randomization, blinding, withdrawals and drop-outs, and intervention
integrity, reducing it to 15 items as shown in Table 2.1. Each checklist item was
scored 0 (no/unable to determine) or 1 (yes), with a maximum score of 15. Three
subscales comprised the Quality Index: reporting (0-7), external validity (0-3), and
internal validity (0-4). Study power was assessed with a single item (0-1). Higher
scores indicated studies of higher methodological quality.
The 15 studies reviewed here reflect research conducted over a 24-year period from
1984 to 2008. The results reflect a global perspective with three studies conducted
in both the United States and Taiwan, two in the United Kingdom, Nigeria, and
Turkey, and one each in Canada, China, and the Netherlands. Eight measures were
used to assess maternal depressive symptoms in the studies reviewed. These were
the Beck Depression Inventory (BDI),10 Center for Epidemiological Studies
Depression Scale (CES-D),11 General Health Questionnaire (GHQ),12 Hospital Anxiety
and Depression Scale (HAD),13 Multiple Adjective Affect Checklist – Depression
Subscale (MAACL-DS),14 Parenting Stress Index (PSI),15 Structured Clinical
Interview for DSM-IV (SCID),16 and Self-Rating Depression Scale (SDS).17
Study Quality
The mean total score on the modified Quality Index was 9.7 (standard deviation
1.7), with scores ranging between 7 and 13. The mean subscale scores were 6.0
(0.9), range 4-7 for reporting, 0.6 (0.8), range 0-2 for external validity, and 3.1 (0.4),
range 3-4 for internal validity. No study reported a formal sample size or power
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calculation. Table 2.2 summarizes the key features of each study reviewed. Of the 15
studies, seven studies assessed the prevalence of maternal depressive symptoms, 1824

five examined correlates for depressive symptoms in mothers,23-27 and nine

investigated the impact of maternal depressive symptoms on child outcomes in
childhood epilepsy.18,

20, 22, 24, 28-32

There were no significant differences between

study types with respect to scores on the overall Quality Index (F2,14=1.14,
p=0.3510) or subscales for reporting (F2,14=0.23, p=0.7951), external validity
(F2,14=0.98, p=0.4028), and internal validity (F2,14=2.67, p=0.1101). Scores were
proportionately lower for the external validity subscale as compared to the
reporting and internal validity subscales.
Prevalence of Maternal Depressive Symptoms
The mean Quality Index score for studies assessing prevalence of maternal
depressive symptoms was 10.6 (1.8). For the reporting, external validity, and
interval validity subscales, the mean scores were 6.2 (0.8), 1.0 (1.0), and 3.4 (0.5),
respectively. Six studies reported between 12% and 49% of mothers caring for
children with epilepsy either met or scored above the clinical cutoffs for depression
based on a self-report screening measure.18-20,

22, 24, 27

One study by Iseri et al.,

measured clinical depression and found that 32% of mothers of children with
epilepsy had a major depressive disorder.21
There is a lack of consistency in results of studies comparing rates of depressive
symptoms in mothers of children with epilepsy and the general population. In a
sample of 115 mothers of adolescents with epilepsy, researchers observed that the
mean score on the CES-D was significantly higher than that of a national sample in
the United States (14.5 vs. 8.7, p<0.0001), indicating higher levels of depressive
symptoms among mothers of children with epilepsy.20 In contrast, Baki et al.,
observed that the difference in proportion of mothers classified as depressed
according to the BDI was not significantly different between Turkish mothers of
children with epilepsy compared to mothers of children without epilepsy (49% vs.
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41%, p>0.05).18 In the only study comparing parents of children with epilepsy and
another chronic illness, Chiou and Hseih observed similar rates of depression
between parents of children with epilepsy and asthma.19 Using parent-report on the
depression subscale of the Parenting Stress Index, 16.3% of children with epilepsy
and 18.5% with asthma from a sample of children 8-13 years old attending a
hospital clinic in Taiwan scored above the threshold for increased risk of depression
(i.e., at or above the 90th percentile). The difference was not statistically significant
(p=0.0861).
Factors Associated with Maternal Depressive Symptoms
The mean Quality Index score was 9.0 (0.8) with subscale scores of 5.8 (0.5), 0.3
(0.5), and 3.0 (0.0) for reporting and external and internal validity, respectively. The
earliest work conducted by Mu et al., investigated correlates of maternal depressive
symptoms among a sample of 324 mothers of children with epilepsy attending
epilepsy day-clinics at teaching hospitals in Taiwan.26 Using the BDI, level of
maternal depressive symptoms was positively associated with role ambiguity and
the worry associated with childhood epilepsy and negatively associated with
maternal age. Mu et al., replicated this study in another sample of 316 mothers.
Results provided further support for the association between role ambiguity and
worry with maternal depressive symptoms.25 In addition, this subsequent study
showed that depressive symptoms were associated with the presence of comorbidities in the child with epilepsy and lower maternal education.
Further research in this area was conducted by Shore et al.23, 27 In their initial study
of 115 mothers of adolescents with epilepsy, Shore et al., utilized the CES-D to
determine the factors associated with level of maternal depressive symptoms.23
Results demonstrated that adolescent behaviour problems had a significant positive
association with maternal depressive symptoms, whereas family income and
satisfaction with family relationships had a significant negative association with
maternal depressive symptoms.
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The results from a recent study by Wood et al.,24 failed to replicate the findings of
maternal and family correlates for maternal depressive symptoms demonstrated by
Mu et al.,25, 26 and Shore et al.23, 27 Wood et al., found that the only factor associated
with maternal depressive symptoms was the presence of behaviour problems,
specifically, attention deficit hyperactivity disorder in the child with epilepsy
(β=0.49; p<0.004).24 However, the absence of significant associations between
maternal and family factors and depressive symptoms might be attributed to lack of
statistical power due to the small sample size studied, rather than a true absence of
correlation.
Impact of Maternal Depressive Symptoms on Child Outcomes
Maternal depressive symptoms have been linked to a host of child health outcomes.
Most commonly, children of mothers with depression are at a significantly higher
risk for internalizing and externalizing behaviour problems33-37 and depression38-42
as compared to children of mothers without depression. As well, research has
demonstrated that mothers with depression have poorer interactions with their
children leading to deficiencies in the overall care of their children.43-45 In childhood
epilepsy specifically, several studies have been conducted describing family factors
that are associated with child outcomes, most commonly behaviour problems. 46-56
Nine studies have specifically focused on the impact of maternal depressive
symptoms. These studies had a mean Quality Index score of 9.5 (1.9) and subscale
scores of 6.0 (1.3) for reporting, 0.5 (0.8) for external validity, and 3.0 (0.0) for
internal validity.
Although Dunn and Austin suggest that a family history of depression is an
important clue in diagnosing depression in children with epilepsy,57 Baki et al.,
showed that there was no correlation between level of maternal depressive
symptoms and depression scores in children with epilepsy.18 This result was also
observed by Dunn et al.20 This contrasts the data analyzed by Adewuya and Ola
demonstrating that presence of psychiatric morbidity in parents as measured by the
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GHQ was significantly associated with either an anxiety (p=0.021) or depressive
(p=0.001) disorder in adolescents with epilepsy.29 This verified earlier work by
Hoare and Hoare and Kerley showing that past and current treatment for
psychiatric disturbances in the mothers of children with epilepsy was associated
with psychiatric disturbances in children.30, 31 In addition, Hoare observed that GHQ
scores in mothers of children with psychiatric disturbances were greater than in
mothers without disturbed children (p=0.04).30
Two studies have examined the impact of depressive symptoms on behaviour
problems in children with epilepsy. In a sample of 91 parents (81 mothers) of
children with epilepsy from a tertiary epilepsy care center in the Netherlands,
Rodenburg et al., demonstrated that parental depressive symptoms were
significantly correlated with both internalizing (r=0.33, p<0.01) and externalizing
behaviour problems (r=0.32, p<0.01).22 In this study, feelings of depression were
measured with the SDS. The data also showed that the impact of parental depressive
symptoms on internalizing problems was mediated by parental rejection of the child
and that relationship quality with the child mediated the association between
parental depressive symptoms and externalizing problems. Yong et al. studied a
sample of 418 parents of children with epilepsy at a tertiary care center in China
using the HAD to measure parents’ level of depressive symptoms.32 Multivariable
regression showed that parental depressive symptoms were significantly associated
with child behaviour problems while controlling for the effects of child mental
development, maternal age, and duration of epilepsy (p=0.04). However, parental
depressive symptoms explained only 5% of the total variance in child behaviour
problems.
Three studies have assessed the impact of maternal depressive symptoms on child
health-related quality of life revealing some support for a negative impact of
maternal depressive symptoms on overall health-related quality of life in children
with epilepsy. In a study by Adewuya conducted in Nigeria of 86 adolescents with
epilepsy recruited from neuropsychiatric outpatient clinics, maternal depressive
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symptoms as measured by the SDS, were significantly associated with child healthrelated quality of life.28 This strong negative association (r=-0.66, p<0.001)
remained after controlling for the effects of number of anti-epileptic drugs, side
effects of treatment, duration of epilepsy, and maternal psychopathology (β=-0.29,
p=0.001). Yong et al., also investigated this relationship and showed a significant
negative association between parental depression and child health-related quality of
life (r=-0.41, p<0.001); however, this association was negated in a multivariable
analysis controlling for number of anti-epileptic drugs, seizure frequency, parental
anxiety, and family socioeconomic status.32 Wood et al., performed a zero-order
correlation analysis and showed that maternal depressive symptoms were
negatively associated with child health-related quality of life, as measured with the
Impact of Pediatric Epilepsy scale, whereby higher scores indicate worse quality of
life (r=0.51, p<0.0001).24
Discussion
This review suggests that a relatively high proportion of mothers of children with
epilepsy exhibit depressive symptoms. However, due to the predominance of crosssectional studies in the field, it remains to be understood what the trajectory of
maternal depressive symptoms is over time. Specifically, it is unknown whether
depressive symptoms in mothers increase, decrease, or remain stable during the
course of childhood epilepsy. In addition, previous studies have primarily examined
mothers of children with prevalent cases of epilepsy, which cannot establish when
during the illness process symptoms of depression began. Such gaps in the literature
suggest the value of developing prospective studies that focus on incident cases of
childhood epilepsy and examine changes in maternal depressive symptoms over
time.
Furthermore, evidence suggests a role for maternal, child, and family risk factors for
depressive symptoms in mothers of children with epilepsy, many of which are
amenable to intervention, including family functioning and support. However,
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results from previous cross-sectional studies simply identify correlates, and not
predictors of maternal depressive symptoms. True predictors can only be identified
with prospective research that includes at a minimum, two measurement occasions.
It is with prospective studies that researchers may identify true risk factors and
develop interventions designed to decrease the risk of mothers developing
depressive symptoms.
Available evidence suggests a significant negative relationship between maternal
depressive symptoms and child outcomes in epilepsy. However, no prospective
studies were found to verify whether these relationships are in fact causal in
childhood epilepsy. Broadening the search to prospective studies in other motherchild populations demonstrates that depressive symptoms in mothers negatively
impact child outcomes including child adjustment and behaviour.58-60 It remains to
be seen whether results can be replicated with prospective studies in childhood
epilepsy and expanded to include other important child outcomes, including clinical
outcomes and health-related quality of life. In addition, moderation and mediation
analyses that help to elucidate the causal mechanisms whereby maternal depressive
symptoms influence child outcomes are needed. Such studies would be valuable in
identifying potential targets for intervention so as to negate the effects of depressive
symptoms on child outcomes in epilepsy.
The studies conducted thus far provide preliminary, albeit important contributions
to understanding the prevalence, correlates, and impact of maternal depressive
symptoms in the context of epilepsy in childhood. With this important groundwork
completed, future research should build upon these initial studies to further the
knowledge base. Development of robust study designs and methods requires an
assessment of the limitations of available literature in order to advance this
research agenda. These limitations, which can be grouped in terms of study design,
external validity, and internal validity, are discussed in the following section.

25
Study Design
All studies reviewed used cross-sectional designs. While they represent an
important initial step in identifying correlates of maternal depressive symptoms,
they are limited to correlation inferences. Causation cannot be inferred from these
studies since temporal order of cause and effect is a necessary criterion for
causation.61 For example, in the studies by Adewuya and Yong et al., it is not possible
to conclude that maternal depressive symptoms caused a decline in child healthrelated quality of life.28, 32 It is equally plausible that a child exhibiting worse healthrelated quality of life led to depressive symptoms in his or her mother.
Implementing prospective cohort studies will clarify the temporal order of cause
and effect and allow for the rigorous examination of various causal mechanisms,
including factors that predict maternal depressive symptoms and the impact
maternal depressive symptoms have on child outcomes in epilepsy over time.
Identification of mediating effects along these causal pathways could inform the
planning of individualized family-centered care strategies for families of children
with epilepsy. In addition, prospective cohort studies make it possible to track rates
of elevated depressive symptoms in mothers over the course of their child’s illness,
which in turn may help healthcare professionals prevent the onset of clinical
depression in these women.
External Validity
Since the majority of studies were conducted at a single clinic at a tertiary care
center and imply use of non-probability convenience sampling for participants, it is
difficult to determine if the samples studied adequately represent the target
population. A mean of 0.6 out of a maximum score of 3.0 on the external validity
subscale of the Quality Index suggests a need for caution in generalizing results from
the studies reviewed. Few studies explicitly reported using convenience sampling20,
25

and only one study used a combination of random and convenience sampling;

however, details of the random sampling procedure were not described. 19 Using
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hospital-based convenience samples of families attending outpatient clinics at
tertiary care centers compromises the external validity of results since these
samples may exclude families whose children’s epilepsy is well-controlled by either
a paediatrician or other healthcare professional. Thompson and Oxley observed that
children recruited from hospital outpatient clinics are more likely to over-estimate
severe cases of epilepsy and as a result, researchers should provide comparative
measures of childhood epilepsy between the sample and population. 62 It is
reasonable to infer that mothers of children with more severe illness may be at
greater risk for clinical depression and thus results from these studies may overestimate the prevalence of elevated levels of depressive symptoms in this
population of mothers. It is also possible that the studies reviewed have an overrepresentation of families who are compliant with the care prescribed for their
children, since they were recruited during their scheduled medical appointment.
This may also lead to an over-estimate of mothers with elevated depressive
symptoms. Research has demonstrated that mothers exhibiting elevated depressive
symptoms utilize more healthcare services, including visits to healthcare
professionals compared to mothers who do not exhibit depressive symptoms.63
Population-based, random sampling procedures provide an efficient strategy to
prevent selection bias since mothers across the epilepsy severity spectrum will be
more adequately represented. Results pertaining to the prevalence and correlates of
maternal depressive symptoms obtained with population-based strategies will
provide stronger evidence to support potential changes to public health policy, as
well as help implement more appropriate family-centered care. However, there are
feasibility constraints in designing population-based studies. In the absence of
population-based registries for epilepsy to facilitate such studies, Speechley et al.,
demonstrated that it may be feasible to recruit a representative population-based
sample of children with epilepsy by targeting paediatric neurologists.64 In this study,
family physicians practicing in southwestern Ontario, reported they would refer
between 80-99% of their patients with childhood epilepsy (depending on the type
of seizure and syndrome) to a paediatric neurologist. The specific geographical
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jurisdiction for this study may limit extrapolation to other areas in Canada and
abroad, however.
Research has shown that a large proportion of children with epilepsy have other comorbid conditions, particularly cognitive disability and other neurological
problems.65, 66 For example, in a recent study by Hoie et al., 35% of children with
epilepsy had severe, non-verbal cognitive problems.67 However, only six studies
reviewed included children with cognitive disabilities or other co-morbidities.22, 2427, 32

Excluding children with epilepsy who have co-morbidities from studies avoids

the methodological challenges of dealing with heterogeneous samples. It also
means, however, that results are unlikely to reflect the realities faced by this large
subgroup, especially in analyses that aim to quantify the impact of epilepsy on the
family. By recruiting more representative samples, these studies may provide more
accurate estimates that can be more readily applied in the paediatric neurology
setting.
Internal Validity
Due to the potential for bias in most observational studies, adequate control of
confounding variables is paramount to producing internally valid results when
assessing causative relationships. A mean score of 3.1 out of a possible 4.0 on the
internal validity subscale of the Quality Index suggests that the studies reviewed
were adequate in generating internally valid results, but there still exists room for
improvement. Studies conducted by Adewuya and Yong et al., controlled for
confounding effects using multivariable regression analyses and are an
improvement over simple unadjusted bivariable correlations.28,

32

Although these

studies do provide adjusted estimates of the impact of maternal depressive
symptoms on child health outcomes, the use of automated modeling techniques may
result in the exclusion of some important confounders, biasing the effect estimates.
Modeling causal relationships between maternal depressive symptoms and child
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outcomes should focus on a model building process that is researcher-driven and
accounts for confounders as determined by theory and empirical evidence.
In addition to confounding, measurement errors can also invalidate results. Due to
the challenging nature of surveying children,68 the use of mothers as a proxy
reporter has become standard in child and family health research despite its
inherent limitations.69 Using only proxy measures fails to capture the fact that
mothers and children with epilepsy may differ in their perception of health. 70 Other
viable options to lessen the impact of information bias may include parallel reports,
whereby both mothers and children are asked to report on outcomes. As well, for
certain outcomes (e.g., behaviour), persons external to the family may be recruited
(e.g., teacher-report of behaviour). Although mothers may have a better
understanding of the health issues being examined and the content of
questionnaires compared to children, the young patient’s experience with illness
should also be acknowledged in future investigations.
Conclusion
Taken together, the results from the preliminary studies reviewed demonstrated
that a significant proportion of mothers caring for children with epilepsy have
elevated levels of depressive symptoms; many correlates of maternal depressive
symptoms are potentially modifiable; and, maternal depressive symptoms have a
significant negative association with health outcomes in children with epilepsy. This
means that a large proportion of children may potentially experience less than
optimal outcomes as a result of the consequences of having a depressed mother.
Results from the current literature indicate that many predictors of maternal
depressive symptoms, as well as mediating factors that impact child outcomes in
epilepsy are modifiable. The fact that the studies reviewed had a mean Quality Index
at approximately the midpoint of the scoring instrument suggests a need for
improvement

for

future

studies.

As

such,

researchers

should

design

methodologically robust studies that address the limitations discussed in this
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review and examine new and important hypotheses. Proportionately lower scores
on the external validity subscale implicate this as an area for investment to improve
the overall quality of future research studies. Future research endeavors should be
tuned to the importance of the external validity of results by implementing
prospective studies that capture repeated measures on a population-based,
representative random sample of individuals over time. In addition, important
confounding factors should be measured and accounted for in the design and
analysis phase of the study in order to present internally valid results. Such cohort
investigations are needed to identify true risk factors and the nature of any causal
relationships. It is with this next phase of research findings that we can identify
potential targets for intervention that could be systematically evaluated in clinical
practice. Such steps will help researchers and clinicians to better understand the
experience of mothers with depressive symptoms and ultimately enhance the lives
of children who are living with epilepsy.
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Table 2.1. The Modified Quality Index.
Reporting
1. Is the hypothesis/objective of the study clearly described?
2. Are the main outcomes to be measured clearly described in the Introduction
or Methods section?
3. Are the characteristics of the patients included in the study clearly
described?
4. Are the main findings of the study clearly described?
5. Does the study provide estimates of the random variability in the data for the
main outcomes?
6. Have actual probability values been reported for the main outcomes except
where the probability value is less than 0.001?
7. Is the response rate clearly described?
External Validity
8. Were the patients asked to participate in the study representative of the
entire population from which they were recruited?
9. Were patients who were prepared to participate representative of the entire
population from which they were recruited?
10. Were the staff, places, and facilities where the patients were studied,
representative of the treatment the majority of patients receive?
Internal Validity (bias and confounding)
11. If any of the results of the study were based on “data dredging”, was this
made clear?
12. Were the statistical tests used to assess the main outcomes appropriate?
13. Were the main outcome measures used valid and reliable?
14. Was there adequate adjustment for confounding in the analyses from which
the main results were drawn?
Power
15. Did the study provide a sample size or power calculation to detect important
effects where the probability value for a difference being due to chance is less
than 0.05?
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Table 2.2. Summary of Studies Reviewed.
Measure

Results
Reported
Child
Outcomes

Citation

Study Design

Sample

QIS

Adewuya, 2006
(Nigeria)

Cross-sectional
Adolescents, mean age 14.4
years

N=86
Tertiary outpatient clinic;
various seizure types

SDS

Adewuya & Ola,
2005
(Nigeria)

Cross-sectional
Adolescents, mean age 14.5
years

N=102
Tertiary outpatient clinic;
various seizure types

GHQ

Child
Outcomes

11

Baki et al. 2004
(Turkey)

Cross-sectional
Epilepsy (n=35):
mothers, mean age 37.7 years
children, mean age 12.8 years
Controls (n=35):
mothers, mean age 38.6 years
children, mean age 12.7 years

N=70
Epilepsy (various seizure
types):
tertiary outpatient clinic
Controls (age- and sexmatched):
two local high schools

BDI

Prevalence
Child
Outcomes

9

Chiou & Hsieh,
2008
(Taiwan)

Cross-sectional, random and
convenience samples
Epilepsy (n=48):
children, mean age 10.6 years
Asthma (n=54):
children, mean age 11.4 years

N=102
Tertiary outpatient clinics;
various seizure types

PSI

Prevalence

10

Dunn et al. 1999
(United States)

Cross-sectional, convenience
sample
Children, mean age 14.4 years

N=115
Two tertiary outpatient clinics
and private practices of
neurologists and

CES-D

Prevalence
Child
Outcomes

13

12
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paediatricians; various seizure
types
Hoare, 1984
(United Kingdom)

Cross-sectional
New-onset epilepsy (n=52):
children, mean age 8.2 years
siblings, mean age 9.4 years
Chronic epilepsy (n=52):
children, mean age 9.4 years
siblings, mean age 10.8 years

N=104
Medical records and personal
contact with regional
paediatricians; various seizure
types

GHQ

Child
Outcomes

7

Hoare & Kerley,
1991
(United Kingdom)

Cross-sectional
Mothers, mean age 37.0 years
Children, mean age 10.4 years

N=108
Tertiary outpatient clinic;
various seizure types

GHQ

Child
Outcomes

8

Iseri et al. 2006
(Turkey)

Cross-sectional
Mothers, mean age 35.6 years
Children, mean age 9.5 years

N=80
Tertiary outpatient clinic;
various seizure types

SCID

Prevalence

9

Mu et al. 2005
(Taiwan)

Cross-sectional, convenience
sample
Mothers, mean age 36.8 years
Children, mean age 9.4 years

N=316
Tertiary outpatient clinic;
various seizure types

BDI

Correlates

10

Mu et al. 2001
(Taiwan)

Cross-sectional
Mothers, mean age 36.7 years
Children, mean age 9.4 years

N=324
Three tertiary outpatient clinic;
various seizure types

BDI

Correlates

9

Rodenburg et al.
2006

Cross-sectional
Mothers, mean age 38.8 years

N=91
Tertiary outpatient clinic;

SDS

Prevalence
Child

9

40

(Netherlands)

Children, mean age 8.4 years

various epilepsy syndromes

Outcomes

Shore et al. 2004
(United States)

Cross-sectional
Mothers, mean age 38.0 years
Children, mean age 11.3 years

N=156
Two tertiary outpatient clinics
and private practices of
neurologists and
paediatricians; various seizure
types

MAACL-DS

Correlates

8

Shore et al. 2002
(United States)

Cross-sectional
Mothers, mean age 39.0 years
Children, mean age 14.4 years

N=115
Two tertiary outpatient clinics
and private practices of
neurologists and
paediatricians; various seizure
types

CES-D

Prevalence
Correlates

9

Wood et al. 2008
(Canada)

Cross-sectional
Children, mean age 9.8 years

N=52
Tertiary outpatient clinic;
intractable epilepsy

BDI

Prevalence
Correlates
Child
Outcomes

12

Yong et al. 2006
(China)

Cross-sectional
Children, mean age 9.0 years

N=252
HAD
Child
10
Tertiary outpatient clinic;
Outcomes
various seizure types
BDI, Beck Depression Inventory; CES-D, Center for Epidemiological Studies Depression Scale; GHQ, General Health
Questionnaire; HAD, Hospital Anxiety and Depression Scale; MAACL, Multiple Adjective Affect Checklist Depression Scale;
MDS, maternal depressive symptoms; PSI, Parenting Stress Index; QIS, Quality Index score; SCID, Structured Clinical Interview
for DSM-IV; SDS, Self-Rating Depression Scale.
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Chapter Three
Do Depressive Symptoms Affect Mothers’ Reports of Child Outcomes in
Children with New-onset Epilepsy?a
Introduction
Due to the challenging nature of surveying children,1 the use of a caregiver as a
proxy reporter is common in paediatric health research despite its inherent
limitations.2 This is especially common when patient-reported outcomes are used as
outcome measures in conjunction with physician-reported clinical endpoints. Valid
assessments by informants (e.g., caregivers and physicians) are important in making
appropriate medical decisions for children, particularly those with chronic illnesses.
This is because discrepancies between informants due to biased ratings may
confuse

interpretation

of

findings,

potentially

compromising

appropriate

treatment.3, 4
In a recent comprehensive review, De Los Reyes and Kazdin examined the
individual,

family,

and

system

characteristics

that

influence

informant

discrepancies.5 Among these characteristics, caregiver depression was found to
distort reports of child internalizing and externalizing behaviour problems.
Specifically, depressed mothers demonstrated a negative bias, whereby they almost
consistently reported worse child behaviour problems as compared to other
informants, including teachers and the children themselves. This “depression
distortion” was described by Richters but he argued that necessary and sufficient
criteria for evidence of distortion were lacking for the majority of studies, including
the absence of a gold standard and inappropriate use of statistical analyses. 6 The
depression distortion hypothesis can be considered a specific case of informant
aA

version of this section was published elsewhere as, Ferro MA, Avison WR, Campbell MK, Speechley
KN. Do depressive symptoms affect mothers’ reports of child outcomes in children with new-onset
epilepsy? Quality of Life Res 2010;19(7):955-64.
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discrepancy as a result of mothers’ depressive symptoms. Some subsequent
research, not affected by the limitations described by Richters, has provided more
robust evidence supporting the depression distortion hypothesis.7-13 For example, in
the study by Najam et al., depressed mothers reported more cases of child
behaviour problems compared to non-depressed mothers and the differences
between mother and child reports were associated with the mothers’ mental health
status.11 Similar results were obtained in a study by Chilcoat and Breslau, which
demonstrated that depressed mothers overstated their child’s behaviour problems
compared to reports completed by the child’s teacher.8 The results from these
studies suggest that depressed mothers’ reports of their children’s behaviour
problems are biased towards over-reporting problems.
One notable gap in research to date is the relative lack of studies examining whether
depressive symptoms in mothers affect their report of outcomes in which the child
has a chronic illness. Though studies have been conducted in general population
samples, we are aware of only two studies that have examined this issue within the
context of chronic childhood illnesses.12,

14

Because families with chronically ill

children are often required to make many medical decisions, bias associated with
caregiver reporting could potentially lead to treatment strategies that may not
optimize outcomes for children. As well, given that caregivers of children with a
chronic illness, such as epilepsy have a relatively high prevalence of depressive
symptoms,15 there may be a greater probability of depression distortion in these
populations.
Also, assessments of the impact of mothers’ depressive symptoms to date have
tended to focus on maternal reports of child behaviour problems. No studies have
examined the potential impact on other important parent-reported child outcomes,
such as health-related quality of life, which have become increasingly common in
clinical research.16,

17

Health-related quality of life refers to the “subjective and

objective impact of dysfunction associated with an illness or injury, medical
treatment, and healthcare policy”.18 Investigators have commonly adopted
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descriptions of four core domains of health-related quality of life: functional status,
psychological functioning, social functioning, and disease state/symptoms.18
This study set out to investigate whether the presence of depressive symptoms in
mothers affects their reports on their children’s health-related quality of life in a
sample of children with new-onset epilepsy. Childhood epilepsy is a relevant
paediatric illness in which to examine the potential for this type of informant bias
given that it is one of the most common neurological illness affecting children, with
an estimated prevalence of 5/1000 children and incidence of 40-60/100,000
children per year in developed countries.19 Also, epilepsy is a multifaceted condition
requiring complex management and collaboration among patients, families, and
physicians.20 Since mothers, as the primary caregiver for the majority of young
children, very often play the key role of proxy reporter in research on children with
epilepsy it is imperative that the depression distortion hypothesis is examined prior
to conducting additional analyses.
The objective of this manuscript was to assess whether there is evidence that
mothers of children with new onset epilepsy experiencing symptoms of depression
report differently on their children’s health outcomes than mothers without
symptoms of depression. If it is the case that depressed mothers’ reports are
negatively biased, this bias can be detected by comparing mothers’ and neurologists’
reports of children’s health-related quality of life.
We hypothesized that maternal depressive symptoms would moderate the
relationship between mothers’ and neurologists’ reports of children’s functional
status, psychological functioning, social functioning, and disease state/symptoms.
That is, the association between mothers’ and neurologists’ reports would vary
significantly when stratified by level of maternal depressive symptoms.
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Methods
Sample and Data Source
Data for this study came from the Health-related Quality of Life of Children with
Epilepsy Study (HERQULES), a prospective cohort study designed to examine the
determinants of health-related quality of life in children with epilepsy during the
first 24 months post-diagnosis. Families were recruited from paediatric neurology
sites across Canada and consisted of a sample of English-speaking families with a
child diagnosed with epilepsy between 4-12 years of age. Participants were
recruited over a 36-month period by a paediatric neurologist and provided written
consent prior to being enrolled in the study. Primary caregivers were contacted by
study investigators by telephone to determine participation status and sent selfadministered questionnaires by mail at diagnosis (baseline), and six, 12, and 24
months. Of the 456 eligible families approached to participate in HERQULES, 443
(97%) provided written consent and 374 (82%) completed the baseline survey. For
this study, only surveys completed at baseline by mothers (i.e., biological, adoptive,
or foster) were analyzed. Of the baseline responses, 339 (91%) were completed by
mothers. Ethical approval for HERQULES was obtained from all relevant research
ethics boards across the country.
Measures
Mothers’ Report
Maternal depressive symptoms were measured with the Center for Epidemiological
Studies Depression Scale (CES-D), a 20-item questionnaire that measures
depressive symptoms in the general adult population over the past week. 21 The
scale includes 20 items that survey mood, somatic complaints, interactions with
others, and motor functioning. The response values are four-point Likert scales (03), and anchor points in terms of days per week “rarely or none of the time (less
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than one day)” to “most or all of the time (5-7 days)”. The final score ranges from 060, with a higher score indicating greater impairment. Individuals with a final score
of ≥16 are typically identified as having clinically relevant depressive
symptomatology. In this sample, the internal consistency reliability was high
(α=0.80).
Mothers completed the Quality of Life in Childhood Epilepsy (QOLCE) and the Child
Health Questionnaire Parent Form-50 (CHQ). The QOLCE is a multifaceted, parentreport, epilepsy-specific instrument for evaluating health-related quality of life in
children with epilepsy aged 4-18 years.22 Item analysis and validation in North
America led to a final questionnaire containing 76 items with 16 subscales spanning
seven domains of life function including, physical activities, social activities,
cognition, well-being, behaviour, general health, and general quality of life.23 Items
are rated on a five-point Likert scale, which are used to calculate the 16 subscale
scores ranging from zero (low functioning) to 100 (high functioning). The subscale
scores are averaged to produce an overall health-related quality of life score. In this
sample it demonstrated very high internal consistency reliability (α=0.92).
The CHQ is a 50-item, parent-rated, generic questionnaire assessing child health,
well-being, and the impact of illness on life function during the previous four
weeks.24 Each of the CHQ dimensions is measured with multiple items, with higher
scores indicating better health-related quality of life. Nine concepts focus on the
child, which include physical functioning; limitations in schoolwork and activities
with friends due to emotional/behavioural difficulties; limitations in schoolwork
and activities with friends due to physical health; bodily pain/discomfort; general
behaviour; mental health; self esteem; general health perceptions; and change in
health. The remaining four concepts measure impact on the family: parental impacttime; parental impact-emotional; family activities; and family cohesion. Two
weighted and standardized summary scores assessing physical and psychosocial
functioning are calculated, with a mean of 50 and a standard deviation of 10. The
CHQ had very high internal consistency reliability in this sample (α=0.90).
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Family functioning, resources, and demands were measured based on mothers’
reports and used in the regression analyses to control for the confounding effect of
family environment on depressive symptoms. The Family Adaptability, Partnership,
Growth, Affection, and Resolve (Family APGAR), was used to measure the
perception of family functioning as assessed by a family member’s self-report of
satisfaction with the following five parameters: adaptation, partnership, growth,
affection, and resolve.25 The Family APGAR is a five-item instrument that uses a fivepoint Likert scale response option, with scores ranging from 0-4 for each item.
Higher scores indicate higher satisfaction with family functioning. The Family
APGAR has been found to be valid and reliable in both the clinical and research
setting with adults and children.25-27
Family demands were quantified using the Family Inventory of Life Events and
Changes (FILE), which assesses the pile-up of simultaneous normal and non-normal
life events and changes in life events experienced by a family during the previous
year.28 The 71 items are grouped into nine scales assessing various strains: intrafamily, marital, pregnancy/childbearing, finance and business, work-family
transitions, illness and family care, losses, transitions in and out, and legal. The score
is computed by giving each “yes” response a score of one. The reliability and validity
of the FILE is well-established.28
The Family Inventory of Resources for Management (FIRM) was used to assess
resources available to aid families’ adaptation to stressful events.29 For this study,
only two scales (family mastery and health, extended family social support), which
have been found to be associated with adaptation to childhood epilepsy, were
used.30 Scores on individual items, which range from 0 (not at all) to 3 (very well),
are summed to provide a total FIRM score. The FIRM has demonstrated adequate
reliability and validity properties.29
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Socio-demographic information included date of birth (mother and child), child
gender, number of children in household, parents’ marital and employment status,
level of education, and yearly household income.
Neurologists’ Report
Paediatric neurologists completed the Global Assessment of Severity of Epilepsy
(GASE), a single-item, seven-point global rating scale (1=extremely severe to 7=not
at all severe) designed for neurologists to assess the overall severity of epilepsy in
children, taking into account all aspects of the patient's epilepsy.31 The GASE
demonstrated minimum burden on participants, adequate validity, and high intraand inter-rater reliability.31 Paediatric neurologists assessed the extent to which
epilepsy interferes with daily activities on a seven-point scale (1=none to 7=severe).
Severity of child behaviour (0=none to 3=severe), cognitive (0=none to 4=severe),
and motor problems (0=none to 3=severe), and other epilepsy characteristics such
as seizure type, age of seizure onset, frequency/intensity of seizures, injuries during
seizures, severity of post-ictal period, and side effects of anti-epileptic drugs were
assessed by questions widely used in Canada previously by the Canadian Epilepsy
Database Registry and items drawn from neurologists’ forms used in testing the
Impact of Pediatric Epilepsy Scale.32, 33
Procedure
Questionnaires used in HERQULES were reviewed by the investigators to identify
several domains of child health on which both mothers and neurologists provided
reports focusing on the four core domains of health-related quality of life. A total of
15 paired variables within these domains were identified for analysis and are
described in Table 3.1. While the same specific measures were not completed by the
two types of informants, it is reasonable to suggest that mothers’ and neurologists’
ratings on each individual domain would be similar. For the functional status
domain, the cognition subscale of the QOLCE was regressed on a five-point (higher
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scores indicate better functioning) neurologist assessment of child cognitive
problems. As well, the QOLCE subscales physical restrictions and energy/fatigue
and the CHQ subscales role-physical and physical functioning were regressed on a
seven-point neurologist assessment of interference of epilepsy or treatment with
daily activities (higher scores indicating fewer disruptions). For psychological
functioning, the behaviour subscale of the QOLCE and the role-emotional/behaviour
and behaviour subscales of the CHQ were regressed on a four-point (higher scores
indicate better functioning) neurologist assessment of child behaviour problems. To
assess social functioning, the QOLCE subscales social interactions, social activities
and stigma were regressed on the neurologist assessment of interference of
epilepsy or treatment with daily activities. In terms of disease state/symptoms,
mother-reported overall QOLCE and CHQ (physical and psychosocial) summary
scores were regressed on the neurologist-reported GASE (higher scores indicate
less severity).
Statistical Analysis
Univariable analysis was used to describe the sample in terms of maternal mental
health status using descriptive statistics and frequency distributions. In order to
address limitations associated with dichotomizing mothers as depressed or nondepressed described by Richters6 and to ensure that results were not an artifact
based on other extraneous variables, tests of moderation using multiple regression
analysis were performed with CES-D scores as a continuous measure of maternal
depressive symptoms and were controlled for potential confounding maternal and
family factors. Fifteen regression models were conducted whereby the mothers’
report was the dependent variable [e.g., QOLCE (total)] and was regressed on the
neurologists’ report (e.g., GASE), mothers’ depressive symptoms (CES-D), and an
interaction term conceptualized as the product between neurologists’ report and
mothers’ depressive symptoms (i.e., GASE×CES-D). The product term is included to
determine whether the relationship between the mother report and the neurologist
report is moderated by the mother’s mental health status. A statistically significant
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product term indicates that mothers with lower versus higher levels of depressive
symptoms differ in the extent to which their reports are similar to neurologists’
reports. In the presence of a statistically significant product term, a conditional
moderator variable based on CES-D scores and the standard deviation of the sample
was used in subsequent post hoc regression analyses as described by Holmbeck to
probe interactions and further describe the effect of mothers’ depressive symptoms
on their reports.34 With a sample size of 339, this study was adequately powered to
detect significant interaction effects (i.e., change of six points on the CES-D) with 1β=0.80 at α=0.05. Data analysis was conducted with Statistical Analysis Software
(SAS 9.1.3 Service Pack 4, SAS Institute Inc., Cary, NC).
Results
Sample Characteristics
A total of 339 mothers participated in this study. Baseline characteristics of the
study sample are shown in Table 3.2. Briefly, mothers had a mean age of 37.9
(standard deviation 5.9) years. Sixty-nine percent were college/university
graduates and 66% were employed. Approximately 80% of mothers were married.
Mothers’ overall mean score on the CES-D was 14.6 (10.5) and 37.7% of mothers
were at risk for clinical depression based on a CES-D score ≥16. The mean age of
their children was 7.9 (2.3) years and 52% were male. Mean scores on the QOLCE,
CHQ (physical), CHQ (psychosocial), and GASE were 69.8 (13.8), 48.6 (10.6), 44.4
(10.8), and 5.5 (1.2), respectively. Neurologist reports indicated that 15% of
children had behaviour problems, 18% had cognitive problems, and 55% had
disruptions in daily activities as a result of epilepsy or its treatment. Mean scores
describing the family environment were as follows: Family APGAR 13.9 (3.8), FILE
9.9 (6.6), and FIRM 49.8 (11.1). Approximately 36% of families had a total
household income of ≥$80,000 per year. These results describe families that were,
on average, functioning well, had low stress, adequate resources, and had high
socio-economic status.
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Effect of Mothers’ Depressive Symptoms on Reporting
To examine whether mental health status moderated mothers’ reports of children’s
health-related quality of life, a series of multiple regression analyses was conducted.
The regression analyses were controlled for the potentially confounding effects of
mothers’ age, education, employment status, marital status, family functioning,
stress/demands, social resources, and income, as these factors are theoretically
linked and empirical evidence has shown to be associated with depression. 35,
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Results of the regression analyses are shown in Table 3.3. In order to ensure that the
null findings were not the result of controlling for these psychosocial factors known
to be associated with depressive symptoms, additional unadjusted (regression
model excluded all potential confounders) and partially adjusted (regression model
included only the following potential confounders: mothers’ age, education,
employment status, and marital status) were conducted. The results were similar to
those reported in Table 3.3 and thus are not presented. Only one significant product
term was observed in the functional status domain for disruptions in daily
activities×CES-D (β=0.24, p=0.008) when modeling QOLCE (energy/fatigue), and
subsequently underwent subsequent post hoc probing of the interaction effect.
The results of the post hoc analysis suggest that mothers with low levels of
depressive symptoms report similar outcomes as neurologists when evaluating
disruptions in daily activities due to the child’s epilepsy. That is, as neurologists
report better functioning, so do mothers. In contrast, mothers with high levels of
depressive symptoms systematically report higher scores on the QOLCE
(energy/fatigue) subscale (indicating little disruptions in activities due to energy/
fatigue) for children with both high and low scores of neurologist-reported
disruptions in daily activities. The results of the post hoc analysis are shown in
Figure 3.1.
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Figure 3.1. Effect of Maternal Depressive Symptoms on Reporting the Impact
of Epilepsy on Disruptions in Daily Activities in Children. The results suggest
that mothers with high scores on the Center for Epidemiological Studies Depression
Scale (CES-D), consistently report elevated scores on the energy/fatigue subscale of
the Quality of Life in Childhood Epilepsy (QOLCE). SD, standard deviation.
Discussion
This is the first study to examine whether depressive symptoms in mothers affects
reporting on children with new-onset epilepsy. Results of this study did not provide
evidence that mothers’ reports of child outcomes are affected by depressive
symptoms. Multiple regression analyses of the four domains of health-related
quality of life: functional status, psychological functioning, social functioning, and
disease state/symptoms, did not yield statistically significant estimates for the
interactions between mothers’ and neurologists’ report of child outcomes, except
for the regression of mothers’ assessments of their child’s energy/fatigue and its
impact on daily activities in the functional status domain. The unbiased estimates
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produced through the control of confounding factors in multiple regression offers a
higher level of evidence than the estimates used in previous studies to indicate a
lack of evidence to support the depression distortion hypothesis. Overall, this
suggests that depressed mothers are not more likely to give biased reports of their
child’s outcomes.
Though evidence for depression distortion in the general population has been
mixed,6 results from studies in other paediatric chronic illnesses support the
hypothesis.12, 14 In a study by Chi and Hinshaw, levels of depressive symptoms in
mothers of children with attention deficit/hyperactivity disorder predicted negative
biases in mothers’ reports of children’s illness symptoms and behaviour problems. 12
Recently, Hood examined the depression distortion hypothesis in a sample of
caregivers whose children were diagnosed with type-1 diabetes.14 Hood
demonstrated that caregivers with elevated depressive symptoms systematically
rated high levels of depressive symptoms in the youth, whereas caregivers with
lower depressive symptoms reported similar levels as the youth themselves.
There was only one exception to the finding that mothers with elevated depressive
symptoms differed in the extent to which mothers’ reports were related to
neurologists’ reports, which was for how the child’s level of energy/fatigue
interrupted their daily activities. This may be attributable to depressed mothers
being less aware of how energy levels affect daily functioning in their child given
their concern with their own depressive symptoms. Thus, mothers with elevated
depressive symptoms may under-estimate the impact of energy levels in children
with epilepsy. However, given that 15 regression models were examined, one must
consider that this significant finding may be the result of the multiple testing
problem. The multiple testing problem occurs when one considers a set of statistical
inferences simultaneously. Errors in inference, including hypothesis tests that
incorrectly reject the null, are more likely to occur when one considers the set of
inferences as a whole.37 Indeed, when the Bonferroni correction (α/15=0.003) is
applied to this set of regression models to account for the multiple testing problem,
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the null hypothesis is not rejected, suggesting that mothers with elevated depressive
symptoms do not provide discrepant reports on how their child’s energy/fatigue
may disrupt daily activities.
The fact that there were no other significant findings was unlikely to be the result of
missing important effects since the study was adequately powered to detect
statistically significant and clinically relevant interaction effects, as described by
McCarthy38 and Wyrwich.39 As well, research has shown that discrepancies due to
depressive symptoms are more apparent when examining negative attributions as
compared to positive attributions.40, 41 The fact that the current study focused on
negative aspects of the illness process, especially behaviour and cognitive problems,
and disruptions in daily activities, offers some assurance that it presented the
opportunity to detect discrepancy in reporting of negative attribution should it have
been present. Since families dealing with incident cases of childhood epilepsy were
recruited, it is possible that mothers may have been highly attuned to their child’s
illness and related symptoms, regardless of their mental health status. Whether
support for informant discrepancy may be found in a sample of prevalent cases of
childhood epilepsy remains to be elucidated.
The results of this study are tempered by several limitations. First, the sample under
study was recruited from paediatric neurology practices that may not be
representative of all families with a child with epilepsy, thus potentially limiting
external validity. However, there are feasibility constraints in designing populationbased studies. In the absence of population-based registries for epilepsy to facilitate
such studies, Speechley et al. demonstrated that it may be feasible to recruit a
representative population-based sample of children with epilepsy by targeting
paediatric neurologists.42 In this study, family physicians practicing in southwestern
Ontario, reported they would refer between 80-99% of their patients with
childhood epilepsy (depending on the type of seizure and syndrome) to a paediatric
neurologist.
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Second, there are some limitations associated with the measures used in the study.
Although the CES-D is a valid, reliable, and widely used measure, it is a self-report
screening measure of psychological distress rather than a diagnostic instrument for
clinical depression.43 Also, mothers and neurologists did not complete the same
measures so we cannot be certain that the two groups were reporting on identical
constructs, which may have masked evidence for distortion. As well, for several of
the neurologists’ assessments of individual domains of health-related quality of life
were based on a single-items measure, which can be viewed as problematic.
However, research has shown that in certain circumstances, multi-item measures do
not perform better than a single-item measure, prompting the recommendation that
the appropriateness of a single-item measure be evaluated by assessing its
psychometric properties prior to rejecting its practicality.44, 45
Third, while not feasible in the current study, self-report for children old enough
would have been helpful. Although mothers may have a better understanding of the
health issues being examined and the content of questionnaires compared to
children, the young patient’s experience with illness should also be acknowledged in
future investigations.
A question arises from this research. If we had found that mothers’ depressive
symptoms affected their reports of children’s health-related quality of life, would
the magnitude of bias be clinically relevant? A study by Sawyer et al. concluded that
in community samples the size of bias in caregivers’ reports of child behaviour
problems due to parental distress was likely to be quite small and of little clinical
significance.46 However, this study was conducted in a general community sample
and whether the results can be extrapolated to chronically ill child populations is
unknown.
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Conclusion
This study did not find evidence to support that depressive symptoms affect
mothers’ reports of child outcomes. The results from this study suggest that
mothers of children with new-onset epilepsy, regardless of their mental health
status are valid informants for various aspects of their child’s health outcomes.
Future investigations examining informant discrepancy are needed and should
implement methodologically rigorous designs with multiple informants, including
child reports, in order to acquire a more thorough understanding of this
phenomenon.
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Table 3.1. Domains of Health-related Quality of Life as Reported by Mothers
and Neurologists.
Domain
Parent Measure
Neurologist Measure
Functional
QOLCE (cognitive)
Cognitive Problems
Status
22-item subscale; attention,
Single-item, 5-point
concentration, language, and memory
scale rating level of
QOLCE (physical restrictions)
cognitive disability
10-item subscale; physical activities
QOLCE (energy/fatigue)
Disruptions in Daily
2-item subscale; energy levels
Activities
CHQ (physical functioning)
Single-item, 7-point
6-item subscale; physical activities
scale rating
CHQ (role physical)
interference of
2-item subscale; limitations due to
epilepsy with daily
physical health
activities
Psychological QOLCE (behaviour)
Behaviour Problems
Functioning
16-item subscale; behaviour
Single-item, 4-point
CHQ (role emotional/behaviour)
scale rating level of
3-item subscale; limitations due to
behaviour problems
behaviour
CHQ (behaviour)
5-item subscale; describing behaviour
problems
CHQ (global behaviour)
Single-item scale; overall behaviour
compared to other children
Social
QOLCE (social interactions)
Disruptions in Daily
Functioning
5-item subscale; problems with social Activities
interactions
Single-item, 7-point
QOLCE (social activities)
scale rating
3-item subscale; limitations in social
interference of
activities
epilepsy with daily
QOLCE (stigma)
activities
Single-item scale; effect of epilepsy
stigma on social activities
Disease
QOLCE (total)
GASE
State/
Total score of quality of life subscales
Single-item, 7-point
Symptoms
CHQ (physical)
scale rating overall
Summary score of physical subscales
severity of epilepsy
CHQ (psychosocial)
Summary score of psychosocial
subscales
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Table 3.2. Characteristics of the Study Sample.
Characteristic
Mother
Age, years
University Graduate, n (%)
Employed, n (%)
Married, n (%)
CES-D
Child
Age, years
Male, n (%)
Health-related Quality of Life
QOLCE
CHQ, Physical
CHQ, Psychosocial
Illness Severity, GASE
Behaviour Problems, n (%)
Cognitive Problems, n (%)
Disruptions in Daily Activities, n (%)
Family
Functioning, Family APGAR
Demands, FILE
Resources, FIRM
Income ≥$80,000, n (%)
For continuous variables, values represent mean (standard deviation).

37.9 (5.9)
203 (69.3)
223 (66.4)
270 (79.7)
14.6 (10.5)
7.9 (2.3)
175 (51.6)
69.8 (13.8)
48.6 (10.6)
44.4 (10.8)
5.5 (1.2)
51 (14.6)
62 (18.0)
186 (54.8)
13.9 (3.8)
9.8 (6.6)
49.8 (11.1)
118 (36.3)
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Table 3.3. Tests of Interaction Examining the Presence of Depression Distortion in Mothers’ Reports of Child Healthrelated Quality of Life.*
95%
β for
Outcome
Model F†
Model R2
Standard Error
Confidence
Interaction
Interval
Functional Status
QOLCE (cognitive)
6.46
0.21
0.05
0.14
-0.23, 0.33
QOLCE (physical restrictions)
3.18
0.12
0.02
0.09
-0.15, 0.19
QOLCE (energy/fatigue)
2.76
0.10
0.24
0.09
-0.06, 0.41
CHQ (physical functioning)
4.44
0.15
0.04
0.08
-0.11, 0.19
CHQ (role physical)
2.86
0.10
0.10
0.11
-0.12, 0.32
Psychological Functioning
QOLCE (behaviour)
9.96
0.27
-0.14
0.12
-0.38, 0.10
CHQ (role emotional/behaviour)
7.12
0.21
-0.19
0.20
-0.59, 0.20
CHQ (behaviour)
10.45
0.28
-0.12
0.13
-0.37, 0.14
CHQ (global behaviour)
10.64
0.28
-0.52
1.80
-4.06, 3.02
Social Functioning
QOLCE (social interaction)
4.02
0.14
-0.08
0.10
-0.12, 0.28
QOLCE (social activities)
3.20
0.11
-0.02
0.11
-0.25, 0.20
QOLCE (stigma)
4.47
0.15
0.00
0.13
-0.26, 0.25
Disease State/Symptoms
QOLCE (total)
6.15
0.20
0.11
0.07
-0.03, 0.25
CHQ (physical)
3.05
0.11
0.01
0.05
-0.09, 0.12
CHQ (psychosocial)
9.05
0.27
0.11
0.23
-0.34, 0.56
*Regression analyses were controlled for maternal age, education, employment status, marital status, and family functioning,
resources, and demands.
†All models had 11 degrees of freedom and were statistically significant at p<0.003.
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Chapter Four
Prevalence and Trajectories of Depressive Symptoms in Mothers of Children
with Newly-diagnosed Epilepsya
Introduction
Caring for a child with a chronic illness can be a significant source of stress for
parents. Similar to other childhood chronic illnesses or disorders, the impact of
epilepsy is not limited to the child having seizures, but affects all members of the
family to a certain degree.1-3 Compared to families of healthy children, families of a
child with epilepsy have been found to experience significantly more stress, anxiety,
and restrictions in family life,2 higher levels of dissatisfaction with their social
situation, lower levels of marital satisfaction and support,3 and lower quality parentchild relationships and poor family adaptation.4 Since mothers are most often
primarily responsible for children’s care,5 they might be particularly at risk for
psychological distress in response to their child’s epilepsy, most notably
depression.6, 7
In the past decade, six studies investigated depressive symptoms in mothers of
children with epilepsy.8-13 A recent systematic review of studies examining
depressive symptoms in mothers of children with epilepsy showed that prevalence
estimates vary widely with between 12% and 49% of mothers scoring at or above
the cutoffs for clinical depression based on self-report screening measures.14
Previous studies were affected by limitations in study design including a lack of
prospective cohort studies, inclusion of non-representative samples, and sampling
procedures prone to selection bias. No study has examined maternal depressive
symptoms prospectively and none has focused on mothers of children with newlydiagnosed epilepsy.
aA

version of this section was published elsewhere as, Ferro MA, Avison WR, Campbell MK, Speechley
KN. Prevalence and trajectories of depressive symptoms in mothers of children with newlydiagnosed epilepsy. Epilepsia 2011;52(2):326-36.
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Given the paucity of research in this area, the objectives of this paper were to: 1)
estimate the prevalence of depressive symptoms among mothers of children with
new-onset epilepsy at diagnosis and six, 12, and 24 months after diagnosis; 2)
identify trajectories of maternal depressive symptoms; and, 3) examine predictors
of depressive symptom trajectories.
Methods
Sample and Data Source
Data for this study came from the Health-related Quality of Life of Children with
Epilepsy Study (HERQULES), a prospective cohort study designed to examine the
determinants of health-related quality of life in children with epilepsy during the
first 24 months post-diagnosis. Paediatric neurologists across Canada seeing
children with new-onset epilepsy approached parents of eligible patients about the
study. Inclusion criteria were: new case of epilepsy (≥2 unprovoked seizures) in a
child 4-12 years of age, in whom a diagnosis had not been confirmed previously,
seen for the first time by a participating paediatric neurologist; and
parent/caregiver, with sufficient English language skills, who had been primarily
responsible for the child’s care for at least the past six months and continued to be
for the duration of the study. Exclusion criteria were: diagnosis of epilepsy that had
been previously confirmed by another physician; and diagnosis of other progressive
or degenerative neurological disorder (e.g., mental retardation) or other major comorbid non-neurological disorders that would have an impact on quality of life (e.g.,
asthma requiring daily medication, renal failure). Parents who agreed to provide
their address for the purpose of this research were mailed a letter describing the
study and outlining what their participation would entail. Specifically, participants
were asked to complete four mailed questionnaires designed for self-administration
[time 1: after diagnosis (baseline), time 2: at six months, time 3: at 12 months, and
time 4: at 24 months], as well as provide informed consent for their child’s
neurologist to complete a brief form providing relevant clinical information. Of the
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456 eligible families approached to participate in HERQULES, 443 (97.1%) verbally
consented. Of these, 374 (83.7%) completed the baseline survey. For this paper,
only surveys completed by a child’s mother (i.e., biological, adoptive, or foster
mother) were used in the analysis [n=339 (91.0%)]. Approval for HERQULES was
obtained from all relevant research ethics boards across the country and parents
provided written consent.
Measures
Maternal Depressive Symptoms
Level of depressive symptoms in mothers was measured with the Center for
Epidemiological Studies Depression Scale (CES-D), a 20-item questionnaire
designed to assess depressive symptoms in the general adult population over the
past week.15 The scale includes 20 items that survey mood, somatic complaints,
interactions with others, and motor functioning. A four-point Likert scale (0-3) is
used to rate the frequency of symptoms experienced, ranging from “rarely or none
of the time (less than one day)” to “most or all of the time (5-7 days)”. The total
score spans from 0-60, with a higher score indicating greater level of depressive
symptoms. Individuals with a total score of ≥16 are typically identified as being at
risk for clinical depression. Among community samples, internal consistency
estimates for the CES-D ranged from 0.8-0.915 and in this sample, estimates ranged
from 0.75-0.80.
Child Health-related Quality of Life
Child health-related quality of life was reported by mothers using the Quality of Life
in Childhood Epilepsy (QOLCE).16 The QOLCE is a multifaceted, parent-report
instrument for evaluating health-related quality of life of children with epilepsy
aged 4-18 years. The QOLCE contains 76 items with 16 subscales spanning seven
domains of life function including, physical activities, social activities, cognition,
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well-being, behavior, general health, and general quality of life.16 Items are rated on
a five-point Likert scale, which are used to calculate the 16 subscale scores ranging
from zero (low functioning) to 100 (high functioning). The subscale scores are
averaged to produce an overall health-related quality of life score. It has
demonstrated good construct validity, internal consistency reliability, and
sensitivity to epilepsy severity.17 The internal consistency reliabilities were
excellent for all measurement occasions in this sample (0.92-0.94).
Epilepsy Characteristics
Physicians completed a questionnaire documenting the clinical factors of each
patient’s epilepsy including: severity of epilepsy, seizure type and frequency, type of
epilepsy syndrome, age at onset and diagnosis, medication information, and adverse
effects. Neurologists were also asked to rate the presence of comorbidities using
single-item measures, specifically, any behavior (0=none to 3=severe), cognitive
(0=none to 4=severe), or motor problems (0=none to 3=severe). Severity of epilepsy
was classified using the Global Assessment of Severity of Epilepsy (GASE), a singleitem measure developed for HERQULES.18 With the GASE, neurologists rate the
overall severity of each child's epilepsy using a seven-point scale ranging from
1=extremely severe to 7=not at all severe. The GASE was quick and easy to
complete, demonstrated adequate validity, and high intra- and inter-rater
reliability.18
Family Environment
Three aspects of the family environment (functioning, resources, and demands)
were measured based on parent-report. The Family Adaptability, Partnership,
Growth, Affection, and Resolve (Family APGAR) was used to assess satisfaction with
family relationships.19 The Family APGAR is a five-item instrument where responses
are based on a five-point Likert scale, ranging from 0-4 for each item, with higher
scores indicating higher satisfaction with family functioning. The Family APGAR has
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been found to be valid and reliable in both the clinical and research setting with
adults and children.19-21 The internal consistency reliabilities ranged from 0.86-0.89
in this sample.
The Family Inventory of Resources for Management (FIRM) was utilized to assess
resources available to aid families’ adaptation to stressful events.22 For this study,
only two subscales (family mastery and health, extended family social support),
which have been found to be associated with adaptation to childhood epilepsy, were
used.23 Scoring procedures for the FIRM involve summing all response values, which
range from 0 (not at all) to 3 (very well), to provide a total FIRM score. The FIRM
has demonstrated adequate reliability and validity properties.22 Internal
consistency reliabilities in this sample ranged from 0.91-0.93 for the Family Mastery
and Health subscale and 0.44-0.54 for the Extended Family Social Support subscale.
Family demands were quantified using the Family Inventory of Life Events and
Changes (FILE), which assesses the accumulation of simultaneous normal and nonnormal life events and changes in life events experienced by a family during the
previous year.24 There are 71 items in the FILE with the score computed by giving
each “yes” response a score of one. Summing responses provides a score for each
subscale and the total FILE score. The reliability and validity of the FILE is wellestablished.24 As measured by Cronbach’s α, the overall reliability of the FILE ranged
from 0.98-0.99 in this sample.
Socio-demographic information was also collected including date of birth (mother
and child), child gender, number of children in household, parents’ marital and
employment status, highest level of completed education, and total annual
household income.
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Perception of Patient-centered Care
A modified version of the Patient Perception of Patient-centeredness (PPPC)
questionnaire, based on the Patient-Centered Model of Care, was used to assess
mothers’ perceptions of the extent to which the healthcare services her child
received were patient-centered.25 Seven of the original 14 items were slightly
modified to make them appropriate for parent-report by replacing “your” with
“your child’s” and “you” with “your child”. The PPPC is scored so that low scores
correspond to positive perceptions. Inter-item reliability has been found to be
adequate for the PPPC and evidence for convergent validity was examined with a
significant correlation with the Measure of Patient-centered Communication.26 In
this sample, the internal consistency ranged from 0.77-0.86.
Statistical Analysis
Univariable analyses used to describe maternal depressive symptoms at each
measurement occasion included descriptive statistics and frequency distributions.
Bivariable analyses (t- and χ2-tests) were used to compare mothers who completed
the 24-month follow-up with those who did not complete the study.
Trajectories of self-reported maternal depressive symptoms, as measured by the
CES-D, during the first 24 months after having a child diagnosed with epilepsy were
investigated with a semi-parametric group-based approach (latent class growth
modeling).27 The essence of this method is to use polynomial functions to identify
unobserved patterns of depressive symptoms over time. Through this approach,
distinctive growth trajectories are identified. The degree to which an individual’s
trajectory resembles the prototypic trajectory is estimated and individuals are
categorized into trajectory groups based on the similarity of the individual
trajectory to the prototypic trajectories. A censored normal model was fitted to the
data since there were a number of mothers who exhibited no or few depressive
symptoms, resulting in a cluster of data at the scale minimum. The number of
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groups to be included in the model is guided by a priori expectations, overall model
fit based on the Bayesian Information Criterion (BIC), and posterior probability
scores for each trajectory group. The model with the maximum BIC, optimized
probability scores, and least number of groups is selected. The modeling process
followed the strategy of Campbell, et al.,28 whereby cubic trajectories were specified
for three groups being examined and additional groups were added to the model
and the change in BIC scores examined to determine the best model. In order to
ensure model parsimony (i.e., most statistically efficient model), non-significant
higher-order terms (i.e., quadratic and cubic) were removed and the model was
respecified until optimal fit was achieved.29
Maternal, child, and family characteristics were compared across trajectory groups
using analysis of variance for continuous variables and χ2-tests for categorical
variables. The Bonferroni correction was applied for multiple comparisons. Pairwise
group contrasts (post hoc Scheffé or χ2-test, when appropriate) were examined only
if a statistically significant overall difference was observed across trajectory groups.
Multinomial logistic regression was conducted to identify predictors of depressive
symptom trajectory using baseline data. A backward, stepwise selection approach
using maternal, child, and family characteristics was utilized. Only variables that
were statistically significant in the bivariate comparisons were included in the
regression analysis. In order to generate a robust model, the condition for variables
to enter and remain in the model was set at α=0.20.30 Continuous variables in the
model were categorized into quartiles to increase interpretability of the model. Data
analysis was conducted with Statistical Analysis Software (SAS 9.1.3 Service Pack 4,
SAS Institute Inc., Cary, NC). Group-based trajectory modeling was conducted with
PROC TRAJ as described by Jones, et al.31 All hypothesis tests were two-sided.
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Results
Sample Characteristics
Of the 339 mothers in the study, 258 completed all four measurement occasions and
81 were lost during follow-up. Mothers who did not complete the study were more
likely to be younger (p=0.0002), unmarried (p=0.0040), less educated (p=0.0122),
have lower household income (p=0.0191), and more likely to have a child rated by
his/her neurologist as having cognitive problems (p=0.0146) at baseline compared
to mothers who remained in the study (Table 1). In addition, those who were lost to
follow-up had more depressive symptoms (p=0.0152), fewer family resources
(p=0.0206), and more family demands (p=0.0211) at baseline compared to those
mothers who completed the study.
Mothers had a mean age of 37.7 (5.8) years at baseline. Approximately half of the
children were male (52.2%). Children had a mean age of seizure onset of 6.9 (2.5)
years and a mean age of 7.4 (2.4) years at baseline. Children had a mean score of
70.4 (13.4) on the QOLCE and the majority of children (58.7%) had “a little severe”
or “somewhat severe” epilepsy severity score based on the GASE. Means scores on
family environment measures were as follows: Family APGAR, 14.0 (3.8); FIRM 50.1
(11.1); and, FILE 9.6 (6.5). Additional baseline characteristics of the study sample
are shown in Table 4.1.
Prevalence of Depressive Symptoms
Mothers’ mean CES-D score was 14.6 (10.6) at baseline; 11.7 (9.5) at six months;
12.2 (9.7) at 12 months; and, 12.0 (10.0) at 24 months. At baseline, 37.9% of
mothers scored as being at risk for clinical depression. This proportion changed to
29.9% at six months, 31.5% at 12 months, and 29.5% at 24 months.
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Trajectories of Change in Depressive Symptoms
Based on model fit indices, a four- or five- group model was most appropriate. The
BIC scores for the four- and five-group models were -15320.25 and -15227.58,
respectively. The four-group model was adopted for the analysis not only in the
interest of parsimony (i.e., most statistically efficient model), but also because the
posterior probabilities of group membership were superior for the four-group
model (0.84-0.96, mean=0.89) compared to the five-group model (0.82-0.91,
mean=0.86).
Estimates for the four-group model parameters are shown in Table 4.2. Inspection
of parameter estimates for the model revealed significant variation in the intercept
across groups (F=25.05, p<0.0001). In other words, each group had a significantly
different CES-D score at baseline. Groups one and two were observed to have two
points of inflection (i.e., the point where the trajectory changes from increasing to
decreasing or vice versa). Although it was more pronounced in group two, both
groups were best modeled with the inclusion of a cubic term to represent time in
order to capture these S-shaped trajectories. Group three had only one inflection
point and was best modeled with the inclusion of a quadratic time term to capture
the concave nature of the trajectory. Group four required the inclusion of a simple
linear time term only since the trajectory continued in one direction (i.e.,
decreasing). Figure 4.1 depicts the four distinct trajectories of maternal depressive
symptoms identified in the analysis. As indicated in Figure 1, the predicted and
observed trajectories appear to correspond well with each other, suggesting that the
data fit the model well.
The first trajectory identified was one of consistently low levels of depressive
symptoms (low stable). Almost two-thirds of the sample (n=201, 59.3%) fell into
this trajectory, with a mean CES-D score of 8.3 at baseline, which decreased to 7.2 at
24 months. The second trajectory included 25.1% (n=85) of the sample and is
described as having borderline symptoms. These mothers had variations in
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depressive symptoms during the 24-month follow-up that straddle the cut-off score
(CES-D ≥16) indicating risk for clinical depression. The third trajectory (n=29, 8.6%)
described a group of mothers that had a moderate increasing symptom trajectory
that was relatively stable during the first 12 months of follow-up, then increased
from 12 to 24 months. The fourth trajectory identified included mothers with a high
decreasing trajectory (n=24, 7.1%). The mean CES-D score at baseline in this group
was 37.7 which decreased to 18.1 at 24 months. CES-D scores for each group during
the 24-month follow-up are shown in Table 4.3.
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Figure 4.1. Trajectories of Maternal Depressive Symptoms during the First 24
Months after having a Child Diagnosed with Epilepsy. Solid lines depict observed
trajectories and dashed lines predicted trajectories. CES-D, Center for
Epidemiological Studies Depression Scale.
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Predictors of Depressive Symptoms Trajectories
Maternal, child, and family characteristics were compared across trajectory groups
and results are summarized in Table 4.4. Statistically significant overall effects were
observed for maternal age (p=0.0001), marital status (p=0.0008), educational
attainment (p<0.0001), child health-related quality of life (p<0.0001), and family
functioning, resources, and demands (p<0.0001). Mothers in the low stable group
were more likely to have higher education, children with better health-related
quality of life, and families with better functioning, more resources, and fewer
demands compared to the other trajectory groups. In pairwise contrasts, mothers in
the low stable and borderline group were significantly more likely to be married
compared to both the moderate increasing and high decreasing group. Mothers in
the borderline group were significantly more likely to have fewer family demands
compared to both the moderate increasing and high decreasing groups. In addition,
the borderline group had significantly higher educational attainment, better child
health-related quality of life, and more family resources compared to the high
decreasing group. Mothers in the moderate increasing group were significantly
younger compared to the low stable group.
Predictors of depression symptom trajectory were examined with multinomial
logistic regression. Odds ratios using the low stable group as the reference category
are summarized in Table 5. Briefly, the borderline group was younger (OR=0.53,
p=0.0284), had worse family functioning (OR=0.65, p=0.0101), and fewer family
resources (OR=0.50, p=0.0003). The moderate increasing group was also younger
(OR=0.31, p=0.0141), had children with cognitive problems (OR=9.29, p=0.0043),
worse family functioning (OR=0.50, p<0.0202), and more family demands (OR=4.00,
p=0.0013). The high decreasing group had less education (OR=0.38, p=0.0005) and
lower QOLCE scores (OR=0.42, p=0.0148) compared to the low stable group.
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Discussion
This study used group-based trajectory modeling, a robust statistical method to
identify trajectories of distinct subgroups within a population over time. Whereas
traditional growth curve modeling is generally most useful for investigating
research questions in which all individuals are hypothesized to change in a
homogeneous trajectory over time,32 some phenomena, such as depressive
symptomatology, may exhibit a multinomial pattern whereby inter-individual
variation may exist in both the magnitude and direction of change.27, 28, 32 In such
circumstances traditional growth curve modeling can mask significant differences
and lead to erroneous inferences about changes in population over time. Thus,
group-based

trajectory

modeling

which

considers

potential

multinomial

heterogeneity in change over time was implemented.
Approximately 90% of surveys were completed by a maternal primary caregiver
indicating that it is predominately mothers who assume the primary caregiving
responsibility for children with epilepsy. This is consistent with previous child
health reports in Canada, where it is the mother who performs the role of primary
caregiving to children in the vast majority of cases.33 Findings describing the family
environment in our sample of families with a child with epilepsy were similar to
other samples of children with a chronic illness,24 but less favourable compared to
families of healthy children.34 For example, in a study of families with healthy
children aged 4-15 years, 95% scored above 10 on the Family APGAR, a measure of
satisfaction with family functioning,34 compared to only 81-85% in the current
sample. The extent to which families have experienced an accumulation of life
events in the past year, as measured by the FILE, was quite similar in the current
sample compared to a sample of families with a child with diabetes (9.6 vs. 10.5).24
Mothers’ depressive symptoms, based on the CES-D and assessed at four times over
the 24 months following the diagnosis of epilepsy, were significantly higher than
those reported in a sample of mothers with a healthy child aged 4-10 years
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(p=0.0017).35 The proportion of mothers at risk for clinical depression ranged from
30% to 38% during the four measurement occasions. These results represent twofold higher prevalence rates compared to mothers of healthy preschool children
whose estimates ranged from 14% to 17% during the years leading to school-age.36
Four distinct trajectories of depressive symptoms in mothers of children with newonset epilepsy were identified during the first 24 months after epilepsy diagnosis.
The shapes of trajectories in this sample were similar to several of the trajectories
identified by Campbell, et al. in their study of depressive symptoms in mothers of
children prior to school entry.28 The socio-demographic differences (e.g., maternal
age, education, and income) across groups reported by Campbell, et al. were not
observed in the current study, however. The largest group consisted of mothers
with low stable CES-D scores who generally had more favourable characteristics
(i.e., better child health-related quality of life, and a more positive family
environment) compared to the other trajectory groups. The second largest group
consisted of mothers with borderline depressive symptoms that varied over time
and straddled the CES-D cut-score for risk of clinical depression. This trajectory
pattern is consistent with current research documenting the periodic recurrence of
depression in a large proportion of women.37 The next largest group was composed
of mothers with moderate increasing depressive symptoms during the 24-month
follow-up. The smallest group consisted of mothers with high decreasing depressive
symptoms. This declining trajectory is consistent with previous research
documenting high initial levels of maternal depressive symptoms at child diagnosis
that diminish over time38-42 and with research that suggests resilience among adults
experiencing trauma is a common response to an adverse event, in this case having
a child diagnosed with epilepsy.43 Interestingly, both the moderate increasing and
high decreasing trajectory groups were observed to have significantly elevated
depressive symptoms at each measurement occasion compared to the low stable
group.
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The multinomial predictive model demonstrated that baseline maternal age and
education, child health-related quality of life, child cognitive problems, and family
functioning, resources, and demands play an important role in determining
membership in a specific depressive symptom trajectory. Having a child with
cognitive problems was the strongest risk factor in the model, significantly
predicting membership in the moderate increasing trajectory group. Such results
may be useful for healthcare professionals since they demonstrate that strong
predictors can be obtained using efficient measures that are well-suited for use in
clinical settings. It was not surprising that epilepsy severity did not predict
depressive symptom trajectory. This study included children aged 4-12 years with
relatively less severe and stable epilepsy and showed little variation among children
and over time. Previous research has shown that children with an earlier age of
onset tend to have less favourable prognoses.44 The absence of correlation between
epilepsy severity and the trajectory of mothers’ depressive symptoms may be
attributable to the fact that the age group studied tends to exclude the most
catastrophic epilepsies.
This predictive model may be useful for healthcare professionals in developing a
psychosocial profile of mothers and families post-diagnosis to assess what extent
individuals’ profiles match the collection of risk factors identified for each
depressive symptom trajectory. The model has the potential to aid in predicting
which trajectory might unfold and whether an intervention may be warranted.
Recognizing that resources for mental health services are limited, priority for early
intervention should be directed at mothers with increasing depressive symptoms in
an effort to improve such an unfavorable trajectory. Our findings suggest there may
be a window of opportunity to intervene on mothers’ depressive symptoms to
potentially interrupt unfavorable trajectories. Treating maternal depression has
been shown to have immediate significant benefits. Recently in the health
economics literature, Perry demonstrated that treatment of maternal depression
resulted in a reduction of healthcare costs in the six months after having a child
diagnosed with asthma.45 This result supports health policy to invest in training
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paediatric healthcare professionals to detect depressive symptoms in adults. Such a
policy can lead to more efficient use of limited healthcare funds.
Being mindful of the mental and emotional state of caregivers is an important
component of family-centered care, and may present an avenue for intervention
that can potentially improve child outcomes.46 It is a multidisciplinary model of
healthcare delivery that may include, for example, physicians, nurses, psychologists,
and social workers. Family-centered care has been shown to be associated with an
increase in parents’ satisfaction with healthcare services, lower parent stress, and
with positive child health outcomes.47 It is understandable how maternal depressive
symptoms can become easily over-shadowed by a presenting child’s epilepsy during
the medical encounter. Healthcare professionals in this situation should be active in
considering how the family environment influences the illness process and vice
versa. The Bright Futures health promotion initiative encourages paediatric
healthcare professionals to support families as part of providing care to children
and

recommends

depression.48,

49

open

questioning

surrounding

symptoms

of

maternal

It is a collaboration of the American Academy of Paediatrics and

other institutional projects that provide resources for healthcare professionals
guided by the principle that “every child deserves to be healthy and that optimal
health involves a trusting relationship between the health professional, the child,
the family, and the community” (http://www.brightfutures.org). There is value in
more formally considering mothers’ mental health during the clinic visit. Referrals
to a social worker or local epilepsy support centers are resources that can be offered
soon after diagnosis to help ensure the best possible outcomes for families.
This study has several strengths. First, to our knowledge this is the only study to
prospectively document the course of depressive symptoms of mothers of children
with epilepsy. In addition, the relatively large sample and strong response and
retention rates increase the external validity of findings. Second, this study utilized
the CES-D, a well-validated and reliable instrument to measure maternal depressive
symptoms. Third, this study focused on incident rather than prevalent cases of
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childhood epilepsy. Results may be useful for healthcare professionals as part of the
initial consultation when diagnosing childhood epilepsy so as to prevent any
potential negative impact of maternal depressive symptoms on child health
outcomes.
This study also has some limitations. First, the sample under study was recruited
from paediatric neurology practices that may not be representative of all families of
a child with epilepsy, thus potentially limiting external validity. While it may be that
some children are diagnosed and treated for new-onset epilepsy by a primary care
paediatrician or family practitioner, it was not feasible to recruit a random sample
of such physicians in a large national study. In the absence of population-based
registries for epilepsy to facilitate such studies, Speechley et al. demonstrated that it
may be feasible to recruit a representative population-based sample of children
with epilepsy by targeting paediatric neurologists.50 In this study, family physicians
practicing in southwestern Ontario, reported they would refer between 80-99% of
their patients with childhood epilepsy (depending on the type of seizure and
syndrome) to a paediatric neurologist.
Second, it is important to consider that mothers with higher levels of depressive
symptoms and other risk factors for clinical depression51 were less likely to
complete the 24-month follow-up compared to mothers who did not exhibit such
traits. A similar trend has been observed in other research of mothers with
depressive symptoms.52, 53 Bias due to losses during follow-up may under-estimate
the proportion of mothers at risk. When baseline characteristics of mothers who did
not complete the study were compared to characteristics from each trajectory
group, results showed that those lost during follow-up most closely resembled the
moderate increasing group (i.e., younger, less likely to be married, lower
socioeconomic status, and less favourable family environment). This means that the
group of mothers classified as having what might be characterized as the most
concerning pattern of depressive symptoms, that of moderate increasing, may
actually be larger than estimated.
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Third, since this study relied on mothers’ perceptions of measures for both
exposures and outcomes, there was potential for mothers’ reports to be biased,
threatening the study validity. This phenomenon, more commonly known as
depression distortion,54 was thoroughly investigated in a previous analysis using a
series of regression analyses to determine if the association between mothers’ and
neurologists’ reports of child health outcomes varied significantly when stratified by
level of maternal depressive symptoms; results suggested no evidence of informant
discrepancy in this sample of mothers.55
Conclusion
Risk for clinical depression is very common among mothers of children with newonset epilepsy and decreases during the first 24 months of diagnosis. This research
has demonstrated that mothers of children with new-onset epilepsy are not a
homogeneous group of women with a single trajectory of change in depressive
symptoms over time, but instead consist of distinct heterogeneous groups. Having a
child with cognitive problems was the strongest risk factor in the model,
significantly predicting those mothers who fell into the moderate increasing
depressive symptoms trajectory group. It is important for healthcare professionals
caring for children with epilepsy to be aware of how diagnosing epilepsy in a child
can impact the mothers’ mental health status. By adopting a family-centered
approach, healthcare professionals may be able to alter trajectories of depressive
symptoms in mothers to in turn promote more positive child outcomes.
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Table 4.1. Sample Baseline Characteristics of Mothers of Children with New-onset Epilepsy.*
Study Sample Completed Follow-up
Lost to Follow-up
N
339
258
81
Maternal Characteristics
Age, years
Marital Status, %
Not Married
Married†
Employment Status, %
Not Employed
Employed
Homemaker
Student
Education, %
Primary School
High School
Technical Training
College/University
Number of Children
Depressive Symptoms, CES-D
Child Characteristics
Age, years
Sex, %
Male
Female
Seizure Type, %
Generalized
Partial

t / χ2

P-value

37.7 (5.8)

38.4 (5.5)

35.6 (6.2)

3.73

0.0002

19.8
80.2

16.3
83.7

30.9
69.1

8.27

0.0040

9.5
66.1
22.9
1.5

7.8
68.5
22.6
1.2

15.2
58.2
24.1
2.5

5.26

0.1539

11.5
20.9
13.6
54.0
2.3 (0.9)
14.6 (10.6)

8.5
20.2
14.3
57.0
2.3 (0.9)
13.8 (10.4)

21.0
23.5
11.1
44.4
2.5 (1.0)
17.0 (10.4)

10.91

0.0122

-1.67
-2.44

0.0953
0.0152

7.4 (2.4)

7.5 (2.4)

7.4 (2.4)

0.23

0.8166

52.2
47.8

51.6
48.4

54.3
45.7

0.19

0.6632

38.6
61.4

37.3
62.7

42.9
57.1

0.77

0.3808
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Quality of Life, QOLCE
Epilepsy Severity, GASE
Co-morbidities, %
Behaviour Problems
Cognitive Problems
Motor Problems

70.4 (13.4)
5.4 (1.2)

71.1 (13.5)
5.4 (1.1)

68.2 (12.9)
5.3 (1.3)

1.64
0.87

0.1030
0.3845

14.1
13.6
6.3

13.3
10.2
5.9

16.5
24.3
7.8

2.46
12.41
0.95

0.4835
0.0146
0.6234

13.4 (3.4)
47.6 (10.3)
11.2 (7.4)
1.6 (0.5)

1.54
2.33
-2.34
-0.17

0.1241
0.0206
0.0211
0.8613

14.3
18.2
16.9
23.4
26.0
1.3

13.50

0.0191

Family Characteristics
Functioning, Family APGAR
14.0 (3.8)
14.1 (3.9)
Resources, FIRM
50.1 (11.1)
50.9 (11.3)
Demands, FILE
9.6 (6.5)
9.1 (6.2)
Perception of Patient-centered
1.6 (0.5)
1.6 (0.5)
Care, PPPC
Annual Household Income, %
< $20,000
7.7
5.7
$20,000-39,999
13.5
12.1
$40,000-59,999
21.2
22.6
$60,000-79,999
18.2
16.5
≥ $80,000
37.2
40.7
Unknown
2.2
2.4
*Reported as mean (standard deviation), unless otherwise stated.
†Includes those in married and common-law relationships.
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Table 4.2. Parameter Estimates for the Four-group Trajectory Model of
Depressive Symptoms in Mothers of Children with Epilepsy during the First 24
Months after Diagnosis.
Standard
Group % Sample Parameter
Estimate
t
P-value
Error
1
59.3
Intercept
14.1
1.8
8.03
<0.0001
Linear
-8.5
2.5
-3.38
0.0007
Quadratic
2.8
1.0
2.76
0.0058
Cubic
-0.3
0.1
-2.38
0.0173
2

25.1

Intercept
Linear
Quadratic
Cubic

34.7
-25.1
10.2
-1.2

3.3
4.6
1.8
0.2

10.43
-5.48
5.54
-5.59

<0.0001
<0.0001
<0.0001
<0.0001

3

8.6

Intercept
Linear
Quadratic

32.1
-9.9
2.0

1.8
1.5
0.2

17.43
-6.81
8.36

<0.0001
<0.0001
<0.0001

4

7.1

Intercept
41.2
1.2
33.81
<0.0001
Linear
-4.5
0.4 -12.61
<0.0001
Group 1 represents mothers with low stable depressive symptoms, Group 2
borderline symptoms, Group 3 moderate increasing symptoms, and Group 4 high
decreasing symptoms.
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Table 4.3. Maternal Depressive Symptoms over Time, Stratified by Trajectory Group.*
Trajectory Group
Moderate
High
Measurement Occasion
Low Stable
Borderline
Increasing
Decreasing
1 (baseline)
8.4 (5.5)
18.9 (6.6)
25.6 (7.8)
37.7 (7.1)
2 (6 months)
6.2 (4.7)
16.5 (7.1)
21.8 (8.8)
31.1 (5.9)
3 (12 months)
6.6 (4.7)
19.5 (7.7)
21.2 (8.7)
28.4 (10.7)
4 (24 months)
7.2 (5.8)
15.7 (7.2)
34.4 (6.6)
18.1 (7.6)
*Reported as mean (standard deviation).
†No significant difference between borderline and moderate increasing groups.
‡No significant difference between borderline and high decreasing groups.

F

P-value

227.1
162.5
123.7
132.1

<0.0001†
<0.0001†
<0.0001†
<0.0001‡

89

Table 4.4. Baseline Characteristics of Mothers of Children With New-onset Epilepsy, Stratified by Trajectory Group.*
Trajectory Group
Moderate
High
Pairwise
Low Stable
Borderline
F / χ 2 P-value
Increasing
Decreasing
Contrasts
Maternal Characteristics
Age, years
38.7 (5.6)
37.1 (5.5)
34.2 (6.2)
35.7 (5.6)
6.99
0.0001
1>3
†
Married , %
85.5
80.0
62.1
58.3
16.76
0.0008
1 > 3, 4
2 > 3, 4
Employed, %
67.3
73.5
44.8
54.2
9.52
0.0231
College/University, %
63.0
45.9
41.4
20.8
21.25 <0.0001
1>2–4
2>4
Child Characteristics
Age, years
Male, %
Partial Seizures, %
Quality of Life, QOLCE
Epilepsy Severity, GASE
Co-morbidities, %
Behaviour Problems
Cognitive Problems
Motor Problems
Family Characteristics
Functioning, Family
APGAR
Resources, FIRM
Demands, FILE

7.6 (2.3)
53.5
61.0
73.6 (12.6)

7.2 (2.3)
52.9
56.1
68.4 (12.2)

7.0 (2.5)
48.3
71.4
65.7 (11.3)

7.9 (2.8)
45.8
69.6
56.4 (15.0)

1.04
0.3761
0.72
0.8886
2.81
0.4212
14.86 <0.0001

5.5 (1.2)

5.3 (1.2)

5.2 (1.2)

5.3 (1.0)

0.69

0.5603

10.1
5.9
4.5

18.3
19.5
9.8

20.7
25.0
10.7

26.1
17.4
4.4

7.65
9.25
3.78

0.0539
0.0262
0.2859

15.1 (3.2)

12.6 (3.3)

12.4 (4.1)

10.8 (5.3)

20.05 <0.0001

1>2–4

54.6 (8.6)

44.8 (10.7)

43.9 (9.9)

38.8 (13.3)

37.74 <0.0001

7.9 (5.5)

10.3 (6.8)

14.4 (5.3)

14.9 (8.5)

17.44 <0.0001

1>2–4
2>4
1<2–4

1>2-4
2>4
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Perception of Patient1.5 (0.5)
1.7 (0.6)
1.4 (0.3)
centered Care, PPPC
Income ≥$80,000, %
40.3
38.3
20.7
*Reported as mean (standard deviation), unless otherwise stated.
†Includes those in married and common-law relationships.

1.7 (0.6)

2.56

0.0550

26.1

5.75

0.1243

2 < 3, 4
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Table 4.5. Multinomial Logistic Regression Identifying Baseline Predictors of
Depressive Symptoms Trajectory Group Membership.*
Trajectory Group
Low
Moderate
High
Borderline
†
Stable
Increasing
Decreasing
Maternal Age
1.00
0.53
0.31
0.64
(0.31, 0.94)
(0.12, 0.79)
(0.27, 1.52)
Maternal Education
1.00
0.88
0.91
0.38
(0.64, 1.20)
(0.53, 1.55)
(0.22, 0.65)
Child Quality of Life
1.00
0.90
1.10
0.42
(0.65, 1.23)
(0.63, 1.94)
(0.21, 0.84)
Child Cognitive Problems
1.00
2.00
9.29
0.56
(0.70, 5.71) (2.01, 42.88)
(0.09, 3.54)
Family Functioning
1.00
0.65
0.50
0.64
(0.46, 0.90)
(0.28, 0.90)
(0.36, 1.16)
Family Resources
1.00
0.50
0.72
0.69
(0.35, 0.73)
(0.37, 1.41)
(0.34, 1.40)
Family Demands
1.00
0.91
4.00
2.00
(0.65, 1.30)
(1.72, 9.31)
(0.95, 4.21)
*Reported as odds ratio (95% confidence interval).
†Reference group.
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Chapter Five
The Impact of Maternal Depressive Symptoms on Health-Related Quality of
Life in Children with Epilepsya
Introduction
Maternal depressive symptoms have been linked to a host of child health outcomes.
Most commonly, children of mothers with depression are at a significantly higher
risk for depression and behavior problems as compared to children of mothers
without depression.1, 2 In childhood epilepsy, few studies have specifically focused
on the impact of maternal depressive symptoms on child health outcomes. Early
work by Hoare and Hoare and Kerley demonstrated that psychiatric disturbances in
mothers were associated with psychiatric problems in children.3,

4

These results

were verified by more recent work by Adewuya and Ola, which showed that
psychiatric morbidity in parents was significantly associated with anxiety and
depression in adolescents with epilepsy.5 Two studies have examined the impact of
maternal depressive symptoms on behavior problems in children with epilepsy and
found a positive association between maternal depressive symptoms and child
behavior problems.6,

7

Three studies have assessed the impact of maternal

depressive symptoms on child health-related quality of life revealing some support
for a negative impact of maternal depressive symptoms on overall health-related
quality of life in children with epilepsy.7-9
Our recent systematic review found that previous studies examining the impact of
maternal depressive symptoms on child outcomes in epilepsy suggested a need for
more methodologically robust research.10 While studies generally reported a
negative association between maternal depressive symptoms and child outcomes,
aA

version of this section was published elsewhere as, Ferro MA, Avison WR, Campbell MK, Speechley
KN. The impact of maternal depressive symptoms on health-related quality of life in children with
epilepsy: a prospective study of family environment as mediators and moderators. Epilepsia
2011;52(2):316-25.
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several limitations in study design including a lack of prospective cohort studies,
inclusion of non-representative samples, and sampling procedures prone to
selection bias make it difficult to reach definitive conclusions. Thus, there is a need
to prospectively assess how maternal depressive symptoms may impact healthrelated quality of life in children newly-diagnosed with epilepsy.
The objectives of this research were to examine the impact of maternal depressive
symptoms on health-related quality of life in children with new-onset epilepsy and
to identify family factors that moderate and mediate this relationship during the
first 24 months after epilepsy diagnosis. Given that previous work in this population
has shown that, on average, child health-related quality of life improves during the
first 24 months after diagnosis,11 it was hypothesized that depressive symptoms in
mothers would negatively impact children’s health-related quality of life, such that
children of mothers with elevated levels of depressive symptoms would have poorer
health-related quality of life and less favourable rate of change during the 24-month
follow-up. Also, it was hypothesized that the negative impact of maternal depressive
symptoms on child health-related quality of life would be moderated by family
resources and maternal perception of the healthcare received by her child. Finally, it
was hypothesized that this relationship would be mediated by family functioning
and family demands such that elevated levels of depressive symptoms would lead to
worse family functioning and more family demands, resulting in poorer child healthrelated quality of life during follow-up.
Methods
Sample and Data Source
Data for this study came from the Health-related Quality of Life of Children with
Epilepsy Study (HERQULES), a prospective cohort study designed to examine the
determinants of health-related quality of life in children with epilepsy during the
first 24 months post-diagnosis. Participants were recruited primarily from
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paediatric tertiary-care neurology practices across Canada, with a minority
recruited from community-based paediatric neurology practices. The inclusion
criteria for patients were as follows: 1) new case of epilepsy (≥2 unprovoked
seizures), in whom diagnosis of epilepsy has not been previously confirmed, seen
for the first time by a participating paediatric neurologist within the data collection
period; 2) epilepsy diagnosed between the ages of 4-12 years; and, 3) parent must
have been primarily responsible for the child's care for ≥6 months and continue to
be for the duration of the study. Children with newly-diagnosed epilepsy with a
prior history of neonatal seizures were included if medication was removed by six
weeks of age without recurrence. Patients were excluded from the study if: 1)
diagnosis of epilepsy had been previously confirmed by another physician; 2)
diagnosed with other progressive or degenerative neurological disorder (e.g.,
mental retardation); 3) diagnosed with other major co-morbid non-neurological
disorders that would have an impact on quality of life (e.g. asthma requiring daily
medication, renal failure); and, 4) parent had insufficient English language skills to
complete questionnaires.
In the absence of population-based registries for epilepsy to facilitate such studies,
Speechley et al. demonstrated that it may be feasible to recruit a representative
population-based sample of children with epilepsy by targeting paediatric
neurologists.12 In this study, family physicians practicing in southwestern Ontario,
reported they would refer between 80-99% of their patients with childhood
epilepsy (depending on the type of seizure and syndrome) to a paediatric
neurologist. Primary caregivers were contacted by telephone to determine
participation status and mailed questionnaires for self-administration after
diagnosis (baseline), and at six, 12, and 24 months. A modified version of the
Tailored Design Method was used to develop a structured follow-up strategy to
enhance retention rates.13 Of the 456 eligible families approached to participate,
443 (97.1%) verbally consented. Of these, 374 (83.7%) completed the baseline
survey. For this analysis, only surveys completed by a child’s mother (i.e., biological,
adoptive, foster) were retained and used in the analysis 339 (91.0%). Approval for
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HERQULES was obtained from all relevant research ethics boards across the
country and parents provided written consent.
Measures
Child health-related quality of life
Child health-related quality of life was reported by mothers using the Quality of Life
in Childhood Epilepsy (QOLCE).14 The QOLCE is a multifaceted, parent-report,
epilepsy-specific instrument for evaluating health-related quality of life of children
with epilepsy aged 4-18 years. The QOLCE contains 76 items with 16 subscales
spanning seven domains of life function including, physical activities, social
activities, cognition, well-being, behavior, general health, and general quality of
life.14 Items are rated on a five-point Likert scale, which are used to calculate the 16
subscale scores ranging from zero (low functioning) to 100 (high functioning). The
subscale scores are averaged to produce an overall health-related quality of life
score. It has demonstrated good construct validity, internal consistency reliability,
and sensitivity to epilepsy severity.15 The internal consistency reliabilities were
excellent for all measurement occasions in this sample (0.92-0.94).
Epilepsy Characteristics
Neurologists completed a questionnaire documenting the clinical factors of each
child’s epilepsy including: severity of epilepsy, seizure type and frequency, type of
epilepsy syndrome, age at onset and diagnosis, medication information, and adverse
effects. Neurologists were also asked to rate the presence of comorbidities using
single-item measures, specifically, any behavior (0=none to 3=severe), cognitive
(0=none to 4=severe), or motor problems (0=none to 3=severe). Severity of epilepsy
was classified using the Global Assessment of Severity of Epilepsy (GASE), a singleitem measure developed for HERQULES.16 Using the GASE, neurologists rate the
overall severity of each child's epilepsy using a seven-point scale ranging from
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1=extremely severe to 7=not at all severe. The GASE has demonstrated minimum
burden on participants, adequate content, convergent, and construct validity, and
high intra- and inter-rater reliability.16
Maternal Depressive Symptoms
Level of depressive symptoms in mothers was measured with the Center for
Epidemiological Studies Depression Scale (CES-D), a 20-item questionnaire
designed to assess depressive symptoms over the past week.17 The scale includes 20
items that survey mood, somatic complaints, interactions with others, and motor
functioning. A four-point Likert scale (0-3) is used to rate the frequency of
symptoms experienced. The total score spans from 0-60, with a higher score
indicating greater impairment. Individuals with a total score of ≥16 are typically
identified as being at risk for clinical depression. In this sample, internal consistency
estimates were good, ranging from 0.75-0.80.
Family Environment
Three aspects of the family environment (functioning, resources, and demands)
were measured based on parent-report. The Family Adaptability, Partnership,
Growth, Affection, and Resolve (Family APGAR) was used to assess satisfaction with
family relationships.18 The Family APGAR is a five-item instrument where responses
are based on a five-point Likert scale, ranging from 0-4 for each item. Higher scores
indicate higher satisfaction with family functioning. The Family APGAR has been
found to be valid and reliable in both the clinical and research setting with adults
and children.18-20 The internal consistency reliabilities in this sample were very
good, with Cronbach’s α ranging from 0.86-0.89.
The Family Inventory of Resources for Management (FIRM) was utilized to assess
resources available to aid families’ adaptation to stressful events.21 For this study,
only two subscales (family mastery and health, extended family social support)
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which have been found to be associated with adaptation to childhood epilepsy were
used.22 Scoring procedures for the FIRM involve summing all response values, which
range from 0 (not at all) to 3 (very well) to provide a total FIRM score. The FIRM has
demonstrated adequate reliability and validity properties.21 Internal consistency
reliabilities in this sample ranged from 0.91-0.93 for the Family Mastery and Health
subscale and 0.44-0.54 for the Extended Family Social Support subscale.
Family demands were quantified using the Family Inventory of Life Events and
Changes (FILE), which assesses the pile-up of simultaneous normal and non-normal
life events and changes in life events experienced by a family during the previous
year.23 There are 71 items in the FILE with the score computed by giving each “yes”
response a score of one. Summing responses provides a score for each subscale and
the total pile-up score. The reliability and validity of the FILE is well-established.23
As measured by Cronbach’s α, the overall reliability of the FILE was excellent,
ranging from 0.98-0.99 in this sample.
Socio-demographic information was also collected including date of birth (mother
and child), child gender, number of children in household, parents’ marital and
employment status, highest level of completed education, and total annual
household income.
Perception of Patient-centered Care
Based on the Patient-Centered Model of Care, a modified version of the Patient
Perception of Patient-centeredness (PPPC) was used to assess mothers’ perceptions
of the extent to which the healthcare services her child received were patientcentered.24 Seven of the original 14 items were slightly modified to make them
appropriate for parent-report by replacing “your” with “your child’s” and “you” with
“your child”. The PPPC is scored so that low scores correspond to positive
perceptions. Inter-item reliability has been found to be adequate for the PPPC and
validity was established through a significant correlation with the Measure of
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Patient-centered Communication.25 In this sample, the internal consistencies were
good, ranging from 0.77-0.86.
Statistical Analysis
Univariable analyses used to describe maternal depressive symptoms at baseline
included descriptive statistics and frequency distributions. Individual growth curve
modeling was used to examine the impact of maternal depressive symptoms on
child health-related quality of life during the 24-month follow-up.26 Such an
approach can handle designs with repeated measures. The models were built
following the guidelines suggested by Singer.27 In particular, time since child was
diagnosed with epilepsy and maternal depressive symptoms as time-varying
predictors of child health-related quality of life. Both the model intercept and slope
were specified as random effects (i.e., differing for each individual in the sample). An
unstructured variance-covariance matrix was specified, which is the most
heterogeneous type and requires estimation of several parameters, thus additional
degrees of freedom, but does not constrain any pairwise comparisons within the
matrix, allowing for additional flexibility.28 Variables were centered on their
respective sample means at 24 months to improve interpretation of results.
Potential confounders were tested a priori to the growth curve modeling. The
variables tested were child age, child sex, epilepsy severity, seizure type, age of
onset, severity of co-morbidities, anti-epileptic drug use, maternal age, education,
employment status, parity, marital status, and family income. Confounding was
determined by adding the variable to the model to examine the change in the effect
estimate. For the purposes of this study, a collapsibility criterion was used to
operationally define confounders as those variables, when entered in the model
resulted in a ≥10% change in the effect estimate of maternal depressive symptoms
on child health-related quality of life.29
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Moderation was examined by sequentially testing growth curve models of child
health-related quality of life regressed on maternal depressive symptoms in the
presence of each potential moderator using a product interaction term.30 To
examine whether family resources or perception of patient-centered care
moderated the impact of maternal depressive symptoms on child health-related
quality of life at the 24-month follow-up, a two-way interaction between maternal
depressive symptoms and the moderator was entered in the model. A three-way
interaction between maternal depressive symptoms, the moderator, and time was
entered to examine whether the magnitude of the moderating effect varied over
time. The moderation analyses conformed to Kleinbaum’s Hierarchy Principle such
that maternal depressive symptoms and moderator main effects were included in
the model assessing the interaction term.31
The product of coefficients method described by MacKinnon et al. was used to
examine the potential mediating effects of family functioning and family demands
on the relationship between maternal depressive symptoms and child healthrelated quality of life as illustrated in Figure 5.1.32 The product of coefficients
method has been shown to have more accurate type I error rates and greater
statistical power compared to the more traditionally employed causal steps
described by Baron and Kenny.33 Instead the product of coefficients approach
involved estimating two growth curve models and computing the product of ̂ and ̂
to form the mediated or indirect effect.

The rationale behind this approach is that mediation is dependent upon the extent
to which the predictor impacts the mediator, α, and the extent to which the
mediator impacts the outcome, β. The proportion of the total effect that is mediated
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was calculated using a ratio of the indirect effect, ̂ , divided by the total effect,
̂

̂ . Significance of the mediated effect was tested by dividing the product by its

standard error and compared to the standard normal distribution and by
construction of confidence intervals. The standard error of ̂ was calculated using
the method described by Sobel.34 The Sobel method is the most commonly used
approach to calculating the standard error and has been shown to produce unbiased
and statistically robust results.32 Growth curve models used in the mediation
analysis were adjusted for potential confounding factors using the methods
described by Li et al. in order to obtain unbiased estimates of effect. 35 Data analysis
was conducted with Statistical Analysis Software (SAS 9.1.3 Service Pack 4, SAS
Institute Inc., Cary, NC). All hypothesis tests were two-sided with α=0.05.
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Time 2
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Time 4

Family Functioning
Family Demands
Time 1
Time 2
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Time 4

Time 1
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Depressive
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Health-related
Quality of Life

Time 2
Time 3

Time 4

Figure 5.1. Hypothesis of the Mediational Relationship between Maternal
Depressive Symptoms and Child Health-related Quality of Life. The illustration
represents a dynamic model that incorporates prospective measurements on each
variable during the 24-month follow-up.
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Missing Data
Handling missing data for children’s health-related quality of life followed the
strategy described by Wirrell et al.36 Briefly, if less than 20% of subscores in the
QOLCE were missing, the child’s health-related quality of life score was calculated
by determining the mean for the other subscales, and applying that mean value for
the missing subscale(s). If more than 20% of subscales were missing, that
participant was excluded from analysis. The number of participants for whom
missing data prevented calculation of a QOLCE score was not systematic over the
24-month follow-up (n=28, n=28, n=24, and n=15 for baseline, and 6, 12, and 24
months, respectively). Because of the extensive use of covariates in the models
examined in this study, it was assumed that the probability of “missingness” was not
dependent on any unobserved data and thus, the data did not violate the
requirements for data that are missing at random. This is a required assumption for
growth curve modeling using PROC MIXED. Participants with at least one
measurement occasion were included in the analysis.
Results
Sample Characteristics
A total of 339 mothers were included in the study. Mothers had a mean age of 37.7
(standard deviation 5.8) years at baseline. Approximately half of the children were
male (52.2%). Children had a mean age of seizure onset of 6.9 (2.5) years and a
mean age of 7.4 (2.4) years at baseline. Children had a mean score of 70.4 (13.4) on
the QOLCE and the majority of children (58.7%) had “a little severe” or “somewhat
severe” epilepsy using the GASE score. Mean scores on family environment
measures were as follows: Family APGAR, 14.0 (3.8); FIRM 50.1 (11.1); and, FILE 9.6
(6.5) indicating that families were functioning well, had adequate resources and
relatively few demands on them. Additional baseline and 24-month characteristics
of the study sample are shown in Table 5.1. At baseline, 38% of mothers scored
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above the cut-point for risk of depression (i.e., CES-D ≥16). This proportion
decreased to 30% at 24 months.
Impact of Maternal Depressive Symptoms on Child Health-related Quality of Life
Growth curve models for changes in child health-related quality of life over time are
shown in Table 5.2. Potential confounders were tested a priori to fitting the growth
curve models and none met the criterion for inclusion, thus in the interest of model
parsimony, unadjusted models are presented. There was significant improvement in
model fit between each step in the modeling strategy (χ2=86.3, df=1, p<0.0001;
χ2=114.5, df=2, p<0.0001). In the first model, a mean score of 73.1 on the QOLCE
was observed for the unconditional means model which assumes static healthrelated quality of life over time. The unconditional growth curve model, which
includes a linear function of time, shows that QOLCE scores increase significantly
during the 24-month follow-up (β=1.17, p<0.0001). The final model includes
mothers’ CES-D scores in predicting child QOLCE scores over time. Maternal
depressive symptoms were observed to have a negative impact on both QOLCE
scores at 24 months (β=-0.47, p<0.0001) and on the rate of change in QOLCE scores
during follow-up (β=-0.04, p<0.0250).
Results from each model suggest a need for additional time-varying and timeinvariant predictors of child health-related quality of life, given by the significant
amount of residual variation in the intra- and inter-individual components of the
growth curve models (Table 5.2). Interestingly, there was significant covariance
observed between the intercept and slope in the growth curve models, indicating
that children with higher QOLCE scores also had greater rates of change over time.
Trajectories for mothers with high and low CES-D scores based on results from the
conditional growth curve model are illustrated in Figure 5.2.
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Figure 5.2. Change in Child Health-related Quality of Life over 24 Months. Child
health-related quality of life was measured using the Quality of Life in Childhood
Epilepsy (QOLCE). The solid line represents the trajectory for children of average
mothers; the dotted line represents the trajectory for children of mothers with a
Center for Epidemiological Studies Depression Scale (CES-D) score in the bottom
5%; and, the dashed line represents the trajectory for children of mothers with a
CES-D score in the top 5%.
Moderating Effects of Family Resources and Perception of Patient-centered Care
The potential moderating effects of family resources and perception of patientcentered care were examined by including an interaction term between mothers’
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CES-D scores and the moderator in the growth curve model. Results from the two
models are shown in Table 5.3. Family resources moderated the impact of maternal
depressive symptoms on child health-related quality of life (β=0.25, p<0.0243) and
the magnitude of the moderating effect varied over time (β=0.09, p<0.0212). This
moderating effect is illustrated in Figure 5.3. In contrast, perception of patientcentered care was not observed to significantly moderate the relationship between
maternal depressive symptoms and child health-related quality of life (β=3.48,
p=0.1281).
Mediating Effects of Family Functioning and Family Demands
The product of coefficients method was used to examine the potential mediating
effects of family functioning and family demands in two sets of growth curve models
during the 24-month follow-up. Results from the mediation analyses are shown in
Table 5.4. Family functioning was observed to partially mediate the impact of
maternal depressive symptoms on child health-related quality of life ( ̂ =-0.07,
p=0.0007). The proportion of the total effect of maternal depressive symptoms on
child health-related quality of life mediated by family functioning was 20%. In
comparison, family demands were also observed to partially mediate this
relationship ( ̂ =-0.12, p=0.0006). The proportion of the total effect mediated by
family demands was 29%.
In a post hoc analysis examining the mediating effect of family functioning and
family demands simultaneously in a two-mediator model, the proportion of total
effect mediated was 45% ( ̂ =-0.19, p<0.0001). There was no significant difference
between the family functioning- and family demands-specific effects ( ̂ =0.05,
p<0.8708).
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Figure 5.3. Moderating Effect of Family Resources on the Relationship between
Maternal Depressive Symptoms and Child Health-related Quality of Life over
24 Months. Child health-related quality of life was measured using the Quality of
Life in Childhood Epilepsy (QOLCE).The solid line represents the trajectory for
children with mothers with average levels of depressive symptoms and average
family resources; the dotted line represents the trajectory for children with mothers
with average levels of depressive symptoms and in the bottom 5% for family
resources; and, the dashed line represents the trajectory for children with mothers
with average levels of depressive symptoms and in the top 5% for family resources.
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Discussion
Based on self-reported screening results, pproximately one-third of mothers of
children with new-onset epilepsy are at risk for clinical depression. This proportion
is much higher compared to mothers in the general population, where previous
research suggests that about 17% are considered at risk for depression. 37 When
assessed over the first 24 months after diagnosis of epilepsy, maternal depressive
symptoms appeared to have a significant negative impact on child health-related
quality of life. This result is consistent with previous estimates from cross-sectional
studies that included samples of children with more established epilepsy. 7-9
However, none of these studies focused specifically on mothers of children with
new-onset epilepsy and none followed participants prospectively over time. Not
only do children of mothers with elevated levels of depressive symptoms have
poorer health-related quality of life compared to mothers with low levels of
depressive symptoms, but their rate of change is also significantly less favourable
during the first 24 months after diagnosis. Whereas children of mothers with lower
levels of depressive symptoms have improved health-related quality of life scores
over time, children of mothers with elevated symptoms show no evidence of
improvement.
Results from this study also demonstrated that family resources, but not perception
of patient-centered care, moderated the impact of maternal depressive symptoms
on child health-related quality of life. Children of mothers experiencing depressive
symptoms, but having more family resources, including social support systems, had
significantly improved health-related quality of life during the first 24 months after
diagnosis, compared to child of mothers with fewer family resources. The children
in this latter group actually experienced declines in their health-related quality of
life over time. The moderating effect of family resources on the relationship
between maternal depressive symptoms and child health outcomes in epilepsy has
been observed in previous cross-sectional studies. Baum et al. reported that family
resources moderated the relationships between temperament and internalizing and
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externalizing behavior problems in children with epilepsy38 and Fastenau et al.
noted a moderating effect of family resources on children’s academic achievement.39
Interestingly, the magnitude of the moderating effect of family resources on
maternal depressive symptoms on child health-related quality of life varied
significantly over time. Larger effects were observed at later measurement
occasions during the 24-month follow-up. This is consistent with the Convoy Model
proposed by Kahn and Antonucci.40 The Convoy Model offers a framework within
which to understand how an assembly of family and friends are available as
resources to an individual in times of need. Convoys are dynamic across time and
situations whereby each life change brings with it the potential to reconstitute the
convoy as the individual seeks to construct a network of resources that meets her
support needs.41 In this sample, mothers may observe improvement in their child’s
health-related quality of life with the addition of supportive resources, which may in
turn lead mothers to acquire additional resources, resulting in further
improvements in child health-related quality of life over time. Thus, it appears that
the accumulation of resources is the driving force for the dynamic moderating effect
observed over time. The fact that perception of patient-centered care did not
moderate the impact of maternal depressive symptoms on child health-related
quality of life was unlikely to be the result of missing important effects since the
study was adequately powered to detect statistically significant interactions, as
described by McCarthy.42
In addition, the study demonstrated that family functioning and family demands
partially mediated the impact of maternal depressive symptoms on child healthrelated quality of life during the 24-month follow-up. This result is consistent with
previous research which has shown that current and past depressive symptoms in
mothers are significant predictors of lower family functioning43 and that family
functioning (as measured by parental behavior), mediates the relationship between
maternal depression and child health outcomes in both healthy and chronically ill
paediatric populations.44-46 Elgar et al. showed that the quality of the child’s rearing
environment mediated the impact of maternal depressive symptoms on child and
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adolescent maladjustment over a two-year period.45 In comparison, Lim et al.
showed that parenting quality partially mediated the relationship between maternal
depression and child internalizing behavior problems.46
Being mindful of the mental state of caregivers and the climate of the family
environment is an important component of family-centered care, and may present
avenues for intervention that can potentially improve child outcomes. 47 Familycentered care has been shown to be associated with an increase in parents’
satisfaction with healthcare services, lower parent stress, and with positive child
health outcomes.48 Detection and treatment of maternal depression have been
shown to have immediate significant benefits. Recently in the health economics
literature, Perry demonstrated that treatment of maternal depression resulted in a
reduction of healthcare costs in the six months after having a child diagnosed with
asthma.49 This result supports health policy to invest in training paediatric
healthcare professionals to detect depressive symptoms in adults. Such a policy can
lead to more efficient use of limited healthcare funds.
This study has several strengths. First, to our knowledge this is the only study to
prospectively document the depressive symptoms of mothers of children with
epilepsy. In addition, the relatively large sample and strong response and retention
rates increase the external validity of findings. Second, this study utilized the CES-D,
a well-validated and reliable instrument to measure maternal depressive symptoms.
Third, the potential for bias in mothers’ reports associated with depression
distortion,50 was investigated in this study and no evidence of informant
discrepancy was found in this sample of mothers.51 If it was the case that depressed
mothers’ reports were negatively biased, this bias should be detected by comparing
mothers’ and neurologists’ reports of children’s health-related quality of life. That is,
the association between mothers’ and neurologists’ reports would vary significantly
when stratified by level of maternal depressive symptoms, if mothers’ reports are
biased by symptoms of depression. Interactions, depicted as product terms between
CES-D scores and neurologist-reported measures, were used to determine the
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presence of depression distortion. There was a lack of evidence to support
depression distortion in this sample.51 Fourth, this study focused on incident rather
than prevalent cases of childhood epilepsy. Results may be useful for healthcare
professionals as part of the initial consultation when diagnosing childhood epilepsy
so as to prevent any potential negative impact of maternal depressive symptoms on
child health outcomes.
Results from this study are tempered by a few limitations. First, the fact that
mothers with higher levels of depressive symptoms and other risk factors for
clinical depression were less likely to complete the 24-month follow-up compared
to mothers who did not exhibit such traits.52 A similar trend has been observed in
other research of mothers with depressive symptoms.53, 54 Bias due to losses during
follow-up may under-estimate the proportion of mothers at risk and limit the
external validity of results. Second, although there was no evidence to suggest that
mothers were not valid informants, concerns regarding the accuracy and
acceptability of parent-proxy ratings of children’s health-related quality of life
continue to be raised, because research has shown that children and parents do not
necessarily share similar views about illness.55 While not feasible in the current
study, the young patient’s perspective on the experience with illness should also be
incorporated in future investigations. Third, this sample may not be completely
representative of the Canadian population.56 Compared to women in the general
population, this sample of mothers had a larger proportion with a college or
university education (54.5% vs. 45.9%), income ≥$80,000 (37.2% vs. 28.3%), and
married (80.2% vs. 46.4%). The fact that this sample had a larger proportion of
married women compared to the general population was expected since this study
focused on mothers of children with epilepsy.
Conclusion
The negative impact of maternal depressive symptoms on health-related quality of
life in children with new-onset epilepsy is significant during the first 24 months of
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diagnosis. This research has demonstrated that children of mothers with elevated
levels of depressive symptoms have poorer health-related quality of life over time
and this relationship is moderated by family resources and partially mediated by
family functioning and family demands. It is important for healthcare professionals
caring for children with epilepsy to be aware of how diagnosing epilepsy in a child
can impact the mothers’ mental health status and the family environment. By
adopting a family-centered approach, healthcare professionals may be able to
intervene at the maternal or family level to in turn promote more positive outcomes
in children with epilepsy.
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Table 5.1. Description of Maternal, Child, and Family Characteristics.
Baseline
24 Months
N=339
N=258
Maternal Characteristics
Age, years
37.7 (5.8)
40.4 (5.5)
Marital Status, %
Not Married
19.8
18.1
Married*
80.2
81.9
Employment Status, %
Not Employed
9.5
6.6
Employed
66.1
77.7
Homemaker
22.9
15.2
Student
1.5
0.4
Education, %
Primary School
11.5
5.0
High School
20.9
19.2
Technical Training
13.6
11.9
College/University
54.0
63.9
Number of Children
2.3 (0.9)
2.3 (0.9)
Depressive Symptoms, CES-D
14.6 (10.6)
12.0 (10.0)
Child Characteristics
Age, years
Age at Onset, years
Sex, %
Male
Female
Seizure Type, %
Generalized
Partial
Anti-epileptic Drugs, %
Health-related Quality of Life, QOLCE
Epilepsy Severity, GASE
Co-morbidities, %
Behavior Problems
Cognitive Problems
Motor Problems
Family Characteristics
Functioning, Family APGAR
Resources, FIRM
Demands, FILE
Perception of Patient-centered Care, PPPC
Annual Household Income, %
< $20,000

7.4 (2.4)
6.9 (2.5)

9.4 (2.4)
6.8 (2.5)

52.2
47.8

51.6
48.4

38.6
61.4
68.2
70.4 (13.4)
5.4 (1.2)

37.3
62.7
76.8
75.9 (13.9)
6.3 (1.0)

14.1
13.6
6.3

20.0
17.5
5.7

14.0 (3.8)
50.1 (11.1)
9.6 (6.5)
1.6 (0.5)

14.1 (3.8)
50.7 (11.5)
7.9 (5.8)
1.6 (0.6)

7.7

4.0
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$20,000-39,999
13.5
$40,000-59,999
21.2
$60,000-79,999
18.2
≥ $80,000
37.2
Unknown
2.2
Reported as mean (standard deviation), unless otherwise stated.
*Includes mothers in married and common-law
relationships.

10.0
18.8
18.4
44.0
4.8
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Table 5.2. Growth Models for the Impact of Maternal Depressive Symptoms on
Child Health-related Quality of Life.
Model A
Model B
Model C
Fixed Effects
Final Status
Intercept
73.14 (0.67)*
76.09 (0.85)*
75.88 (0.72)*
CES-D
-0.47 (0.06)*
Rate of Change
Time
1.17 (0.19)*
0.99 (0.15)*
CES-D × Time
-0.04 (0.02)§
Variance Components
Level 1
Intra-individual
Level 2
Final Status
Linear
Covariance

56.26 (2.88)*

41.32 (2.62)*

41.89 (2.70)*

129.31 (11.74)*

166.62 (17.86)*
4.22 (0.90)*
12.36 (3.22)†

133.99 (15.64)*
2.79 (0.82)†
8.95 (2.90)‡

Goodness-of-Fit
Deviance
8224.5
8138.2
8023.7
Values denote β-coefficient (standard error). Model A is the unconditional means
model; Model B is the unconditional growth model; Model C is the growth model
conditional on maternal depressive symptoms.
*p<0.0001, †p<0.001, ‡p<0.01, §p<0.05
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Table 5.3. Moderating Effects on the Relationship between Maternal
Depressive Symptoms on Child Health-related Quality of Life.
Standard
Estimate
P-value
Error
Model A
Final Status
Intercept
77.05
0.81
<0.0001
CES-D
-1.43
1.38
0.3016
Family Resources
0.41
0.06
<0.0001
CES-D × Family Resources
0.25
0.11
0.0243
Rate of Change
Time
1.43
0.20
<0.0001
CES-D × Time
0.18
0.46
0.6976
Family Resources × Time
0.02
0.02
0.2565
CES-D × Family Resources × Time
0.09
0.04
0.0212
Model B
Final Status
Intercept
76.19
0.85
<0.0001
CES-D
-5.62
1.32
<0.0001
Perception of Patient-centered Care
-2.00
1.19
0.0933
CES-D × Perception of Patient-centered
3.48
2.28
0.1281
Care
Rate of Change
Time
1.30
0.20
<0.0001
CES-D × Time
-0.57
0.45
0.1983
Perception of Patient-centered Care ×
0.01
0.39
0.9758
Time
CES-D × Perception of Patient-centered
1.52
0.84
0.0710
Care × Time
Model A includes family resources as the moderating variable and Model B includes
perception of patient-centered care as the moderating variable.

120

Table 5.4. Mediating Effects on the Relationship between Maternal Depressive Symptoms on Child Health-related
Quality of Life.
̂
Equation 1
Equation 2
95% CI
Z-value
P-value
Mediator: Family Functioning
Intercept
76.20 (0.76)*
14.00 (0.20)*
-0.07
-0.11, -0.03
3.39
0.0007
Time
1.08 (0.18)*
-0.02 (0.05)‡
CES-D
-0.30 (0.06)*
-0.11 (0.01)*
Family APGAR
0.64 (0.17)†
Mediator: Family Demands
Intercept
76.14 (0.77)*
Time
1.09 (0.19)*
CES-D
-0.29 (0.07)*
FILE
-0.45 (0.12)†
Values denote β-coefficient (standard error).
CI, confidence interval.
*p<0.0001, †p<0.001, ‡not significant

7.98 (0.28)*
-0.25 (0.08)†
0.27 (0.02)*

-0.12

-0.19, -0.05

3.44

0.0006
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Chapter Six
General Discussion and Conclusions
Introduction
This chapter summarizes the results and implications of the study, discusses the
broader strengths and limitations of the work, and provides future research
directions.
The purpose of this study was to 1) estimate the prevalence and course of
depressive symptoms over 24 months among mothers of children with new-onset
epilepsy; 2) identify subgroups of mothers with similar trajectories of depressive
symptoms; and, 3) assess the family factors involved in the causal pathway between
maternal depressive symptoms and child health-related quality of life over 24
months. As well, the question of whether depressive symptoms affect the validity of
mothers’ reports of child health-related quality of life was examined. Data were
obtained from the Health-related Quality of Life of Children with Epilepsy Study
(HERQULES).
Research evidence reviewed in Chapter Two suggested that approximately onethird of mothers of children with epilepsy experience elevated levels of depressive
symptoms and that maternal, child, and family factors predict risk for clinical
depression. In addition, previous research suggested a negative relationship
between maternal depressive symptoms and child outcomes, particularly healthrelated quality of life. Access to a sample of mothers of children newly-diagnosed
with epilepsy provided a unique opportunity to study these relationships in this
population. This was of interest given that epilepsy is the most common
neurological condition affecting children and that the clinical management of
epilepsy is dynamic during the first year after diagnosis.1, 2 Also, given that mothers
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are most often the primary caregivers for children, it is important to better
understand mothers’ mental health status during this time.
Summary of Results
Sample Characteristics
This study had a good initial response rate and high rate of retention. Over 300
mothers participated. Mothers who were lost to follow-up during the study were
more likely to be younger, not married, less educated, have lower household
income, and more likely to have a child rated by his/her neurologist as having
cognitive problems at baseline compared to mothers who remained in the study. In
addition, those who were lost to follow-up had more depressive symptoms, fewer
family resources, and more family demands at baseline compared to those mothers
who completed the study.
Mothers were approximately 40 years of age at baseline and the majority were
married, employed, and had college/university education. Maternal depressive
symptoms were measured using the 20-item Center for Epidemiological Studies
Depression Scale (CES-D).3 Across all measurement occasions mothers’ mean CES-D
score was slightly below the cut-off for being at risk for clinical depression (CES-D
≥16).
Approximately half of the children in the study were male. Children were
approximately seven years of age at baseline. The majority of children had partial
seizures. As measured by the Quality of Life in Childhood Epilepsy (QOLCE)4 and
Global Assessment of Severity of Epilepsy (GASE),5 children had relatively good
health-related quality of life and benign epilepsy.
Results from measures of family environment [Family Adaptability, Partnership,
Growth, Affection, Resolve (Family APGAR),6 Family Inventory of Life Events and
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Changes (FILE),7 Family Inventory of Resources for Management (FIRM)8] describe
families that were, on average, functioning well, had low stress, adequate resources,
and high socio-economic status.
Depressive Symptoms as Moderating Maternal Reports
Mothers with elevated depressive symptoms were not observed to provide biased
reports of their child’s health-related quality of life. That is, as neurologists reported
higher scores on health-related quality of life outcomes, so did mothers, regardless
of their mental health status. This suggested that mothers were valid informants for
reporting on outcomes pertaining to their child with epilepsy.
Prevalence, Trajectories, and Predictors of Depressive Symptoms
Across all measurement occasions, approximately one-third of mothers were at risk
of clinical depression. These proportions are congruent with previous research that
suggested 12-49% of mothers were at risk of clinical depression.9 These findings
showed that mothers of children with new-onset epilepsy are not a homogenous
group, but instead consist of distinct subgroups with different trajectories and
predictors of depressive symptoms.
Four trajectories of depressive symptoms were identified by statistical modeling.
The first trajectory identified was one of consistently low levels of depressive
symptoms (low stable). Almost two-thirds of the sample fell into this trajectory. The
second trajectory included one-quarter of the sample and was described as having
borderline symptoms. These mothers had marked variations in depressive
symptoms during the 24-month follow-up that straddled the CES-D cut-off score for
clinical depression. The third trajectory described a group of mothers who had a
moderate increasing symptom trajectory that was relatively stable during the first
12 months of follow-up, and then increased from 12 to 24 months. About 9% of
mothers were classified as moderate increasing. The fourth and smallest trajectory
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identified included mothers with a high decreasing trajectory. This trajectory had
the highest CES-D score at baseline that decreased over time.
The low stable group had favourable characteristics that may have provided an
optimal environment for mothers to cope with their child’s epilepsy. With a strong
and supportive family environment, as well as children with relatively good healthrelated quality of life, these mothers maintained low levels of depressive symptoms
that remained stable during the 24-month follow-up.
Compared to the low stable group, the borderline group was younger, had worse
family functioning, and fewer family resources. The variations observed in this
group may reflect the challenges of managing childhood epilepsy and the
unpredictable nature of seizures1,

2

in mothers with less life experiences and

compromised family circumstances.
The moderate increasing group was also younger, had children with cognitive
problems, worse family functioning, and more family demands. This group is
characterized with a moderately high CES-D score during the first 12 months that
increases dramatically from 12 to 24 months after the child’s diagnosis. This
significant increase may be attributable to additional challenges associated with the
child’s health. Child cognitive problems may be an adverse event as the result of
treatment with anti-epileptic drugs.10 As well, this group has the largest proportion
of children with partial seizures which are indicative of a poorer prognosis. 11
Furthermore, coping mechanisms may be challenged as mothers come to the
realization that their children’s illness is not going away. Such hardships or chronic
strains are illustrated in the stress process model to have an impact on mothers’
levels of depressive symptoms.
The high decreasing group had less education and lower child health-related quality
of life. This group of mothers was observed to have an initially high CES-D scores
that declined steadily over time. This initial experience of elevated depressive
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symptoms is congruent with the stress process model that suggests the diagnosis of
epilepsy in a child may have an immediate impact on the mother’s mental health. It
is possible that the initial distress experienced by mothers at diagnosis subsided
during the 24-month follow-up as these mothers came to understand that their
children’s epilepsy can be managed effectively. These mothers also had family
characteristics similar to mothers in the low stable group, which may suggest that
their family environment was conducive to their improvement in depressive
symptoms. Despite their reduction in depressive symptoms, mothers in the high
decreasing group still had significantly higher depressive symptoms at 24 months
compared to the low stable group. It remains unknown whether these mothers
would have continued this trajectory where their depressive symptoms decreased
to levels similar to the low stable group if follow-up continued past 24 months.
Impact of Depressive Symptoms on Child Health-related Quality of Life
Maternal depressive symptoms were observed to have a negative impact on both
child health-related quality of life at 24 months and on the rate of change in healthrelated quality of life during follow-up. There was significant covariance observed in
the growth curve models, indicating that children with better health-related quality
of life at baseline also had greater rates of change in their health-related quality of
life scores over time.
Family resources moderated the impact of maternal depressive symptoms on child
health-related quality of life and the magnitude of the moderating effect varied over
time. A moderator is a variable (e.g., family resources) that changes the direction or
strength of the effect of the exposure (e.g., maternal depressive symptoms) on the
outcome (e.g., child health-related quality of life) and can be tested by examining the
effects of the exposure on the outcome across varying levels of the moderator.12 In
other words, the effect of maternal depressive symptoms on child health-related
quality of life is different for mother-child dyads in families with more compared to
fewer resources. In families with more resources, the negative impact of maternal
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depressive symptoms on child health-related quality of life is negated, and
children’s health-related quality of life improves over time; however, in families
with fewer resources, children’s health-related quality of life worsens over time. In
contrast, perception of patient-centered care was not observed to significantly
moderate the relationship between maternal depressive symptoms and child
health-related quality of life.
Family functioning was observed to partially mediate the impact of maternal
depressive symptoms on child health-related quality of life. Similarly, family
demands were also observed to partially mediate this relationship. A mediator is a
variable (e.g., family functioning, demands) that lies in the causal pathway between
the exposure (e.g., maternal depressive symptoms) and the outcome (e.g., child
health-related quality of life).12 In a subsequent analysis examining the mediating
effect of family functioning and family demands simultaneously, the proportion of
total effect mediated increased. There was no significant difference between the
family functioning- and family demands-specific effects.
The results from the moderation and mediation analysis are important. Managing
epilepsy at the child level through pharmacological interventions is vital; however,
these results provide evidence for intervention at the family level to improve the
health-related quality of life in children with newly-diagnosed epilepsy. By
incorporating the entire family as the focus of care and targeting characteristics
such as maternal depression, family functioning, resources, and demands, a child’s
health-related quality of life can be potentially improved further. Though a mother’s
perception of patient-centered care did not moderate the effect of maternal
depressive symptoms on child health-related quality of life, it is unknown whether
actually adopting family-centered care in the clinical setting will have a positive
effect on the health-related quality of life in children with new-onset epilepsy.
The heterogeneity of depressive symptoms in mothers and its negative impact on
health-related quality of life in children with new-onset epilepsy is an important
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issue that requires clinical consideration by healthcare professionals caring for
these children. Paediatric neurologists should be aware that epilepsy can affect the
entire family and the mental health of mothers can have profound effects on the
course of a child’s illness. Utilizing information gained from the predictor models
developed would require little time in the clinical setting and may provide
important information for determining which depressive symptom trajectory a
mother is likely to belong. Subsequent discussion and potential treatment of
maternal depressive symptoms could then be initiated to potentially prevent or
limit the impact on the child’s health outcomes.
Potential Implications and Applications of Study Results
Screening for Maternal Depression
Recent research has indicated that healthcare specialists in childhood conditions,
including epilepsy, are central to the successful implementation of interventions for
mothers with depressive symptoms as a means to improve child outcomes based on
the family-centered care approach.13-16 Healthcare professionals caring for children
with epilepsy have close contact with families that can foster trust and allow for
open discussions surrounding maternal depression and its treatment. In a sample of
559 mothers with children ≤18 months of age, Kahn et al. observed that at least 85%
of mothers were supportive of having their child’s healthcare professional screen
for depression.17 Olson et al. found that 57% of paediatricians felt a responsibility to
recognize maternal depression and 7% of these felt it was their responsibility to
treat these mothers.15 Confirming the results by Olson et al., a study by Heneghan et
al. demonstrated that 77% of paediatricians surveyed identified maternal
depression in their practice.13 Of these, 82% referred mothers to another healthcare
professional for treatment and 7% treated the patients themselves. The researchers
reported that paediatricians who utilized at least one method to screen for maternal
depressive symptoms were more than two-times more likely to either identify or
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refer or treat mothers compared to paediatricians who did not screen for
depression at all.
In the study by Olson et al., the majority of paediatricians used an unstructured
approach to identifying depression in mothers.15 This informal technique of
identification may limit diagnosis to only more severe cases of maternal depressive
symptoms, thus under-estimating the true burden of this condition and its effect on
children.18 To overcome this barrier, healthcare professionals involved in caring for
children with epilepsy should consider using widely available structured
questionnaires, such as the CES-D in their practices. However, due to the time
required to administer some of these screening questionnaires, researchers have
investigated the psychometric properties of the two-item Patient Health
Questionnaire, and have shown it to yield similar detection rates of maternal
depression as compared to other previously validated measures.19,

20

This

instrument has been endorsed by the United States Preventive Services Task Force
and can be used by healthcare professionals in the paediatric epilepsy setting to
either treat or refer mothers exhibiting depressive symptoms.21, 22
It is anticipated that maternal depressive symptoms can become easily overshadowed by a presenting child’s epilepsy during the medical encounter. Healthcare
professionals in this situation should be active in considering how the family
environment influences the illness process and vice versa. Healthcare professionals
can find useful resources at Bight Futures (http://www.brightfutures.org).23 This
national health promotion initiative encourages paediatric healthcare professionals
to support families as part of providing care to children and recommends open
questioning surrounding symptoms of maternal depression.24, 25
In addition, healthcare professionals caring for children with epilepsy should openly
discuss how maternal mood can affect child outcomes by impacting the quality of
mother-child interactions and parenting behaviour. Information regarding local
epilepsy centers should be provided as early in the treatment process as possible to
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facilitate development of supportive social networks for families. Healthcare
professionals caring for children with epilepsy cannot be expected to make formal
diagnoses of depression in mothers. However, discussing the possibility of a
depressive disorder and its impact on the child and providing referrals, when
indicated, would be appropriate actions for paediatric healthcare professionals.
Such actions may exert their effects upstream in the stress process to buffer the
impact the epilepsy diagnosis has on the mental health status of mothers (Figure
1.1). Routine screening for maternal depression and communication regarding
supportive resources for families may also help mothers adapt more positively to
the hardships and chronic strains associated with childhood epilepsy and
potentially ward off development of clinically relevant levels of depressive
symptoms.
Interventions to Improve Maternal and Child Outcomes
Maternal Depression
This study demonstrated that maternal depressive symptoms negatively impact the
health-related quality of life in children with new-onset epilepsy. Other populationbased research has shown that mothers with depression are at particular risk of
providing their children with suboptimal caregiving environments and these
children are at high risk for development of early-onset psychopathology.26 Given
these important findings, it is of interest to consider whether interventions aimed at
reducing depressive symptoms in mothers would result in more favourable
outcomes for their children.
The Sequenced Treatment Alternatives to Relieve Depression (STAR*D) is a largescale study designed to address this issue.27 This study provided a unique
opportunity to investigate whether successful pharmacological treatment for
mothers with depression would lead to improvement in psychiatric disorders and
symptoms among their children. The study of outcomes in these children is referred
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to the STAR*D-Child.28,

29

In a recent study of 151 mother-child dyads followed

during the year after initiation of treatment, results showed that decreases in the
severity of maternal depression were significantly associated with decreases in the
number of psychiatric symptoms in children.30 Subgroup analysis showed that
children whose mothers achieved remission of depressive symptoms had
significantly fewer psychiatric symptoms compared to children whose mothers did
not achieve remission. Furthermore, results were more favourable for children of
early remitters (i.e., ≤3 months following initiation of treatment) compared to late
remitters (i.e., ≥3 months following initiation of treatment). In another study using
STAR*D-Child participants, remission of maternal depression was associated with
improvements in child-reported parenting/family functioning, which mediated the
relationship between maternal depression remission and child internalizing
behaviour problems.31
Other researchers have investigated how non-pharmacological treatment of
maternal depression can impact child behaviour problems. Verduyn et al. conducted
a randomized, placebo-controlled trial to evaluate the effect of group cognitivebehavioural therapy on child behaviour problems and maternal depression in a
group of 119 women with children up to four years of age.32 Three treatment groups
were evaluated: cognitive-behavioural therapy, mothers’ support group, and no
intervention. Significant improvements in child behaviour problems and maternal
depression were observed at 12 months for those mothers randomized to cognitivebehavioural therapy, whereas no improvements were observed for mothers or
children in the control groups.
Only one study has investigated reducing depression in mothers of children with
epilepsy. Using a pre-/post-test quasi-experimental design, Mu and Chang
developed a program to enhance resiliency by reducing family boundary ambiguity
and maternal depression in a small sample of mothers of children with epilepsy. 33
The first stage of the intervention involved an assessment of parental needs,
boundary ambiguity, and maternal depression completed by the child’s mother. The
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second and third stages involved an in-depth interview to construct the meaning of
the families’ experience and needs and an investigator-led educational dialogue.
Three months after the intervention, there was a significant improvement in
maternal depression.
These studies are encouraging. They provide evidence that successful treatment of
mothers with depression may result in significant changes in the family
environment,

which

have

implications

for

reducing

children’s

risk

of

psychopathology. Such results are congruent with the direction of causality
suggested in the stress process model. This suggests the value of treating maternal
depression to improve health outcomes in children. However, it is unknown
whether such interventions can positively impact the health-related quality of life in
children with epilepsy, or other chronic illnesses.
Family-centered Care
Evidence suggests that childhood chronic illnesses impact entire families, but also
that the family environment is able to impact the illness process. DeMaso et al.
demonstrated that mothers’ behaviour and perceptions of child expectations, stress,
and severity of the condition were better predictors of child outcomes compared to
more objective clinical measures in children with congenital heart disease. 34 In their
study, 33% of the variability in child adjustment was accounted for by maternal
perceptions, whereas illness severity accounted for only 3% of the total variability.
This suggests that healthcare professionals caring for children should adopt familycentered care strategies and be mindful of the mental and emotional state of parents
since these may present avenues for intervention that can potentially improve child
outcomes. Given this important preliminary work, it is important to consider
whether interventions that incorporate family-centered care strategies are effective
at improving child health outcomes.
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A recent study by Shaw et al. addressed this issue with a sample of 731 families
receiving services from a national food supplement and nutrition program. 35
Families with toddlers 2-3 years old were screened and then randomized to a brief
family intervention, the Family Check-Up, which included linked interventions that
were tailored and adapted to the families’ needs. The Family Check-Up was
originally developed as a preventive intervention to address the needs of
adolescents at risk for behaviour problems and emphasizes methods to promote a
family’s motivation to change.36 Results in the families with toddlers study revealed
intervention effects for externalizing and internalizing problems in children and
reductions in maternal depression. In addition, reductions in maternal depression
mediated improvements in both children’s externalizing and internalizing
behaviour problems after accounting for the potential mediating effects of
improvements in positive parenting.
Another example of a family-centered intervention is the Keeping Families Strong
Program, which is a family-based program to promote child and family resilience in
the face of maternal depression.37 This 10-week program is delivered in a multifamily group format, with the parents meeting together and the children (aged ≥10
years) meeting weekly in a group. By involving all members of the family and
utilizing a multi-family format, Keeping Families Strong aims to ensure that all
family members are understood and supported, while decreasing the stigma
associated with depression. Preliminary results examining Keeping Families Strong
in a sample of 13 parents and 15 children suggest that the program is effective.37
Using Cohen’s recommendations for interpreting effect sizes,38 both parents and
children reported significant small to moderate reductions in children’s behaviour
problems, large improvements in family functioning, and moderate to large
decreases in maternal depressive symptoms.
The results from these recent studies implementing family-centered care strategies
are promising. The success of these programs is likely the result of adhering to the
guidelines of Beardslee and Knitzer stating that family-centered interventions must
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be compatible with the treatment and recovery of the parent with depression, as
well as targeting aspects of family functioning, including family resilience, parentchild relationships, and cohesion,39 which is highlighted as an avenue for
intervention in the stress process model in order to improve health outcomes in
children with epilepsy. However, due to the unpredictable nature of seizures, the 2.5
hour yearly in-home assessments used as part of the Family Check-Up may make
this intervention less effective for families with a child with epilepsy. The biological,
emotional, and social changes that occur in children and adolescents, independent of
their epilepsy, may warrant more frequent meetings in a setting that allows parents
and children to share their experiences with epilepsy. In addition, the use of an inhome observation by a trained “parent consultant” is likely to result in social
desirability bias, whereby mothers understate their depressive symptoms and
children’s behaviour problems in order to appease study investigators. This bias
may thus over-estimate the effect of the Family Check-Up intervention. Instead, the
Keeping Families Strong program may be more amenable to use in the paediatric
epilepsy population. The use of parent and child groups allows for participants to
learn from each other’s experiences; however, group leaders must be explicit in
explaining that participants should learn from and not compare one another.
Without this understanding, this program can easily have the unintended
consequence of improving the health of parents and children who feel that their
situation is better than another without implementing any change. On the other
hand, others may become discouraged because they perceive their situation as
worse than another and thus lead to deteriorating health.
Implementation of such family-centered care strategies in paediatric chronic illness
populations that aim to improve outcomes other than behaviour problems, such as
health-related quality of life, are clearly lacking and warrant investigation. However,
implementation of hybrid programs with the goal of improving both maternal
depressive symptoms and child health-related quality of life are complicated by the
presence of a chronic illness in the child. Program developers must be aware of the
challenges of working with families coping with a child recently diagnosed with
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epilepsy. Specifically, families will likely be quite heterogeneous in terms of level of
maternal depressive symptoms, epilepsy severity, presence of comorbidities in the
child, and the general family environment. Thus, adaptation of programs shown to
be successful in the general population should be carefully scrutinized before
implemented in families with a child with epilepsy.
In addition, it is important for healthcare professionals to consider that fathers may
also experience depressive symptoms in caring for a child with epilepsy. A study by
Mu, showed that fathers also exhibit symptoms of depression, albeit to a lesser
extent compared to mothers.40 Although this thesis focused on maternal depressive
symptoms, it is the primary caregiver’s mental health that should be of interest to
healthcare professionals due to the potential negative impact on child health
outcomes. Thus, screening for and intervening on depressive symptoms is
warranted regardless of whether the child’s mother or father is the primary
caregiver of a child with epilepsy.
Strengths and Limitations
Study Strengths
This study had several strengths that allowed it to overcome some of the
methodological shortcomings of previous research. First, due to its national
perspective and longitudinal design, this study was able to develop and empirically
test complex causal pathways that answer questions about trajectories of change
over time, including the identification of potential moderating and mediating
processes. Previous studies in this population have been relatively small-scale,
regional, cross-sectional endeavours and thus causal inferences were limited by the
temporality of exposure and outcome assessment. This was the first study to
prospectively investigate a cohort of mothers from the onset of their child’s
epilepsy.
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Second, this study involved a large sample of mothers and children (n=339)
followed over four time-points. There was a good response rate and retention with
relatively few missing data in this study. Using a modified version of the Tailored
Design Method41 to develop a structured follow-up strategy to enhance retention
rates in this motivated sample promoted completeness of the data and thus helped
produce robust estimates of effect.
Third, this study investigated incident cases of epilepsy in children, rather than
prevalent cases. By restricting to newly-diagnosed children, trends and trajectories
early in the illness process were elucidated and provided an ideal window of
opportunity for interventions aimed at decreasing maternal depressive symptoms
and in turn, improving child health-related quality of life.
Fourth, the models presented in this study were novel in this research field and the
complex strategies employed followed the guidelines of experts for statistical
modeling of longitudinal data. Thus, robust estimates of effects could be obtained
and presented in a logical and meaningful way. In addition, being mindful of the
stress process, as illustrated in the theoretical framework, permitted statistically
significant results observed in the causal pathway having practical implications for
clinicians, researchers, and families involved in the care of children with epilepsy.
Study Limitations
Despite the novel contributions of this research to the academic field, there are a
few limitations that must be considered. Since this study was a secondary data
analysis of HERQULES, the limitations are discussed in the context of the larger
study. First, measurement occasions were not based on empirical evidence of
depressive symptoms trajectories; instead data collection was guided by the clinical
course of epilepsy and associated follow-up appointments with paediatric
neurologists. However, it was believed that the measurement occasions were close
enough together to avoid missing potential fluctuations in maternal depressive
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symptoms and distanced enough to allow for sufficient time to detect important
changes. Three assessments were completed in the first 12 months, since during
this time maternal and family factors and clinical management of epilepsy were
hypothesized to be relatively dynamic. Whereas, in the second year, circumstances
were believed to stabilize and thus an assessment at 24 months was deemed
appropriate. In addition, since it was impossible to recruit patients and their
families prior to diagnosis, this study was unable to capture true baseline data,
especially for maternal depressive symptoms. However, “baseline” data were
collected within a short period after diagnosis. Nonetheless, results from this study
may have been affected by incidence-prevalence bias.42
Second, the inclusion criteria for HERQULES included an age criterion of 4-12 years
and thus results may not be valid if extrapolated to families with children with
epilepsy outside of this age range. Children younger than four years were excluded
because many suffer from catastrophic forms of epilepsy that are difficult to
diagnose and have a known negative impact on the family. As well, several of the
measurement instruments have not been validated for children less than four years
of age. Since the focus of HERQULES was on child and family factors, the upper age
range was limited to children 12 years of age. This is because at the beginning of
adolescence (i.e., 13-14 years), the sphere of influence on children broadens
considerably to include peers.
Third, only parents’ perceptions of child and family factors were considered in
HERQULES and these may differ from that of the neurologist or child with epilepsy.
The results from this study suggest that mothers of children with new-onset
epilepsy, regardless of their mental health status, are valid informants of various
aspects of their child’s health outcomes. Only one discrepancy was observed
between mothers’ and neurologists’ reports. Mothers with low levels of depressive
symptoms reported similar outcomes as neurologists when evaluating disruptions
in daily activities due to the child’s epilepsy. That is, as neurologists reported better
functioning, so did mothers. But, mothers with high levels of depressive symptoms
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systematically reported higher scores in children regardless of the neurologists’
reports. Although it is important to consider both child and parent perceptions on
the illness process, this would have introduced several methodological complexities
into HERQULES. A mail survey design was the only viable strategy for data
collection given the national scope of the study and it could not be ascertained as to
whether children completed the questionnaires independently. As well, it has been
determined that on average, only children eight years of age or older can reliably
self-report.43-46 This would have resulted in a data for only a fraction of participants.
Fourth, this study hypothesized a direct effect of maternal depressive symptoms on
child health-related quality of life, as well as effects moderated and mediated by
family environment variables. This hypothesis was guided by the theoretical
underpinnings of Pearlin’s stress process model47-49 and empirical evidence from
previous research examining the antecedent-consequence relationship between
maternal depressive symptoms and child outcomes50-52 and the casual link between
maternal depressive symptoms, family environment, and child health outcomes.53-57
For example, Elgar et al. used the National Longitudinal Survey of Children and
Youth to show that maternal depressive symptoms tended to precede child
aggression and hyperactivity in children aged 4-11 years.51 In a subsequent study by
Elgar et al., parenting quality (as a measure of family functioning) mediated the
impact of maternal depressive symptoms on child and adolescent maladjustment
over a two-year period among 10-15 year old youth sampled in the National
Longitudinal Survey of Children and Youth.56
Despite such evidence supporting this direction of causal effect, one may speculate
whether the direction of effects may be reversed, such that changes in child health
outcomes lead to changes in maternal depressive symptoms. In a study of mothers
of children with difficult temperament 3-6 years of age, Gartstein and Sheeber
observed that child behaviour problems predicted maternal depressive symptoms
and this relationship was mediated by measures of family functioning during a 12month follow-up.58 In another study, Weaver et al. reported that maternal
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depressive symptoms mediated the relationship between parenting self-efficacy (a
measure of family functioning) and child behaviour problems in a sample of
mothers of children aged 2-4 years.59
In such circumstances, applying Hill’s criteria for causation60 does not help to
elucidate which mechanism is correct since each is possible, not to mention the
concept of reciprocal effects. Given the feasibility and potential ethical restraints in
determining the direction of causality, the best that researchers can do is present a
case for their chosen causal mechanism that decreases the probability that an
alternative mechanism is operating. This study was a secondary data analysis of
HERQULES in which the objective was to examine the health-related quality of life of
children with epilepsy. Extending this outcome within the context of the family
environment, it was reasonable for this study to posit maternal depressive
symptoms as the exposure, child health-related quality of life as the outcome, and
family environment factors as moderators and mediators of this relationship.
Conclusions and Future Directions
This study demonstrated that approximately one-third of mothers of children with
newly-diagnosed epilepsy are at risk for clinical depression during the first 24
months after diagnosis. This group of mothers is not homogeneous, instead four
distinct trajectories of depressive symptoms were observed during the follow-up
and each trajectory had its own unique set of predictors for group membership.
Importantly, a negative relationship was observed between maternal depressive
symptoms and child health-related quality of life. This relationship was moderated
by family resources and mediated by family functioning and family demands.
Future work should continue with this population and sample of mothers and
children to understand the long-term effects of depression on child health-related
quality of life. This would follow similar studies conducted by Sillanpaa et al. in
Finland of incidence, prognosis, and quality of life in adults who had epilepsy in
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childhood.61-64 Questions relating to whether maternal depressive symptoms early
in a child’s illness predict later health outcomes and how the impact of the family
environment changes as the child grows through adolescence into young adulthood
can be investigated. Such research may further highlight the importance of early
intervention to prevent or dampen the negative effect of maternal depressive
symptoms on health-related quality of life in individuals with epilepsy.
In addition, this work would benefit from testing the models developed throughout
the course of this research in external samples of mothers of children with epilepsy.
Such work could provide important validation for the models, thus increasing their
clinical utility for healthcare professionals caring for children and families with
epilepsy. Examining models in both incident and prevalent cases of epilepsy would
broaden the utility of these models.
Development of a family-centered intervention for families with a child with
epilepsy is another important undertaking that is a logical follow-up to this study.
This intervention should follow the examples set by similar programs in other
populations, but adapted for childhood epilepsy. This could be feasibly
accomplished with the inclusion and support of the Epilepsy Support Centre in
London. A systematic approach to implementing such a program would be to
conduct pilot studies at the local or regional level in order to determine the
feasibility of such an intervention. From there, randomized controlled trials
comparing the intervention to a suitable control will permit a better understanding
of the effectiveness of the intervention and whether there is merit in adopting such
a program into standard clinical care for families who are impacted by both
depression and epilepsy. A systematic program evaluation for this intervention
should also become an active area of family-centered care research. By addressing
the needs and building on the strengths of the family the harmful effects of maternal
depressive symptoms on outcomes in children with epilepsy can be prevented and
reduced.
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Appendix A
Appendices
Data Collection
The data for this study come from the Health-related Quality of Life of Children with
Epilepsy Study (HERQULES), a national prospective cohort study in which children
aged 4-12 years with new-onset epilepsy in Canada were followed for 24 months.1
Study Design
Measurement occasions for assessment were post-diagnosis (baseline), and 6, 12,
and 24 months later. Since there is no precedent for determining the optimal
measurement occasions at which to collect data to accurately capture the course of
health-related quality of life in childhood epilepsy, the specified measurement
occasions were selected based on the following a priori considerations for the
original protocol: 1) data should be captured as close to the date of diagnosis as
possible to capture the immediate impact of diagnosis on health-related quality of
life and any factors hypothesized to affect health-related quality of life; 2)
measurement occasions should be close enough together to avoid missing potential
fluctuations in both predictor and outcome variables; and, 3) measurement
occasions should be distanced enough to allow for sufficient time to detect
important changes in variables and to avoid participant fatigue. Three assessments
were completed in the first 12 months since during this time family factors and
clinical management are hypothesized to be relatively dynamic. Whereas, in the
second year, circumstances are believed to stabilize and thus an assessment at 24
months was deemed appropriate.
Sample Characteristics
The study population was mothers whose children were receiving care from a
paediatric neurologist in Canada for new-onset epilepsy. Patients were recruited
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prospectively over a 36-month period from April 2004 to April 2007. Parents of
each consecutive child diagnosed with epilepsy were approached to participate in
the study. The inclusion criteria for patients were as follows: 1) new case of epilepsy
(≥2 unprovoked seizures), in whom diagnosis of epilepsy has not been previously
confirmed, seen for the first time by a participating paediatric neurologist within the
data collection period; 2) epilepsy diagnosed between the ages of 4-12 years; and, 3)
parent must have been primarily responsible for the child's care for ≥6 months and
continue to be for the duration of the study. Children with newly-diagnosed epilepsy
with a prior history of neonatal seizures were included if medication was removed
by six weeks of age without recurrence. Patients were excluded from the study if: 1)
diagnosis of epilepsy had been previously confirmed by another physician; 2)
diagnosed with other progressive or degenerative neurological disorder (e.g.,
mental retardation); 3) diagnosed with other major co-morbid non-neurological
disorders that would have an impact on quality of life (e.g. asthma requiring daily
medication, renal failure); and, 4) parent had insufficient English language skills to
complete questionnaires. In addition to these criteria for HERQULES, this research
excluded parent questionnaires completed by anyone other than the patient’s
mother (i.e., biologic, adoptive, foster). International League Against Epilepsy (ILAE)
guidelines for the implementation of observational studies in childhood epilepsy
were adopted in an effort to generate robust findings comparable with past and
future investigations.2 Types of seizure and epilepsy syndrome were classified in
terms of ILAE’s 1981 and 1989 classification system, respectively.3, 4
Data Collection Strategy
Investigators from HERQULES used a modified version of the Tailored Design
Method (TDM) in designing a mail survey study to assess health-related quality of
life in children diagnosed with epilepsy.5 The TDM applies a set of guidelines and
procedures shown to be effective in producing high quality data and attaining high
participation and retention rates.5 Participant recruitment for HERQULES occurred
in two stages. All practicing paediatric neurologists in Canada who reported caring
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for children with new-onset epilepsy were invited to participate in the study.
Neurologists were asked to identify all children receiving a new diagnosis of
epilepsy who met the inclusion criteria and to subsequently introduce HERQULES to
families.
Physician Recruitment
All paediatric neurologists practicing in Canada were approached to participate in
HERQULES. The current membership list of the Canadian Association of Child
Neurology (CACN) served as the sampling frame.6 Although the CACN is a voluntary
association, almost all paediatric neurologists currently practicing in Canada are
members. This resulted in a sample of 103 paediatric neurologists. To ensure
inclusiveness, a small panel of members from across the country reviewed the list
and added the names of a small number of paediatric neurologists who were not on
the list and excluded a few members who were no longer practicing. Neurologists
were excluded from the list if they did not treat paediatric epilepsy. Through this
process, the sampling frame was reduced to a total of 72 eligible members, all of
whom agreed to participate. A total of 53 paediatric neurologists (74%) recruited
participants. The remainder either did not see a patient meeting the inclusion
criteria during the recruitment period or enrolling participants was not feasible
given the constraints of their clinical practice. At the initiation of the study,
physicians were provided with all study material in a prepared package including an
overview of the study, physician-report forms, study timelines, inclusion/exclusion
criteria documentation, and a token of appreciation. The study package oriented the
physician to the study and attempted to increase its feasibility within the
constraints of their clinical practice, by providing all necessary study documents.
Throughout the study, physicians were sent 2-3 newsletters annually describing
study updates and reminders. Neurologist participation included two components:
1) approaching the family to introduce HERQULES; and, 2) providing clinical
information regarding the child’s epilepsy at four measurement occasions for each
consenting patient. In order to minimize loss of data, participating neurologists
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were also sent an individualized physician report approximately every six weeks
listing the physician’s patient data not yet returned to the investigators.
Parent Recruitment
Paediatric neurologists and their healthcare teams identified consecutive patients
who met the inclusion criteria during the recruitment period. When a paediatric
neurologist identified an eligible patient, he/she approached the parents with
information regarding HERQULES. If parents agreed to be contacted by
investigators, they signed a release of information that was faxed to the HERQULES
office so that a letter of information outlining HERQULES and the requirements of
participation could be mailed. Within a few days of receiving the letter, investigators
contacted the family to address questions and to determine participation status.
Primary caregivers were asked to complete a questionnaire that required
approximately 45-60 minutes. The post-diagnosis questionnaire was sent to families
to complete upon consent to participate. Subsequent questionnaires were mailed 6,
12, and 24 months after diagnosis. The questionnaire was rated at a grade seven
level using the Flesch-Kincaid Grade Score.1,

7

The questionnaire included

measurement tools assessing child health-related quality of life, family demands,
functioning, and resources, parental depressive symptoms, parents’ perception of
patient-centered care, and demographic factors. A small financial token of
appreciation was included with every questionnaire mailed. At the final contact at
24 months, parents were given the opportunity to specify if they would like to
receive a summary of the study results, which were prepared upon study
completion. There were 456 eligible participants identified in HERQULES between
April 2004 and April 2007, 97% of whom consented to take part in the study. Figure
A.1 is a diagram of the complete study hierarchy.
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Patients
Identified
(496)

Ineligible
(40)

Eligible
(456)

Contacted
(451)

Consent
(443)

Baseline
(443)

Returned
(374)

6-month
(374)

Attrition
(69)

Mothers
(339)

Returned
(336)

Unable to
contact (5)

Refused (8)

12-month
(335)

Attrition
(38)

Mothers
(312)

Returned
(304)

Mothers
(281)

24-month
(302)

Attrition
(31)

Returned
(283)

Attrition
(19)

Mothers
(258)

Figure A.1. Study Hierarchy for HERQULES.
Data Management
Epilepsy characteristics completed by paediatric neurologists were recorded at each
study site and faxed or mailed to the HERQULES office in the Department of
Paediatrics at the Children’s Hospital of Western Ontario in London, Canada. Parent
questionnaires were mailed directly to the HERQULES office for data entry, analysis,
and quality control. Completed questionnaires received by the HERQULES office
were examined to remove any identifying information and to ensure that all
sections were completed. If sections were missing, parents were contacted and sent
the missing sections for completion. Data were entered by graduate students in the
Department of Epidemiology and Biostatistics, at The University of Western Ontario
throughout the data collection period with Statistical Package for the Social Sciences
(SPSS, Windows build 16, SPSS Inc., Chicago, IL). Any responses not accommodated
by the established coding structure were brought to the attention of other study
personnel and the principal investigator. All decisions made during the process of
entering data were recorded in a log for quick reference for other data entry
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personnel. Data verification was performed on 100% of entered data by research
assistants other than those who initially entered the data. Data correction logs were
maintained and corrections were made by the student who originally entered the
data.
Ethical Approval
Approval for the original HERQULES protocol was obtained from all relevant
research ethics board across the country. A revised approval to conduct the
proposed study was sought from the Research Ethics Board at The University of
Western Ontario and obtained prior to starting work on this study (Appendix B).
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Appendix B
Ethics Approval
Due to margin requirements, statements of ethical approval to conduct this research
are shown on subsequent pages.
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Appendix C
Measurement
Measures used in the study are briefly summarized in Table C.1 and the complete
study package is shown in Appendix D. Study variables included maternal, child and
family factors.
Maternal Depressive Symptoms
Maternal depressive symptoms were measured with the Center for Epidemiological
Studies Depression Scale (CES-D), a 20-item questionnaire that measures
depressive symptoms in the general adult population.1 The CES-D is a self-report
scale which is an amalgamation of previously devised depressive inventories,
including the Beck Depression Inventory, Zung’s depression scale, a scale developed
by Raskin, and a scale developed by the Minnesota Multiphasic Personality
Inventory. The scale includes 20 items that survey mood, somatic complaints,
interactions with others, and motor functioning. The response values are four-point
Likert scales, with range 0-3, and anchor points in terms of days per week “rarely or
none of the time (less than one day)” to “most or all of the time (5-7 days)”. The final
score spans from 0-60, with a higher score indicating greater impairment. Four of
the items (items 4, 8, 12, 16) are positively worded and therefore are reversescored. Individuals with a final score of ≥16 are typically identified as a depressive
case. This generally represents an individual who has reported ≥6 items to be
frequently present over the course of the previous week, or most of the 20 items to
be present for a shorter duration.
Among community samples, internal consistency estimates range from 0.80-0.90;
test-retest reliability, ranging from two weeks to one year, is reported to be between
0.40-0.70.1, 2 Four factors have consistently, but not always, been reported for the
CES-D: depressed affect, positive affect, somatic and retarded activity, and
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interpersonal.1-4 The factors appear to be robust across time and populations
varying in ethnicity and health.2, 4, 5 An important early validation of the CES-D was
done by Weissman et al.6 The scale demonstrated acceptable concurrent and
discriminant validity in a study of a large two-site community sample and a sample
of psychiatric patients. It was able to discriminate between psychiatric patients
being treated for depression and other psychiatric patients, as well as to identify
patients with a secondary diagnosis of depression among those with a primary
diagnosis of alcoholism, drug addiction, and schizophrenia. High sensitivity and
specificity were reported for people with major depression, schizophrenia, and
alcohol dependence. Recent studies using the CES-D have aimed to understand
depressive symptoms among chronically ill persons,7-9 and their caregivers.10, 11
Family Environment
Three aspects of family environment (demands, functioning, resources) were
measured based on parent-report. Family demands were quantified using the
Family Inventory of Life Events and Changes (FILE) developed by McCubbin et al.,
which assesses the pile-up of simultaneous normal and non-normal life events and
changes in life events experienced by a family during the previous year. 12 As a
family life events inventory, all events experienced by any single member are
recorded. This is because, in the context of a family systems perspective, a change in
any one family member likely affects other family members to a varying degree. The
71 items in the FILE are grouped into nine scales assessing various strains: intrafamily, marital, pregnancy/childbearing, finance and business, work-family
transitions, illness and family care, losses, transitions in and out, and legal. The FILE
is designed to be administered to adult members of the family unit. The score is
computed by giving each “yes” response a score of one. Summing all “yes” responses
provides a score for each subscale and the total pile-up score. The reliability and
validity of the FILE is well-established.12 As measured by Cronbach’s α, the overall
reliability of the FILE is 0.72. The overall scale reliability is α=0.81 with the subscale
scores ranging from 0.30-0.73. This indicates that internal consistency is most
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stable for the entire FILE scale, with each subscale being less stable. As well, testretest reliability investigations showed correlations ranging from 0.72-0.77,
indicating acceptable reliability over time. Initial examinations of validity
demonstrated strong discriminant validity comparing low and high conflict families
with cerebral palsy, with high conflict families experiencing a significantly higher
pile-up of life events and changes.
The Family Adaptability, Partnership, Growth, Affection, and Resolve (Family
APGAR), developed by Smilkstein, was the instrument used to assess satisfaction
with family relationships.13 It was designed on the premise that the perception of
family functioning could be assessed by a family member’s self-report of satisfaction
with the following five parameters: adaptation (assistance received when family
resources are needed); partnership (mutuality in family communication and
problem solving); growth (freedom to change roles and attain physical and
emotional maturation); affection (intimacy and emotional interaction among
members); and, resolve (time commitments made to the family by members). The
Family APGAR is a five-item instrument completed by an adult family member and
responses are based on a five-point Likert scale, ranging from 0-4 for each item. The
total score is computed by summing each item score, ranging from 0-20. Higher
scores on the Family APGAR are indicative of higher satisfaction with family
functioning. The Family APGAR has been found to be valid and reliable in both the
clinical and research setting with adults and children.13-15 Reliability analyses have
demonstrated an internal consistency of Cronbach’s α=0.80 and test-retest
reliability of 0.83.15
In an attempt to assess the repertoire of resources available to aid families
adaptation to stressful events, the Family Inventory of Resources for Management
(FIRM), developed by McCubbin et al. was used in this study.16 The items included in
the FIRM were influenced by theory and empirical findings in the areas of personal
resources, family system internal resources, and social support. The 68-item, selfreport instrument is completed by an adult family member and includes four scales
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representing perceived family resources. The scales include family esteem and
communication, family mastery and health, extended family social support, and
financial well-being. For this study, only two scales (family mastery and health,
extended family social support) which have been found to be associated with
adaptation to childhood epilepsy were used.17 The family mastery and health
subscale includes 20 items that reflect family resources with the following
dimensions: 1) sense of mastery over events and outcomes; 2) family mutuality;
and, 3) physical and emotional health. The extended family social support subscale
is four items and reflects the mutual help and support given to and received from
relatives. Scoring procedures for the FIRM involve summing all response values,
which range from 0 (not at all) to 3 (very well) to provide a total FIRM score. The
FIRM has demonstrated adequate reliability and validity properties.16 The internal
consistency for the four subscales is Cronbach’s α=0.89, with individual reliabilities
for the family mastery and health and extended family social support subscales of
0.85 and 0.62, respectively. Significant correlations between the FIRM and family
environment dimensions of cohesion, expressiveness, conflict, and organization
(p<0.01) of the Family Environment Scale, indicate adequate criterion (concurrent)
validity of the FIRM.
Epilepsy Characteristics
Physicians completed a two-page questionnaire documenting the clinical factors of
each patient’s epilepsy including: severity of epilepsy, seizure type and frequency,
type of epilepsy syndrome, age at onset and diagnosis, medication information,
adverse effects, other major co-morbidities, gender, and age. Severity of epilepsy
was classified using the Global Assessment of Severity of Epilepsy (GASE), a singleitem measure developed for HERQULES. With the GASE, neurologists rate the
overall severity of each child's epilepsy using a seven-point scale ranging from
1=extremely severe to 7=not at all severe. The GASE demonstrated minimum
burden on participants, adequate validity, and high intra- and inter-rater
reliability.18
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Child Health-related Quality of Life
To assess child health-related quality of life, parents completed a generic and
epilepsy-specific instrument. The Child Health Questionnaire Parent Form-50 (CHQ)
is a 50-item, parent-rated, generic questionnaire assessing child health, well-being,
and the impact of illness on life function during the previous four weeks.19 The CHQ
was designed as a multidimensional profile of health-related quality of life and was
the first comprehensive paediatric health-related quality of life measure developed
with norms for children <18 years of age and established reliability and validity in
both healthy and chronically ill children, including epilepsy.19-27 Each of the CHQ
dimensions is measured with multiple items, with higher scores indicating better
health-related quality of life. Parents respond to items along a four- to six-level
response continuum to capture both the presence and the extent of limitations
during the previous four weeks. The CHQ provides individual scale scores for each
of the 13 concepts measured and two summary scores for physical and psychosocial
health. Nine concepts focus on the child, which include physical functioning;
limitations in schoolwork and activities with friends due to emotional/behavioral
difficulties; limitations in schoolwork and activities with friends due to physical
health; bodily pain/discomfort; general behavior; mental health; self-esteem;
general health perceptions; and change in health. The remaining four concepts
measure impact on the family: parental impact-time; parental impact-emotional;
family activities; and family cohesion. Two weighted and standardized summary
scores assessing physical and psychosocial functioning are calculated, with a mean
of 50 and a standard deviation of 10. The physical health summary scale measures
the child’s general health, pain, and limitations in physical and social activities due
to health. The psychosocial health summary scale measures the child’s self-esteem,
mental health, and the impact of the illness on physical and social activities. The
scale also measures the impact of illness on the family.
The Quality of Life in Childhood Epilepsy (QOLCE) is a multifaceted, parent-report,
epilepsy-specific instrument for evaluating health-related quality of life of children
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with epilepsy aged 4-18 years. The QOLCE was developed from an original
questionnaire containing 91 items.27 Item analysis and validation in North America
led to a final questionnaire containing 76 items with 16 subscales spanning seven
domains of life function including, physical activities, social activities, cognition,
well-being, behavior, general health, and general quality of life.28 Items are rated on
a five-point Likert scale, which are used to calculate the 16 subscale scores ranging
from zero (low functioning) to 100 (high functioning). The subscale scores are
averaged to produce an overall health-related quality of life score. It has
demonstrated good construct validity, internal consistency reliability (0.72-0.93),
and sensitivity to epilepsy severity.27
Perception of Patient-centered Care
Based on the Patient-Centered Model of Care, a modified version of the Patient
Perception of Patient-centeredness (PPPC) was used to assess parents’ perceptions
of the extent to which the healthcare services (i.e., interaction with the paediatric
neurologist) their child received were patient-centered.29 Seven of the original 14
items were slightly modified to make them appropriate for parent-report by
replacing “your” with “your child’s” and “you” with “your child”. A total score, as
well as subscale scores on “exploring the disease and illness experience” (items 1-4),
and “finding common ground” (items 5-13) can be formed.29 The PPPC is coded so
that low scores correspond to positive perceptions. The total score is calculated by
summing the all item responses and dividing by the number of items completed.
Subscale scores are determined by calculating their mean scores. While test-retest
reliability has not been assessed, inter-item reliability has been found to be
adequate for the PPPC (Cronbach’s α=0.71).30 The validity of the PPPC was
established through a significant correlation with the Measure of Patient-centered
Communication (r=0.16; p=0.01) and significant correlation with patient health
outcomes and with the efficiencies in the use of health services.30 The adapted
version was pre-tested on a sample of 59 parents of patients being seen by a
paediatric neurologist in London, Ontario. The participation rate was 100%. It took
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parents 1-4 minutes to complete with an average of three minutes. No ceiling or
floor effects were detected.
Demographic Characteristics
Questions regarding demographic characteristics of families, including parent age,
education, marital status, employment status, and household income were adapted
from previous studies employing these items successfully.
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Table C.1. Summary of Variables from HERQULES Considered for Inclusion.
Variable

Scale of Measurement
Analysis

Measure

Original

Age

Date of birth

Continuous

NC

Marital status

Current marital status

Nominal
1. Married
2. Widowed
3. Divorced
4. Separated
5. Remarried
6. Never married

Nominal
1. Married*
2. Not married

Education

Highest level of completed
education

Ordinal
1. <8 years
2. 8-12 years
3. Completed high school
4. Completed technical training
5. Completed college or university
6. Completed graduate school

Ordinal
1. Less than high school
2. Completed high
school
3. Completed technical
training
4. Completed college or
university

Employment status

Current employment status

Nominal
1. Not working due to child’s
health

Nominal
1. Not working
2. Homemaker

Maternal
Demographics
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2. Not working for other reasons
3. Looking for work outside the
home
4. Working full- or part-time,
inside or outside the home
5. Full-time homemaker
6. Student
Parity

3. Student
4. Working

Number of children in
household

Ordinal

NC

CES-D

Continuous

NC

Age

Date of birth

Continuous

NC

Gender

Child sex

Nominal
0. Female
1. Male

NC

Mental Health
Depressive symptoms
Child
Demographics

Epilepsy Factors
Family history

Presence of family history of Nominal
epilepsy
1. No
2. Yes

NC
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Illness Severity

GASE

Ordinal
1. Extremely severe
2. Very severe
3. Quite severe
4. Moderately severe
5. Somewhat severe
6. A little severe
7. Not at all severe

NC

Duration

Age at onset subtracted
from date of baseline survey

Continuous

NC

Seizure classification

Broad classification of
seizures

Nominal
1. Generalized
2. Partial

NC

Seizure type

Specific subtype of seizures

Nominal
1. Primary generalized
2. Absence
3. Simple/complex partial
4. BECRS
5. Secondary generalized
6. BECRS & secondary generalized
7. Undetermined

NC

Age at onset

Age of seizure onset

Continuous

NC

Medication use

Current and total number of
anti-epileptic drugs
prescribed

Continuous

NC
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Behaviour

Severity of behaviour
problems

Ordinal
1. None
2. Mild
3. Moderate
4. Severe

NC

Cognitive

Severity of cognitive
disability

Ordinal
1. None
2. Borderline
3. Mild
4. Moderate
5. Severe

NC

Motor

Severity of motor
limitations

Ordinal
1. None
2. Mild
3. Moderate
4. Severe

NC

QOLCE
CHQ

Continuous
Continuous

NC
NC

Gross annual household
income

Ordinal
1. <$10,000
2. $10,000-19,999

Ordinal
1. <$20,000
2. $20,000-39,999

Health
Health-related quality
of life
Family
Demographics
Income
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3. $20,000-29,999
4. $30,000-39,999
5. $40,000-49,999
6. $50,000-59,999
7. $60,000-69,999
8. $70,000-79,999
9. $80,000-89,999
10. $90,000-99,999
11. >$100,000
12. Don’t know

3.
4.
5.
6.

Family Factors
Demands

FILE

Continuous

NC

Functioning

Family APGAR

Continuous

NC

Resources

FIRM

Continuous

NC

Patient-centered care
PPPC
Continuous
NC, no change.
*Includes mothers in married and common-law relationships.

NC

Perception of Healthcare

$40,000-59,999
$60,000-79,999
>$80,000
Don’t know
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Appendix D
Study Package
The complete HERQULES study package is contained in this Appendix, including
both the parent and physician forms. Specific measurement instruments can be
found in the following sections of the study package.
Section 1: Quality of Life in Childhood Epilepsy (QOLCE)
Section 2: Patient Perception of Patient-centered Care (PPPC)
Section 3: Family Inventory of Resources for Management (FIRM)
Section 4: Family Inventory of Life Events and Changes (FILE)
Section 5: Family Adaptability, Partnership, Growth, Affection, Resolve (APGAR)
Section 6: Center for Epidemiological Studies Depression Scale (CES-D)
Section 7: Measure of Processes of Care (MPOC-20)
Section 8: Child Health Questionnaire – Parent Form (CHQ)
Section 9: Demographics
Physician Form
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Appendix E
Data Analysis
Introduction
Data analysis was conducted with Statistical Analysis Software (SAS 9.1.3 Service
Pack 4, SAS Institute Inc., Cary, NC). All hypothesis tests were two-sided with a type
I error rate of α=0.05. Univariable analysis was used to describe the sample at each
measurement occasion (baseline, and 6, 12, 24 months) in terms of maternal, child,
and family factors using descriptive statistics, frequency distributions, and missing
data (Appendix F). Examination of attrition on study results was also conducted
(Appendix F). Since subjects were recruited from neurologists’ clinics, clustering
effects within recruitment site were examined to ensure that analytic models
presented unbiased estimates (Appendix G). Variables included in analytic models
underwent diagnostic testing to identify issues such as the presence of outliers and
influence that could potentially bias results (Appendix I). Potential confounding
variables were also investigated (Appendix J).
Longitudinal data are central to studying change in outcomes. There are several
statistical techniques that can be employed to analyze longitudinal data. 1 One such
approach is to examine raw change scores computed as the difference between
scores at two different measurement occasions and analyzed as a function of
individual or group characteristics.2 Student t-tests, analysis of variance (ANOVA),
or multiple regression are generally used to analyze raw change scores.
Alternatively, residualized change scores can also be used to study longitudinal data.
In this approach, change is calculated as the residual between the observed Time 2
score and the expected Time 2 score as predicted by the score at Time 1.2
Residualized change scores are typically analyzed with multiple regression or
analysis of covariance (ANCOVA). Although both techniques can be useful under
specific circumstances of longitudinal data, their use usually results in efficiency loss
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as a result of not using all relevant data, bias from selectively omitting or ignoring
data, and over-simplification of conclusions and inferences surrounding the
research question.1
Frequently, researchers are interested in modeling patterns of change in an
outcome over multiple (i.e., ≥3) measurement occasions. For example, describing
the course of psychopathologies such as depression,3 understanding criminal
behaviour over the life course,4 educational achievement in children and
adolescents,5 and the impact of medical intervention on the disease progression.6
One common approach to studying these patterns, or developmental trajectories, is
to use latent class growth modeling. As developed by Nagin,7 latent class growth
modeling is a semi-parametric analytic approach to identify subgroups of
individuals that follow a similar trajectory in a given sample. The distribution of
individual differences of change is summarized using mixtures of appropriately
defined probability distributions, each corresponding to a unique trajectory. In
other words, this group-based approach assumes that the population under study is
composed of a mixture of discrete subgroups defined by their developmental
trajectory. Unlike individual growth curve models, this technique fixes the intercept
and slope within each trajectory, allowing for an additional degree of freedom to
estimate higher-order terms (i.e., quadratic, cubic) for the time variable (Note that
individual growth curve modeling can also accommodate fixed intercepts and
slopes). Latent class growth modeling can also incorporate both time-varying and
time-invariant covariates in order to delineate their effects on the shape and
proportion of individuals of a specific trajectory.
Individual growth curve modeling8 or structural equation/latent growth curve
modeling is a second approach to studying patterns of change over time. 9 These
techniques use a measure of time (e.g., age, months since diagnosis) as an
independent variable to estimate the magnitude and direction of a single trajectory
that averages all individual trajectories for an entire sample. Individual differences
are captured by estimating a random coefficient that represents the variability
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around the averaged intercept and slope. Flexibility in this technique allows
researchers to model additional time-varying or time-invariant covariates
representing potential risk factors that predict inter-individual differences in
intercepts and slopes. In addition, by centering the time variable, the intercept can
be set to any predetermined value of interest.
Individual growth curve modeling is generally most useful for investigating research
questions in which all individuals are hypothesized to change in a homogeneous
trajectory over time, with the magnitude of change being the only source of interindividual variation in a given sample.10 However, some phenomena, such as
depressive symptomatology, may exhibit a multinomial pattern whereby interindividual variation may exist in both the magnitude and direction of change.3, 7, 10 In
such circumstances individual growth curve modeling can mask significant
differences and lead to erroneous inferences about changes in population over time.
Research questions such as these require alternative modeling strategies that
consider potential multinomial heterogeneity in change over time, such as latent
class growth modeling. The next two sections describe the two most common
approaches to modeling patterns of change in an outcome over multiple
measurement occasions.
Overview of Latent Class Growth Modeling
Given the substantial contribution of Nagin to both the theory and methodology of
latent class growth modeling, the following discussion of this analytic technique
draws primarily from his work and from the work of his collaborators.7, 11 Latent
class growth models have two defining features: 1) the predicted trajectory of each
group; and 2) the probability that a randomly chosen individual from the sample is a
member of each group. Technically, this approach is an application of finite mixture
modeling, since it involves combining a mixture of single-group models within the
common multiple-group structure.

203
Using maximum likelihood estimation, the aim of latent class growth modeling is to
identify groups of individuals with similar trajectories. The underlying likelihood
function, Yi = {yi1, yi2, yiT} denotes a longitudinal sequence of measurements on
individual i over T periods. The objective is to estimate a set of parameters that
maximizes the probability of Yi, P(Yi). For continuous data, P(Yi) is specified as the
censored normal distribution (which is also used for continuous data without
censoring). It is assumed that individual differences in trajectories can be
summarized by a finite set of different polynomial functions of time. Each set
corresponds to a trajectory group denoted by j. Pj(Yi) denotes the probability of Yi
given membership in group j, and πj denotes the probability of a randomly chosen
individual belonging to group j. However, since group membership is not observed,
the proportion of the population comprising each group j, πj, is an important
parameter of interest. Thus, the likelihood function requires aggregation of the J
conditional likelihood functions, Pj(Yi), to form the unconditional probability of the
data, Yi:

( )

∑

( )

This equation describes a finite mixture model, because it sums across a finite
number of groups that compose the population under study. The term “mixture” is
included since the model specifies that the population is composed of a mixture of
unobserved groups. Terms in the model include: P(Yi), the unconditional probability
of observing individual i’s longitudinal sequence of measurements; Yi. It equals the
sum across the J groups of the probability of Yi given i’s membership in group j
weighted by the probability of membership in group j, πj.
The general form of the model as shown in the above equation can be adapted to
estimate trajectory models where yit is a censored variable, in which there are
clusters of data at the scale maximum or minimum. For example, top students have
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grade point averages that cluster at the maximum grade point or individuals may
have a score of zero on a measure of number of depressive symptoms. In addition,
this model can also be used to model data that are continuous without censoring,
such as body mass index.
Adaptation of the general model to censored data requires two important
assumptions: 1) choice of an appropriate form of Pj(yit) for characterizing the
distributional properties of censored data; and, 2) specification of a link function
that connects the course of the outcome with time. For censored data, the censored
normal distribution is used to define Pj(Yi) and the linkage between time and the
outcome is established via the latent variable,

, which can be conceptualized as

measuring individual i’s potential for the outcome at time t. The censored normal
model is described as:

where t, t2, t3, are linear, quadratic, and cubic measures of time (e.g., age, months
since diagnosis), for individual i, respectively, εit is the random error on each
measurement assumed to be normally distributed with mean zero and standard
deviation ς, j represents the trajectory group,
the intercept and

,

,

are the parameters that determine the shape of the

trajectory. In this model, the latent variable,
observed counterpart, yit, as follows: If
outcome scale,
when MIN ≤

= MIN and if
≤ MAX does

is the parameter that determines

=

, is linked to its censored, but

is less than the minimum value on the

is greater than the maximum,

= MAX. Only

.

During the model building process it is important to have a priori knowledge of the
number and shape of trajectories, whenever theory or empirical findings exist in the
research area. Interpretation and comparison of the Bayesian Information Criterion
(BIC) is used to guide selection of the most appropriate model that fits the data.
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Raftery has argued in favour of the BIC when choosing the number of groups in a
mixture model.12 Nested models examining different numbers of trajectories can be
compared using an estimate of the log Bayes Factor [i.e., 2loge(B10) ≈ 2(ΔBIC)], as
defined by Jones et al.13 Both time-varying and time-invariant predictors of group
membership can be incorporated into the censored normal model and tested for
statistical significance using procedures described by Nagin.7
Overview of Individual Growth Curve Modeling
Individual growth curve modeling is another analytic method that allows
researchers to measure change over time in a phenomenon of interest (e.g., change
in child health-related quality of life) at both the population and individual levels. 8
Other names for this class of statistical methods include random regression
models,14 hierarchical linear models,15 mixed models,16 and multilevel models.17 A
convenient way to conceptualize individual growth curve modeling is to consider
two levels of analysis as given by the equations below following the notation used
by Singer and Willett.8
Level 1 model:

(

Level 2 model:

( )

)

( )
The level 1 model is commonly referred to as the intra-individual change model; it
captures individual-specific growth rates (Table E.1). The level 2 model is
commonly referred to as the inter-individual change model; it captures betweenindividual variability in the growth rates (Table E.2). In other words, the level 1
model is specified to describe the trajectory of individual change and the level 2
model is specified to represent the relationships between the shapes of individual
trajectories and predictors of change.18 In these equations, tij and vi are independent
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variables whereby tij represents the value of time and vi represents some covariate
(e.g., gender). Subscript i denotes the individual the observation was made on and j
denotes the measurement occasion. Since y and t can carry both i and j subscripts,
both the outcome and time variable are allowed to vary by individuals and
occasions. When vi is absent, the growth model is considered unconditional, since
the estimates are not conditional on other covariates in the model.
The structural component of the level 1 model, representing the dependence of true
status on time includes the following parameters: π0i + π1i(tij). The random error
that accumulates on each measurement is denoted by the error term, εij. Upon
inspection, the level 1 model resembles a basic ordinary least squares regression
model. The level 1 residuals assumed to be normally distributed with a mean of zero
and common variance  2 and are conditionally independent, given the random
effects. However, the marked feature of the level 1 model that differentiates it from
the basic regression model is that both the intercept and slope parameters are not
fixed, but allowed to vary across individuals. Although the level 1 model has only a
single predictor (i.e., tij), additional time-varying covariates can be included (e.g.,
family functioning), further reflecting the flexibility of the method.
In the level 2 model, it is helpful to conceptualize the parameter estimates from the
level 1 model as outcomes. For example, the intercept of individual i, π0i, is written
as a function of the population intercept γ00, plus his/her deviation from the
population intercept δ0i. The same holds for the slope. In the level 2 model, the
population-level estimates (i.e., γ00, γ01, γ10, and γ11) are referred to as the fixed
effects. Similar to the basic regression model, these effects are assumed fixed for all
individuals. The individual deviations (i.e., δ0i and δ1i), which can be thought of as
the level 2 residuals, are referred to as the random effects. The random effects are
assumed to be bivariate normally distributed with means of zero and population
variance  02 for the intercept, population variance  12 for the slope, and population
covariance ς01. It is the estimation of the deviations of individuals from the
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population curve that puts the “individual” in individual growth curve modeling.
The mixture of fixed and random effects in a single model gives rise to other names
for this analytic method such as, random coefficient models.19 An early task in
individual growth curve modeling is establishing whether variability associated
with the random effects in the growth curves is present. If there is significant
variability, the level 2 model can be expanded to include time-invariant risk factors
of variability in the individual growth curves (e.g., gender). Testing of main,
moderated, and mediated effects in individual growth curve modeling can be
implemented following the guidelines of Delucia and Pitts,20 Aiken and West,21 and
MacKinnon,22 respectively.
Modeling Assumptions
Evaluating the tenability of individual growth curve modeling assumptions (i.e.,
functional form, normality, homoscedasticity) followed the guidelines suggested by
Singer and Willett.8 Results of analyses evaluating modeling assumptions are shown
in Appendix H. It was assumed that individual change trajectories and relationships
between individual growth parameters and level 2 predictors were linear. A direct
way of examining the functional form assumption in an individual growth curve
model is to inspect level 1 and level 2 plots of the outcome and predictors. At level 1,
ordinary least squares-estimated individual growth trajectories were superimposed
on empirical growth plots for all individuals. At level 2, ordinary least squares
estimates of the individual growth parameters were plotted against each level 2
predictor. With respect to normality, it was assumed that all residuals (at both level
1 and level 2) were normally distributed. Exploratory analyses of the raw residuals
were conducted to assess normality. For each residual, a normal probability plot of
their values against their associated normal scores was examined, as well as
frequency distributions of residual values. Departures from linearity on the normal
probability plot indicate a departure from normality. Plots of standardized residuals
against predictors were also used to provide insight into the tenability of the
normality assumption. That is, if the raw residuals are normally distributed, then
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approximately 95% of the standardized residuals will fall within ±2 standard
deviations of their center. Plots of standardized residuals by individuals were used
to identify outliers in the data. It was assumed that there are equal variances of the
level 1 and level 2 residuals at each level of every predictor (homoscedasticity). The
homoscedasticity assumption was examined by plotting raw residuals against
predictors at each level (i.e., level 1 residuals vs. level 1 predictors).
Homoscedasticity holds if the residual variability is approximately equal at every
predictor value.
Advantages of Growth Curve Modeling Compared to Traditional Methods
As mentioned previously, relative to traditional methods for analyzing longitudinal
data, growth curve modeling offers several advantages. First, ANOVA (i.e., repeated
measures ANOVA for longitudinal data) generally focuses on growth curves at the
population level. Although ANOVA does allow individual variability in intercepts,
individual variability in slopes is not explicitly modeled.14,

23

That is, the rate of

linear change is assumed to be equal for all individuals under study, which under
developmental theory is often unrealistic. In growth curve modeling, data are truly
modeled at the individual level, allowing for the examination of individual
variability in both intercepts and slopes in the phenomenon under study.
Second, the growth curve modeling approach offers researchers greater flexibility in
its treatment of the time variable compared to ANOVA. That is, time can be treated
continuously rather than as a factor with a finite number of levels and individuals
can be observed at different measurement occasions with growth curve modeling
with unequal intervals between measurement occasions.18,

20

In contrast, ANOVA

assumes that all individuals were measured on the same occasions and
complications arise in analysis when the interval between occasions varies.24
A third strength of growth curve modeling is that individuals with missing data at
random can be retained in the analysis. Although ANOVA models can incorporate
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individuals with partial missing data, researchers often utilize listwise deletion
when missing data are encountered, thus potentially resulting in substantial loss of
information and can introduce bias into the analysis.14, 24-26
Fourth, ANOVA is grounded in a generally untenable assumption of compound
symmetry, that repeated measurements are equally correlated over time with
constant variance and covariance.14 This is a far too restrictive assumption since,
measurements taken closer together are generally more highly correlated than
measurements taken further apart. Adjustments to significance testing to account
for violation of this assumption have resulted in considerable sacrifices in statistical
power. Growth curve modeling allows flexibility in modeling the covariance
structure and thus provides more accurate estimates while maintaining statistical
power with relatively smaller sample sizes.1
Other advantages of growth curve modeling include the ability to increase the
precision of estimates by incorporating an unlimited number of data collection
occasions and the ability to model change as linear, curvilinear, or even
discontinuous or piecewise function where there may be a “jump” in the growth
trajectory at a specific measurement occasion.18
Important Considerations in Growth Curve Modeling
Growth curve modeling is deeply rooted in statistical theory. Thus, researchers
implementing growth curve modeling must be aware of the conditions that
constrain its application. Like most other statistical methods, growth curve
modeling was developed on asymptotic theory and as a result may not be
appropriate for studies with a small sample size.1, 14, 15, 20, 27 Use of growth curve
modeling in relatively small study samples can lead to systematic errors or bias in
parameter estimates.14 Sample size considerations must account for both the intraand inter-individual correlations that occur in multilevel studies by applying a
design effect to formal sample size calculations based simple random sampling. 28
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The design effect incorporates the intraclass correlation coefficient and thus inflates
the sample required to maintain statistical power and provide unbiased estimates
as compared to single-level studies.
Also, in growth curve modeling, both the outcome and growth parameters are
assumed to be normally distributed.14, 15 Deviations from normality can introduce
bias into the estimates of parameters. If the normality assumption is violated,
researchers must utilize any one of a number of transformations (e.g., Box-Cox
power transformation, natural logarithm) in order to generate valid results. 1, 29, 30
Due to the fact that levels of depressive symptoms generally exhibit positive
skewness, it was anticipated that a natural logarithm transformation would have
been required to satisfy the normality assumption.31,
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However, plots shown in

Appendix H show that the residuals are normally distributed in this study, thus no
transformation was required for analysis.
Furthermore, all time-varying variables (i.e., predictors and outcome) should be
measured equitably across all measurement occasions when implementing growth
curve modeling.15, 33 The pilot phase of a study is when measurement modification is
to be undertaken and not during data collection. Although researchers may be
tempted to alter measures, especially during a long study with many intervals of
data collection, the so-called “conditioning effects” observed in longitudinal studies
are negligible compared to the consequences of modifying measurement
instruments.34,

35

In HERQULES, which is the data source for this study, no

modification to the measurement instruments occurred during data collection.
A final consideration in using growth curve modeling considers the number of
measurement occasions. At a minimum, researchers must have at least one more
measurement occasion than unknown parameters in the level 1 model.33 For
example, in the level 1 model, there are two unknown parameters, the intercept, π 0i
and slope, π 1i , thus at least three measurement occasions are required. This is
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because with three measurement occasions, there remains one degree of freedom. If
only two measurement occasions were completed, the model would be considered
saturated and there would be no degrees of freedom; a straight line would connect
both measurement occasions. Continuing with this logic, if a researcher wanted to
include a third parameter in level 1 to model a quadratic function of time (i.e., π 2i ),
four measurement occasions would be required. The number of measurement
occasions must be critically examined prior to implementing a longitudinal study,
since feasibility issues may constrain subsequent analyses. HERQULES included four
measurement occasions which permitted modeling of non-linear change over time.
Data Analysis
Objective: Informant Bias
Determine if mothers of children with new-onset epilepsy exhibiting depressive
symptoms provide bias reports of child outcomes.
In order to address limitations associated with dichotomizing mothers as depressed
or non-depressed described by Richters and to ensure that results were not an
artifact based on other extraneous variables, moderation was assessed using
product terms in multiple regression analyses.36 Fifteen regression models were
conducted whereby the mothers’ report was the dependent variable [e.g., Quality of
Life in Childhood Epilepsy (QOLCE) (total)] and was regressed on the neurologists’
report [e.g., Global Assessment of Severity of Epilepsy (GASE)], mothers’ depressive
symptoms (Center for Epidemiological Studies Depression Scale, CES-D), and an
interaction term conceptualized as the product between neurologists’ report and
mothers’ depressive symptoms (i.e., GASE×CES-D). The product term is included to
determine whether the relationship between the mother report and the neurologist
report is moderated by the mother’s mental health status. A statistically significant
product term indicates that mothers with lower versus higher levels of depressive
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symptoms differ in the extent to which their reports are similar to neurologists’
reports.
For the functional status domain, the cognition subscale of the QOLCE was regressed
on a five-point (higher scores indicate better functioning) neurologist assessment of
child cognitive problems. As well, the QOLCE subscales physical restrictions and
energy/fatigue and the CHQ subscales role-physical and physical functioning were
regressed on a seven-point neurologist assessment of interference of epilepsy or
treatment with daily activities (higher scores indicating fewer disruptions). For
psychological functioning, the behavior subscale of the QOLCE and the roleemotional/behavior and behavior subscales of the CHQ were regressed on a fourpoint (higher scores indicate better functioning) neurologist assessment of child
behavior problems. To assess social functioning, the QOLCE subscales social
interactions, social activities and stigma were regressed on the neurologist
assessment of interference of epilepsy or treatment with daily activities. In terms of
disease state/symptoms, mother-reported overall QOLCE and CHQ (physical and
psychosocial) summary scores were regressed on the neurologist-reported GASE
(higher scores indicate less severity).
In the presence of a statistically significant product term, a conditional moderator
variable based on CES-D scores and the standard deviation of the sample was used
in subsequent post hoc regression analyses as described by Holmbeck to probe
interactions and further describe the effect of mothers’ depressive symptoms on
their reports.37 Briefly, high and low maternal depressive symptoms conditional
moderator variables are created by adding (HIGH_CESD) and subtracting
(LOW_CESD) the standard deviation from the mean CES-D score. New interaction
terms are computed by multiplying the neurologists’ report (NEURO) and the
conditional moderator (i.e., HIGH_INT = NEURO × HIGH_CESD and LOW_INT =
NEURO × LOW_CESD). Then, two post hoc regression models are run, each of which
include the NEURO main effect, one of the conditional depressive symptoms
moderator (HIGH_CESD or LOW_CESD), and the new interaction (HIGH_INT or
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LOW_INT). These regression models generate the slope for both the high depressive
symptoms and low depressive symptoms condition. The regression lines can then
plotted to visual the effect of depressive symptoms on maternal reports of child
health-related quality of life.
Objective: Prevalence and Trajectory
Estimate the prevalence and course of depressive symptoms over 24 months among
mothers of children with new-onset epilepsy.
Univariable analyses used to describe maternal depressive symptoms at each
measurement occasion included descriptive statistics and frequency distributions.
Bivariable analyses (i.e., t- and χ2-tests) were used to compare mothers who
completed the 24-month follow-up with those who did not complete the study.
Patterns of self-reported maternal depressive symptoms, as measured by the CES-D,
during the first 24 months after having a child diagnosed with epilepsy were
investigated with the semi-parametric, group-based approach developed by Nagin.7,
11

The group-based trajectory model is an example of a latent class model whereby a

polynomial function is used to model the relationship between depressive
symptoms and time. This approach estimates individual growth trajectories and
then identifies prototypical trajectories that best describe the data. The degree to
which an individual’s trajectory resembles the prototypic trajectory is estimated
and individuals are categorized into trajectory groups based on the similarity of the
individual trajectory to the prototypic trajectories. A censored normal model was
fitted to the data since there were a number of mothers who exhibited no or few
depressive symptoms, resulting in a cluster of data at the scale minimum. By
accounting for this censoring in specifying the likelihood function, the censored
normal model provides consistent estimates of the parameters that describe each
trajectory group. The number of groups to be included in the model is guided by a
priori expectations, overall model fit based on the Bayesian Information Criterion
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(BIC), and posterior probability scores for each trajectory group. The model with the
maximum BIC, optimized probability scores, and least number of groups is selected.
The modeling process followed the strategy of Campbell et al.3 whereby, cubic
trajectories were specified for three groups being examined and in order to ensure
parsimony, non-significant higher-order terms (i.e., quadratic and cubic) were
removed and the model was respecified until optimal fit was achieved. 38 Additional
groups were added to the model and the change in BIC scores examined to
determine the best model. The resulting model was considered unconditional since
no predictors, other than time (i.e., linear, quadratic, and cubic terms), were
included. Latent class growth modeling was conducted with PROC TRAJ as described
by Jones et al.13, 39
Objective: Risk Factors
Determine the risk factors that predict trajectory group membership among
mothers over 24 months.
Maternal, child, and family characteristics were compared across trajectory groups
using ANOVA for continuous variables and χ2-tests for categorical variables. To
avoid errors in statistical inference due to multiple testing, the Bonferroni
correction (α/18=0.003) was applied to hypothesis tests across trajectory groups.
Pairwise group contrasts (post hoc Scheffé or χ2-test, when appropriate) were
examined only if a statistically significant overall difference was observed across
trajectory groups.
Multinomial logistic regression was conducted to identify predictors of trajectory
group membership using baseline data. A backward, stepwise selection approach
using maternal, child, and family characteristics was utilized. Only variables that
were statistically significant in the bivariate comparisons were included in the
regression analysis. In order to generate a robust model, the condition for variables
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to enter and remain in the model was set at α=0.20.40 Continuous variables in the
model were categorized into quartiles to increase interpretability of the model.
Objective: Causal Modeling
Assess the family factors involved in the causal pathway between maternal
depressive symptoms and child health-related quality of life over 24 months.
Individual growth curve modeling was used to examine the impact of maternal
depressive symptoms on child HRQL during the 24-month follow-up.8 Individual
growth curve modeling is one of several approaches developed to handle the
violation of independence between repeated measures for individuals studied in
prospective cohort designs in order to produce robust and unbiased estimates. This
approach accounts for the violation of independence by specifying both intra- and
inter-individual equations, such that the structure of the data is conceptualized as
repeated measures clustered within individuals.8 Individual growth curve models
were analyzed following the guidelines described by Singer, which considered time
of assessment (in terms of months since child was diagnosed with epilepsy) and
maternal depressive symptoms as time-varying predictors of child health-related
quality of life.41 Both the model intercept and slope were specified as random effects
(i.e., differing for each individual in the sample). An unstructured variancecovariance matrix was specified which is the most heterogeneous type and requires
estimation of several parameters, thus additional degrees of freedom, but does not
constrain any pairwise comparisons within the matrix, allowing for additional
flexibility.1 Variables were centered on their respective sample means at 24 months
to improve interpretation of results.
To obtain unbiased estimates of effect, potential confounders were tested a priori to
the growth curve modeling. Potential confounders tested were maternal age, marital
status, employment status, education, parity, child age, child sex, seizure type, age of
onset, total number of anti-epileptic drugs, illness severity, behaviour problems,
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cognitive disability, motor dysfunction, and family income. Confounding was
determined by adding the variable to the model to examine the change in the effect
estimate. For the purposes of this study, a collapsibility criterion was used to
operationally define confounders as those variables, when entered in the model
resulted in a ≥10% change in the effect estimate of maternal depressive symptoms
on child health-related quality of life and was thus retained in the model.42
Moderation was examined by sequentially testing growth curve models of child
health-related quality of life regressed on maternal depressive symptoms in the
presence of each potential moderator using a product interaction term. To examine
whether family resources or perception of healthcare moderated the impact of
maternal depressive symptoms on child health-related quality of life the 24-month
follow-up, a two-way interaction between maternal depressive symptoms and the
moderator was entered in the model. A three-way interaction between maternal
depressive symptoms, the moderator, and time was entered to examine whether the
magnitude of the moderating effect varied over time. The moderation analyses
conformed to Kleinbaum’s Hierarchy Principle such that maternal depressive
symptoms and moderator main effects were included in the model assessing the
interaction term.43
The product of coefficients method described by MacKinnon et al. was used to
examine the potential mediating effects of family functioning and family demands
on the relationship between maternal depressive symptoms and child healthrelated quality of life as illustrated in Chapter Five (Figure 5.1).44 The product of
coefficients method has been shown to have more accurate type I error rates and
greater statistical power compared to the more traditionally employed causal steps
described by Baron and Kenny.45 Instead, the product of coefficients approach
involved estimating two growth curve models:
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And then computing the product of ̂ and ̂ to form the mediated or indirect effect.
The rationale behind this approach is that mediation is dependent upon the extent
to which the predictor impacts the mediator, α, and the extent to which the
mediator impacts the outcome, β. The proportion of the total effect that is mediated
was calculated using a ratio of the indirect effect, ̂ , divided by the total effect,
̂

̂ . Significance of the mediated effect was tested by dividing the product by its

standard error and compared to the standard normal distribution and by
construction of confidence intervals:

αβ  Z  α 2ς β2  β 2ς α2

The standard error of ̂ was calculated using the method described by Sobel:46

z

αβ
α 2ς β2  β 2ς α2

The Sobel method is the most commonly used approach to calculating the standard
error and has been shown to produce unbiased and statistically robust results. 44
Growth curve models used in the mediation analysis were adjusted for potential
confounding factors using the methods described by Li et al. in order to obtain
unbiased estimates of effect.47
Study Power
This study will use HERQULES as its framework for data analysis. At baseline, 339
individuals were enrolled in the study. Due to the novel contribution of this
research, there is a lack of prior information required for calculating an appropriate
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sample size. Baseline data were used to determine the precision in which the mean
score on the CES-D can be estimated. The calculations were based on the squareroot transformation of baseline CES-D scores in order to satisfy the assumption of
normality.
Since this study implemented growth curve modeling, several pieces of information
were required in order to determine the precision of estimates.28 First, the
intraclass correlation coefficient is needed to determine the magnitude of the design
effect that will be applied to equation. The intraclass correlation coefficient is given
by the following equation:

ρ

MS B  MSW
MS B  k  1MSW

where, MSB is the mean squared
error between groups;
MSW is the mean squared
error within groups; and,
k is the mean number of
subjects per clinical site

Conducting an ANOVA and substituting into the equation resulted in an intraclass
correlation coefficient of ρ=0.017. Next, the design effect introduced by deviating
from a simple random sampling strategy was determined with the following
equation for multilevel analyses:

DEFF  1  n  1ρ
Substituting values into the equation resulted in a design effect of 1.102. Finally,
using estimates of population parameters of CES-D scores from HERQULES (μ=14.6;
ς=10.6) and previous studies,48, 49 the precision of the estimate of mean CES-D score
was calculated with the following equation:
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p  DEFF 

Z 1α 2  ς
N μ

where, Z1-α/2 is the level of confidence;
ς is the population standard
deviation;
μ is the population mean; and,
N is the number of baseline
mothers in HERQULES

Based on the number of individuals participating in HERQULES at baseline, the
estimate of maternal depressive symptoms can fall within 3% of the population
mean CES-D score.
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Table E.1. Definition and Interpretation of Parameters in the Level 1 Model.
Illustrative
Symbol Definition
Interpretation
Fixed effects
Intercept of the true change
Individual i’s true value of
 0i
trajectory for individual i in
child health-related
the population
quality of life at time 1
(i.e., true initial status)
Slope of the true change
Individual i’s rate of
 1i
trajectory for individual i in
change in true child
the population
health-related quality of
life (i.e., true rate of
change between
measurement occasions)
Variance
component

 2

Level 1 residual variance
across all occasions of
measurement, for individual i
in the population

Adapted from Singer and Willett.8

Summarizes the net
(vertical) scatter of the
observed data around
individual i’s
hypothesized change
trajectory
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Table E.2. Definition and Interpretation of Parameters in the Level 2 Model.
Illustrative
Symbol Definition
Interpretation
Fixed effects
Population average of the
Population average true
 00
initial status for females
level 1 intercepts,  0i , for
(reference category)
individuals with a level 2
predictor value of 0

Variance
components

 01

Population average difference
in level 1 intercept,  0i , for a
one-unit difference in the
level 2 predictor

Difference in population
average true initial status
between females and
males

 10

Population average for the
level 1 slopes,  1i , for
individuals with a level 2
predictor value of 0

Population average rate
of true change for females

 11

Population average difference
in level 1 slope,  1i , for a oneunit difference in the level 2
predictor

Difference in population
average rate of true
change between females
and males

 02

Level 2 residual variance in
true intercept,  0i , across all
individuals in the population

Population residual
variance of true initial
status, controlling for
gender

 12

Level 2 residual variance in
true slope,  1i , across all
individuals in the population

 01

Level 2 residual covariance
between true intercept,  0i ,

Population residual
variance of true rate of
change, controlling for
gender
Population residual
covariance between true
initial status and true rate
of change, controlling for
gender

and true slope,  1i , across all
individuals in the population
Adapted from Singer and Willett.8
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Appendix F
Sample Characteristics and Attrition
Introduction
Measurement occasions were not based on empirical evidence of depressive
symptom trajectories; instead data collection was guided by the clinical course of
epilepsy and associated follow-up appointments with paediatric neurologists.
However, it is believed that the measurement occasions were close enough together
to avoid missing potential fluctuations in maternal depressive symptoms and
distanced enough to allow for sufficient time to detect important changes. Three
assessments were completed in the first 12 months since during this time maternal
and family factors and clinical management of epilepsy are hypothesized to be
relatively dynamic. In the second year, circumstances are believed to stabilize and
thus an assessment at 24 months was deemed appropriate.
Sample Characteristics
Characteristics of the study sample at diagnosis (baseline), and 6, 12, and 24 months
are shown in Table F.1. Briefly, mothers were generally married, employed, and had
obtained post-secondary education. Children generally had partial seizures, good
health-related quality of life, less severe epilepsy. There were approximately equal
numbers of males and females and relatively few children had cognitive, behaviour,
or motor comorbidities. Families were generally functioning well, had adequate
resources, few demands, and had high-income.
Attrition
This study had relatively low attrition with 76% of individuals completing all four
measurement occasions. A total of 81 individuals were lost during the follow-up (27
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between baseline and six months; 31 between 6 and 12 months; and, 23 between 12
and 24 months). Mothers with higher levels of depressive symptoms and other risk
factors for clinical depression1 were less likely to complete the 24-month follow-up
compared to mothers who did not exhibit such traits (Chapter 4). A similar trend
has been observed in other research of mothers with depressive symptoms. 2, 3 This

CES-D Score

is shown in Table F.1 and Figure F.1.

Attrition Status

Figure F.1. Examining Attrition in HERQULES. Mothers who did not complete the
24-month follow-up (attrition=1), were observed to have higher scores on the
Center for Epidemiological Studies Depression Scale (CES-D).
Using individual growth curve modeling (Appendix E), attrition status was observed
to be positively associated with depressive symptoms, but this relationship was
negated when controlling for the potential confounding effects of maternal and
family characteristics (Table F.2). Bias due to losses during follow-up may underestimate the proportion of mothers at risk. When baseline characteristics of
mothers who did not complete the study were compared to characteristics from
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each trajectory group, results showed that those lost during follow-up most closely
resembled the moderate increasing group (Chapter 4).
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Table F.1. Description of Maternal, Child, and Family Characteristics at each Measurement Occasion during the 24Month HERQULES Follow-up.
Baseline
6 Months
12 Months
24 Months
Sample Size
339
312
281
258
Maternal Characteristics
Age, years
Marital Status, %
Not Married
Married*
Employment Status, %
Not Employed
Employed
Homemaker
Student
Education, %
Primary School
High School
Technical Training
College/University
Number of Children
Depressive Symptoms, CES-D
Child Characteristics
Age, years
Sex, %
Male
Female
Seizure Type, %
Generalized

37.7 (5.8)

28.5 (5.7)

39.2 (5.7)

40.4 (5.5)

19.8
80.2

20.0
80.0

19.3
80.7

18.1
81.9

9.5
66.1
22.9
1.5

8.3
70.2
19.5
2.0

4.7
74.4
18.8
2.2

6.6
77.7
15.2
0.4

11.5
20.9
13.6
54.0
2.3 (0.9)
14.6 (10.6)

8.1
20.6
11.5
59.8
2.3 (0.9)
11.7 (9.5)

6.5
19.1
13.3
61.2
2.3 (0.9)
12.2 (9.7)

5.0
19.2
11.9
63.9
2.3 (0.9)
12.0 (10.0)

7.4 (2.4)

7.9 (2.4)

8.4 (2.4)

9.4 (2.4)

52.2
47.8

51.3
48.7

50.9
49.1

51.6
48.4

38.6

39.7

39.2

37.3
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Partial
Health-related Quality of Life, QOLCE
Epilepsy Severity, GASE
Co-morbidities, %
Behavior Problems
Cognitive Problems
Motor Problems

61.4
70.4 (13.4)
5.4 (1.2)

60.3
74.0 (13.0)
6.0 (1.1)

60.8
74.9 (13.4)
6.1 (1.1)

62.7
75.9 (13.9)
6.3 (1.0)

14.1
13.6
6.3

21.2
14.1
6.8

19.1
15.1
7.7

20.0
17.5
5.7

14.1 (3.6)
51.0 (10.9)
NM
NM

14.0 (3.9)
50.5 (11.4)
8.1 (6.1)
1.6 (0.6)

14.1 (3.8)
50.7 (11.5)
7.9 (5.8)
1.6 (0.6)

8.5
13.3
19.1
16.4
40.6
2.1

5.2
13.9
16.9
16.5
43.8
3.8

4.0
10.0
18.8
18.4
44.0
4.8

Family Characteristics
Functioning, Family APGAR
14.0 (3.8)
Resources, FIRM
50.1 (11.1)
Demands, FILE
9.6 (6.5)
Perception of Patient-centered Care, PPPC
1.6 (0.5)
Annual Household Income, %
< $20,000
7.7
$20,000-39,999
13.5
$40,000-59,999
21.2
$60,000-79,999
18.2
≥ $80,000
37.2
Unknown
2.2
Reported as mean (standard deviation), unless otherwise stated.
NM, not measured.
*Includes mothers in married and common-law relationships.
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Table F.2. Growth Models for the Impact of Attrition on Maternal Depressive
Symptoms.
Model A
Model B
Model C
Fixed Effects
Final Status
Intercept
12.60 (0.57)*
12.46 (0.56)*
12.20 (0.45)*
Attrition Status
4.41 (1.18)†
3.10 (1.12)‡
0.76 (1.03)§
†
Age
-0.28 (0.07)
-0.25 (0.06)*
Education
-1.10 (0.35)‡
-0.87 (0.31)‡
*
Employment Status
-2.05 (0.49)
-1.60 (0.51)‡
Marital Status
3.46 (0.92)†
0.83 (0.85)§
Functioning
-0.39 (0.09)*
Resources
0.39 (0.06)*
Demands
-0.28 (0.03)*
Rate of Change
Time
-0.26 (0.15)§
-0.10 (0.16)§
-0.15 (0.14)§
Variance Components
Level 1
Intra-individual
Level 2
Final Status
Rate of Change
Covariance

38.54 (2.29)*

38.07 (2.32)*

32.88 (2.30)*

56.72 (8.02)*
1.64 (0.59)‡
1.91 (1.73)§

49.06 (7.43)*
1.49 (0.59)‡
2.44 (1.71)§

18.38 (5.00)†
0.44 (0.56)§
-1.22 (1.30)§

Goodness-of-Fit
Deviance
8364.9
7974.1
5649.0
Values denote β-coefficient (standard error). Model A is the unconditional growth
model; Model B is the semi-conditional growth model, controlling for maternal
factors (age, education, employment, and marital status); Model C is the fully
conditional growth model, controlling for maternal and family factors (functioning,
resources, and demands).
*p<0.0001, †p<0.001, ‡p<0.01, §p<0.05
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Appendix G
Growth Curve Modeling and Intraclass Correlation
Introduction
As discussed in the methodological details of the study (Appendix A), there is
potential for clustering effects that may introduce biased effects estimates if not
appropriately accounted for in the analyses. Since subjects were recruited from
paediatric neurology clinics across Canada, analyses may require a three-level
approach, whereby repeated measures on individuals were clustered at the
recruitment site. Thus, there is potential for intra-individual, inter-individual, and
inter-site variation that must be addressed.
Intraclass Correlation
If it is the case that a three-level model is correct, clustering effects must be
addressed since individuals within clusters are more likely to be similar with
respect to the variables of interest compared to those individuals in other clusters.1
It is this violation of the assumption of independence that can result in biased
estimates.1 The intraclass correlation coefficient (ICC) is a measure of the degree of
dependence of individuals and can be used to determine whether clustering effects
were present in the data.2 An equation for the ICC is given as:3



MS B  MSW
MS B  k  1MSW

where, MSB is the mean squared
error between groups;
MSW is the mean squared
error within groups; and,
k is the mean number of
subjects per clinical site

There are differing views regarding when an ICC is large enough that it must be
included in the analyses. Kreft and de Leeuw suggest that an ICC less than 0.1 may
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be safely ignored,2 whereas others such as Barcikowski, note that even a small ICC
can have substantial effects on significance tests especially when the number of
individuals within a cluster is large.4 Given the discrepancies highlighted, a formal
test of the ICC was conducted using the equation below:3

Fg1 , g k 1  

1  k  1
1 

where, k is the mean number of
subjects per clinical site; and,
g is the number of clinical
sites

The ICC was calculated using analysis of variance of maternal depressive symptom
scores, based on the Center for Epidemiological Studies Depression scale, across
recruitment sites at each measurement occasion. An F-test was then used to
determine the statistical significance of the ICC.
Table G.1 displays the results of the analysis. Since the calculated F-statistics were
not more extreme than the critical F-value, F*, the results suggest that no clustering
effects at the level of recruitment site were present in the data. In addition, since the
number of individuals per cluster was relatively small, the ICCs were ignored for all
analyses. As a result, two-levels (level 1, intra-individual; level 2, inter-individual)
were used in all analytic models. The violation of independence due to repeated
measures on the same individual over time is accounted for with the use of PROC
MIXED and PROC TRAJ, resulting in unbiased effect estimates.5, 6
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Table G.1. Parameters Involved in Estimating Potential Clustering Effects.
MSB
MSW
k
g
ICC
F
Time 1
113.20
111.02
7
49
0.003
1.02
Time 2
66.05
91.32
6
49
-0.048
0.73
Time 3
105.43
98.49
6
49
0.012
1.07
Time 4
70.46
106.97
5
49
-0.073
0.66
See text and equations for definitions of abbreviations.

F*
1.40
1.41
1.41
1.42
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Appendix H
Tenability of Modeling Assumptionsa
Evaluation of modeling assumptions required for individual growth curve modeling
followed the suggestions described by Singer and Willet.1
The assumption of functional form (i.e., linearity) was examined by inspecting level
1 and level 2 plots of the outcome and predictors. At level 1, ordinary least squaresestimated individual growth trajectories were superimposed on empirical growth
plots of health-related quality of life for all individuals. A random sample of these
plots is shown in Figure H.1. The hypothesis of linear individual change seemed
reasonable for the subjects shown, except for subject 8406, with which there may be
evidence of quadratic change. It is however, difficult to argue for systematic
deviation from linearity for this individual given that the departure observed might
be attributable to measurement error. Inspection of empirical growth plots for all
individuals in the study led to similar conclusions. At level 2, examination of the
level 2 assumption of linearity was facilitated by plotting ordinary least squares
estimates of the individual growth parameters (i.e., intercept and slope) against the
level 2 predictor, maternal depressive symptoms, as measured with the Center for
Epidemiological Studies Depression Scale (CES-D). As shown in Figure H.2, the data
suggested a strong linear relationship between the individual growth parameters
and maternal CES-D scores.
The assumption of normality was explored using normal probability plots at both
levels 1 and 2, as well as frequency distribution curves. In addition, plots of
standardized level 2 residuals against maternal depressive symptoms were also
examined to assess normality. Plots of standardized residuals against subject ID
were also examined to identify potential extreme individuals in the data. As shown
aDue

the number of figures in this Appendix, they are shown sequentially at the end of the Appendix
rather than within the text.
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in Figures H.3 and H.4, the normal probability plots at levels 1 and 2 appear linear,
indicating that the normality assumption was satisfied. This is supported with the
histograms in Figures H.5 and H.6 that exhibit normally distributed residuals at
levels 1 and 2. Although the normal probability plot for residuals of the level 2
intercepts appeared somewhat bent, individual growth curve modeling is an
analytic technique that can handle deviations from normality and still provide
robust conclusions.1 Plots of standardized level 2 residuals against maternal CES-D
scores are shown in Figure H.7. These plots provide additional evidence for the
normality assumption since approximately 95% of the standardized residuals lie
within ±2 standard deviations of their center. Figures H.8 and H.9 show plots of
standardized residuals against subject ID. Again, the results appeared to conform to
normal theory assumptions since the vast majority lie within ±2 standard deviations
of their centers at both level 1 and level 2.
The assumption of homoskedasticity was investigated by plotting level 2 raw
residuals against maternal CES-D scores. As shown in Figure H.10, the assumption
appeared to hold since residual variation was approximately equal across values of
the CES-D for both the intercept and slope.
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Subject 514

Subject 1102

Subject 2004

Subject 2303

QOLCE = 83.24 + 7.61t

QOLCE = 79.71 – 5.95t

QOLCE = 60.97 + 1.37t

QOLCE = 90.34 + 6.52t

Subject 4514

Subject 6715

Subject 7211

Subject 8406

QOLCE = 82.62 + 0.08t

QOLCE = 80.48 + 1.70t

QOLCE = 93.40 + 4.79t

QOLCE = 79.44 + 0.13t

Figure H.1. Examination of the Level 1 Linearity Assumption. A random sample of ordinary least squares-estimated
individual growth trajectories were superimposed on empirical growth plots of child health-related quality of life scores, as
measured with the Quality of Life in Childhood Epilepsy (QOLCE) over 24 months. The solid line represents a fitted regression
trajectory, dotted lines represent the probability that the population trajectory falls between the bands, while the shaded
region depicts the 95% confidence intervals.
t, time, centered at 24 months.
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Figure H.2. Examination of the Level 2 Linearity Assumption. Ordinary least squares-estimated individual growth
parameters (left, intercept; right, slope) plotted against the level 2 predictor, maternal CES-D scores. Both plots suggested a
strong linear relationship between the QOLCE intercept (r=-0.40, p<0.0001) and slope (r=-0.31, p<0.0001) with maternal CESD scores. CES-D, Center for Epidemiological Studies Depression Scale; QOLCE, Quality of Life in Childhood Epilepsy.
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Figure H.3. Level 1 Normal Probability Plot. The “S” shape in the plot suggests
that there was slightly more variance than would be expected for completely
normally distributed data. However, the linear component of the plot suggests that
the normality assumption is satisfied at level 1.
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Figure H.4. Level 2 Normal Probability Plots (left, intercept; right, slope). The intercept plot displays a slight bend
indicating a left skew in the data (further evidence is shown in Figure H.6) and the slope plot shows a similar shape to the level
1 residual plot. Again, these slight deviations from linearity in the normal probability plot were not extreme enough to violate
the normality assumption.
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Figure H.5. Histogram of Level 1 Standardized Residuals. As a complement to
Figure H.3, level 1 residuals appeared normally distributed.
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Figure H.6. Histogram of Level 2 Residuals (left, intercept; right, slope). As a complement to Figure H.4, level 2 residuals
for the intercept and slope appeared normally distributed.
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Figure H.7. Standardized Level 2 Residuals Plotted against Maternal CES-D
Score (top, intercept; bottom, slope). These plots provide further evidence for
assuming normality in the data at level 2 since approximately 95% of the data lie
within ±2 standard deviations from the center. CES-D, Center for Epidemiological
Studies Depression Scale.
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Figure H.8. Standardized Level 1 Residuals Plotted against Subject ID. There
appeared to be no extreme individuals in the data at level 1, supporting normal
theory.
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Figure H.9. Standardized Level 2 Residuals Plotted against Subject ID (top,
intercept; bottom, slope). There appeared to be no extreme individuals in the data
at level 2, supporting normal theory.
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Figure H.10. Examination of the Level 2 Homoscedasticity Assumption (top,
intercept; bottom, slope). Plots of the raw residuals of level 2 growth parameters
showed that the homoskedasticity assumption was not violated. Residual variances
were similar across all values of the Center for Epidemiological Studies Depression
Scale (CES-D).
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Appendix I
Identification and Treatment of Outliers
Introduction
Outliers were examined prior to conducting all growth curve models. An outlier is
any rare or unusual observation that appears at one extreme of the data range.1
They are important to the extent that they influence the size and precision of
estimated β-coefficients. The covariance ratio (COVRATIO) and MDFITS statistics
were used to evaluate whether outliers were influential.
Identification of Outliers
The COVRATIOi statistic measures the role of the ith subject on the precision of
estimation.2 Subjects with a COVRATIO >1 improves precision, whereas subjects
with a COVRATIO <1 will improve precision if removed from the model. 2 Subjects
were investigated for which:

COVRATIO i  1 

COVRATIO i  1 

3  1  k 
n

where, k is the number of regression
coefficients; and,
n is the number of subjects

3  1  k 
n

For this study, COVRATIO statistics that fell outside the range of 0.95 and 1.05 were
investigated as potentially influential. As shown in Table I.1, seven subjects in the
study sample had COVRATIO values that were outside the range. For brevity, only
those subjects that were potentially influential were included in the table. Subjects
511, 1102, 1303, and 6213 had COVRATIO values that were borderline outside the
range, whereas subjects 2227, 2404, and 8602 had values that were well outside the
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range. These results are illustrated in Figure I.1, which plots COVRATIO statistics
against subject ID.

COVRATIO

1.05
1.00

0.95
0.90
0

100

200

300

Deleted Level of Subject ID
Figure I.1. Plot of COVRATIO Statistics against Subject ID. The plot shows seven
potential outliers that may also be influential in the data.
The MDFITSi statistic is the multivariate DFITSi statistic that measures the
difference between predicted values estimated using all subjects and predicted
values obtained by the refitted model omitting the ith subject.2 Large (absolute)
MDFITS statistics indicate potentially influential subjects. Subjects were
investigated for which:

MDFITSi  2

1  k 
n

where, k is the number of regression
coefficients; and,
n is the number of subjects
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For this study, MDFITS >0.25 were investigated as potentially influential. No
subjects in the study sample were observed to have a MDFITS value indicative of
being influential.
Plots of standardized residuals by individuals were also used to identify outliers in
the data. As described in Appendix H, no outliers were observed at level 1 and level
2 using this approach.
Treatment of Outliers
Diagnostics were intended to identify subjects deserving of more careful scrutiny.
Raw data for each of the seven subjects identified (using COVRATIO and MDFITS
statistics) were reviewed and none of the variables associated with each subject was
outside of the realm of possibility. Growth models that sequentially deleted of each
of the identified subjects were conducted and results of the reduced model were
compared to the full model.2 There were no significant differences between the
seven reduced models and the full model (data not shown). A final reduced model
that removed all seven of the identified subjects was then specified and compared to
the full model.2 Again, there were no significant differences between the reduced
and full models.
Comparing results from the original and outlier analysis, Table I.2 shows that the
proportion of individuals in each trajectory group was similar to the original
analysis [group 1 (low stable): 59.3% vs. 59.9%; group 2 (borderline): 25.1% for
both; group 3 (moderate increasing): 8.6% vs. 9.1%; and, group 4 (high decreasing):
7.1% vs. 5.8%]. Also, the parameter estimates and associated standard errors were
nearly identical. As a result, the trajectories illustrated in Figure I.2 remain
unchanged from the original analysis.
Similarly, in the analysis examining the impact of maternal depressive symptoms on
child health-related quality of life, the parameter estimates and standard errors for
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the growth models’ fixed effects and variance components were very similar (Table
I.3). Trajectories of child health-related quality of life did not significantly deviate
from the original model (Figure I.3). The models with potential outliers removed did
exhibit better goodness-of-fit based on the deviance statistic; however, this is
inadequate to suggest that these individuals be removed from all analyses. Thus, it
was concluded that none of the identified subjects was influential and were thus
retained in all analyses.
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Figure I.2. Trajectories of Maternal Depressive Symptoms during the First 24
Months after having a Child Diagnosed with Epilepsy with Potential Influential
Subjects Removed. Solid lines depict observed trajectories (mean CES-D score) and
dashed lines predicted trajectories. CES-D, Center for Epidemiological Studies
Depression Scale.
It is important to note that this outlier and influence analysis was performed under
the assumption that the chosen model is correct. Changing the model structure can
alter the conclusions. For example, modeling these data with a fixed slope for each
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individual or using an autoregressive covariance matrix may affect the conclusions
about which individuals are influential on the analysis and how this influence
manifests itself.
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Figure I.3. Change in Child Health-related Quality of Life over 24 Months with
Potential Influential Subjects Removed. Child health-related quality of life was
measured using the QOLCE. The solid line represents the trajectory for children of
average mothers; the dotted line represents the trajectory for children of mothers
with a CES-D score in the bottom 5%; and, the dashed line represents the trajectory
for children of mothers with a CES-D score in the top 5%. CES-D, Center for
Epidemiological Studies Depression Scale; QOLCE, Quality of Life in Childhood
Epilepsy.
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Table I.1. Influence Diagnostics for Levels of Subject ID.
Influence Statistics
Subject ID
COVRATIO
511
0.9489
1102
1.0527
1303
1.0540
2227
0.9325
2404
0.9354
6213
1.0555
8602
0.8995

MDFFITS
0.01747
0.01685
0.00872
0.02431
0.02393
0.03087
0.05496
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Table I.2. Parameter Estimates for the Four-group Trajectory Model of
Depressive Symptoms in Mothers of Children with Epilepsy during the First 24
Months after Diagnosis with Potential Influential Subjects Removed.
Standard
Group % Sample Parameter
Estimate
t
P-value
Error
1
59.9
Intercept
14.0
1.8
7.9
<0.0001
Linear
-8.4
2.5
-3.3
0.0008
Quadratic
2.8
1.0
2.8
0.0058
Cubic
-0.3
0.1
-2.4
0.0165
2

25.1

Intercept
Linear
Quadratic
Cubic

34.9
-25.3
10.2
-1.2

3.4
4.6
1.9
0.2

10.4
-5.5
5.5
-5.6

<0.0001
<0.0001
<0.0001
<0.0001

3

9.1

Intercept
Linear
Quadratic

30.7
-8.9
1.9

1.8
1.5
0.2

16.6
-6.0
7.6

<0.0001
<0.0001
<0.0001

4

5.8

Intercept
41.1
1.3
31.0
<0.0001
Linear
-4.3
0.4
-11.4
<0.0001
Group 1 represents mothers with low stable depressive symptoms, Group 2
borderline symptoms, Group 3 moderate increasing symptoms, and Group 4 high
decreasing symptoms.
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Table I.3. Growth Models for the Impact of Maternal Depressive Symptoms on
Child Health-related Quality of Life with Potential Influential Subjects
Removed.
Model A
Model B
Model C
Fixed Effects
Final Status
Intercept
73.28 (0.68)*
75.87 (0.85)*
75.98 (0.72)*
CES-D
-0.44 (0.05)*
Rate of Change
Time
1.03 (0.18)*
0.95 (0.15)*
CES-D × Time
-0.04 (0.02)†
Variance Components
Level 1
Intra-individual
Level 2
Final Status
Rate of Change
Covariance

50.52 (2.60)*

38.36 (2.43)*

42.54 (2.37)*

130.03 (11.72)*

171.69 (18.13)*
3.41 (0.78)*
12.32 (3.04)*

103.70 (9.90)*
0.04 (0.02)†
0.17 (0.38)‡

Goodness-of-Fit
Deviance
8028.2
7950.3
7744.7
Values denote β-coefficient (standard error). Model A is the unconditional means
model; Model B is the unconditional growth model; Model C is the growth model
conditional on maternal depressive symptoms.
*p<0.0001, †p<0.05, ‡not significant
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Appendix J
Examination of Confounding Variables
Examination of potential confounding variables in the moderation and mediation
analyses in the impact of maternal depressive symptoms on child health-related
quality of life followed the suggestion of Rothman and Greenland.1 To obtain
unbiased estimates of effect, potential confounders were tested a priori to the
growth curve modeling. Potential confounders tested were maternal age, marital
status, employment status, education, parity, child age, child sex, seizure type, age of
onset, total number of anti-epileptic drugs, illness severity, behaviour problems,
cognitive disability, motor dysfunction, and family income.
Confounding was determined by adding the variable to the model to examine the
change in the effect estimate. For the purposes of this study, a collapsibility criterion
was used to operationally define confounders as those variables, when entered in
the model that resulted in a ≥10% change in the effect estimate of maternal
depressive symptoms on child health-related quality of life and would then be
retained in the model:1
βunadjusted  βadjusted
βadjusted

 100%

Changes in β–coefficients in the presence of confounding variables are presented in
Table J.1. Potential confounding variables were tested in each growth curve model
used in the moderation and mediation analyses. Results suggested that no variable
examined met the collapsibility criterion for definition as a confounding factor. Thus
all analyses investigating the impact of maternal depressive symptoms on child
health-related quality of life conducted did not control for any other maternal, child,
or family characteristic.
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Table J.1. Change in β-coefficients in the Presence of Potential Confounding Variables for Moderation and Meditation
Analyses.
CES-D1
CES-D2
FILE3
CES-D4
Family APGAR5
Unadjusted
-0.4654
0.2703
-0.6897
-0.1143
0.8748
Maternal Age, years
-0.4591 (1.4)
0.2738 (1.3)
-0.6830 (1.0)
-0.1162 (1.7)
0.8721 (0.3)
Marital Status
-0.4556 (2.1)
0.2689 (0.5)
-0.6606 (4.2)
-0.1128 (1.3)
0.8485 (3.0)
Employment Status
-0.4514 (3.0)
0.2695 (0.3)
-0.6758 (2.0)
-0.1125 (1.6)
0.8803 (0.6)
Education
-0.4637 (0.4)
0.2707 (0.1)
-0.6811 (1.2)
-0.1122 (1.8)
0.8959 (2.4)
Parity
-0.4709 (1.2)
0.2703 (0.1)
-0.6966 (1.0)
-0.1145 (0.2)
0.8707 (0.5)
Child Age, years
-0.4653 (0.1)
0.2698 (0.2)
-0.6867 (0.4)
-0.1146 (0.3)
0.8639 (1.2)
Child Sex
-0.4678 (0.5)
0.2737 (1.3)
-0.6926 (0.4)
-0.1132 (1.0)
0.8983 (2.7)
Seizure Type
-0.4781 (2.7)
0.2755 (1.9)
-0.6996 (1.4)
-0.1171 (2.4)
0.9314 (6.5)
Onset Age, years
-0.4609 (1.0)
0.2724 (0.8)
-0.6737 (2.3)
-0.1124 (1.7)
0.9030 (3.2)
Total AEDs
-0.4662 (0.2)
0.2764 (2.3)
-0.7127 (3.3)
-0.1220 (6.7)
0.8722 (0.3)
Illness Severity, GASE
-0.4236( 9.0)
0.2724 (0.8)
-0.7027 (1.9)
-0.1201 (5.1)
0.8836 (1.0)
Behaviour Problems
-0.4761 (2.3)
0.2724 (0.8)
-0.7400 (7.3)
-0.1203 (5.2)
0.9037 (3.3)
Cognitive Disability
-0.4759 (2.3)
0.2744 (1.5)
-0.7566 (9.7)
-0.1188 (3.9)
0.8754 (0.1)
Motor Dysfunction
-0.4764 (2.4)
0.2797 (3.5)
-0.7450 (8.0)
-0.1182 (3.4)
0.8674 (0.8)
Family Income
-0.4277 (8.8)
0.2517 (7.4)
-0.6463 (6.7)
-0.1111 (2.9)
0.8129 (7.6)
Values denote β (Δ%).
AEDs, anti-epileptic drugs; CES-D, Center for Epidemiological Studies Depression Scale; Family APGAR, Family Adaptability,
Partnership, Growth, Affection, Resolve; FILE, Family Inventory of Life Events and Changes; GASE, Global Assessment of
Severity of Epilepsy; QOLCE, Quality of Life in Childhood Epilepsy.
1QOLCE regressed on CES-D (XY)
2FILE regressed on CES-D (XM)
3QOLCE regressed on FILE (MY)
4Family APGAR regressed on CES-D (XM)
5QOLCE regressed on Family APGAR (MY)
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